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Abstract
One of the important challenges in Systems Biology is reasoning and per-
forming hypotheses testing in uncertain conditions, when available knowledge
may be incomplete and the experimental data may contain substantial noise.
In this thesis we develop methods of probabilistic reasoning and inference
that operate consistently within an environment of uncertain knowledge and
data. Mechanistic mathematical models are used to describe hypotheses about
biological systems.
We consider both deductive model based reasoning and model inference from
data. The main contributions are a novel modelling approach using continuous
time Markov chains that enables deductive derivation of model behaviours and
their properties, and the application of Bayesian inferential methods to solve the
inverse problem of model inference and comparison, given uncertain knowledge
and noisy data.
In the ﬁrst part of the thesis, we consider both individual and population
based techniques for modelling biochemical pathways using continuous time
Markov chains, and demonstrate why the latter is the most appropriate. We
illustrate a new approach, based on symbolic intervals of concentrations, with
an example portion of the ERK signalling pathway. We demonstrate that the
resulting model approximates the same dynamic system as traditionally deﬁned
using ordinary diﬀerential equations. The advantage of the new approach is
quantitative logical analysis; we formulate a number of biologically signiﬁcant
queries in the temporal logic CSL and use probabilistic symbolic model checking
to investigate their veracity.
In the second part of the thesis, we consider the inverse problem of model
inference and testing of alternative hypotheses, when models are deﬁned by
non-linear ordinary diﬀerential equations and the experimental data is noisy
and sparse. We compare and evaluate a number of statistical techniques, and
implement an eﬀective Bayesian inferential framework for systems biology based
on Markov chain Monte Carlo methods and estimation of marginal likelihoods
by annealing-melting integration. We illustrate the framework with two case
studies, one of which involves an open problem concerning the mediation of
ERK phosphorylation in the ERK pathway.3
Computer Science is no more
about computers than
astronomy is about telescopes.
Edsger Dijkstra4
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Introduction
Overview
In this chapter we give a general background to the thesis and provide
motivation for our work. We brieﬂy describe the beneﬁts of our work.
1.1 Challenges of Systems Biology
Systems Biology is a discipline of science which studies biological systems and
their behaviour in an integrative way, using methods of mathematical modelling
and analysis.
Burbeck and Jordan (2006) emphasise the central challenge of Systems Bi-
ology to assist in understanding how the various parts of a biological system ﬁt
and function together, and provide a list of major themes and focus areas which
have emerged in Systems Biology:
• Modelling. Descriptive mathematical models are built to summarise and
organise data.
• Simulation. Mathematical models are built to use researchers’ knowledge
about the parts of a biological system to better understand the implications
of their interactions.
• Automated analysis. Automated analysis techniques to make inferences
and predictions from accumulated knowledge and data.
14CHAPTER 1. INTRODUCTION 15
• Integration of computational biology and experimental biology. Compu-
tational results are used to guide new experimentations followed by addi-
tional computational analysis and modelling of the new data.
All these themes play an important role in shaping Systems Biology, and a
cyclic workﬂow from experimentations to computational analysis and back to
experimentalists is a commonly accepted way to unravel the complexities of
biological systems.
We consider Systems Biology as a methodological framework to operate on
knowledge, experimental data, and hypotheses about biological systems, and
assist in the development of a uniﬁed understanding of the involved biological
processes.
In the scope of this thesis we concentrate our eﬀorts on methods for compu-
tational analysis of biological data and knowledge in conditions of uncertainty.
We focus on biochemical pathways and networks for practical applications for
the methods considered in this thesis.
To establish the cyclic workﬂow between computational analysis and bio-
chemical experimentation, we consider the methods of interest within the sci-
entiﬁc method paradigm. The scientiﬁc method is a body of techniques for
investigating phenomena and acquiring new knowledge, as well as for correcting
and integrating with previous knowledge. It is based on gathering observable,
empirical, measurable evidence, subject to principles of reasoning. Having the
roots in ancient philosophy, it was preconditioned by the works by Sir Francis
Bacon, Ren´ e Descartes, and ﬁrst formally introduced by Newton.
The scientiﬁc method suggests the following guideline for the research:
1. Formulate hypotheses;
2. Perform experiments and collect evidence;
3. Analyse the collected evidence and test the hypotheses formulated at the
ﬁrst step;
4. Interpret the result and draw conclusions that serve as a starting point for
new hypotheses.
Sir Harold Jeﬀreys’ book on Scientiﬁc Inference (Jeﬀreys 1937) argues for
reasoning on probability inversion, the basis of what is known today as BayesianCHAPTER 1. INTRODUCTION 16
inference; this book emphasises the consistency of Bayesian inferential methodol-
ogy with the scientiﬁc method, and demonstrates many examples from diﬀerent
areas of science on how this method is applied to provide sound and consistent
evidential reasoning.
One of the important features in the life sciences is that there can be many
competing hypotheses and corresponding models to explain some phenomenon.
When evidence is collected all these competing hypotheses have to be tested.
We propose to represent such competing hypotheses with mathematical models,
and employ formal methods for the analysis and comparison of such models.
This thesis focuses on methods of formal reasoning and inference which allow
knowledge and hypotheses to be operated in a natural and sound way according
to established scientiﬁc method.
1.2 Models as Knowledge Representation
Mathematical models are used to represent knowledge and hypotheses about the
structure and dynamics of a biological system. Generally speaking, there are two
meta-approaches to biological systems modelling. The ﬁrst one is data-driven
modelling, and the second one is mechanistic modelling.
A data-driven modelling approach means that the main goal of the mod-
els is to mimic the observed behaviour of the model. Such models are often
quantitative, and their main advantage is a precise simulation of the observed
dynamic behaviour of the biological system. An example of a data-driven model
is described in Example 1.1. There are a number of approaches to data-driven
modelling ranging from Gaussian processes (see Rasmussen and Williams 2006)
to S-systems (see Voit 2000). Data-driven models can sometimes be used to pre-
dict system behaviour in yet untested experimental conditions, however, their
explanatory capabilities are limited due to a lack of structural information about
the studied system.
Example 1.1 (Data-Driven Model of a Feedback Ampliﬁer)
A feedback ampliﬁer is a system which ampliﬁes the input signal utilising a
negative feedback to gain stability of ampliﬁcation (see Figure 1.1). This struc-
ture can be found in many biological systems, this is possibly due to the evolu-
tionary pressure to sustain a stable behaviour while amplifying some stimuli.CHAPTER 1. INTRODUCTION 17
Input
A
β
Output
Figure 1.1: Feedback Ampliﬁer
The basic idea of a feedback ampliﬁer is to feed the output of the system back
to the input of an ampliﬁcation cascade with a negative feedback, thus inhibiting
ampliﬁer’s input.
The data-driven model for the feedback ampliﬁer does not consider the parts
of the system separately, but rather deﬁnes the law by which the output of the
system can be obtained from its input:
Output =
A
1 + βA
· Input,
where A is the ampliﬁer’s gain, and β is the strength of the negative feedback.
Mechanistic models are used not only to mimic the observed behaviour but
also to describe processes involved in producing such behaviour. A mechanistic
model usually considers a system to be built from parts which interact with
each other. In biological modelling, mechanistic models often employ the laws
of molecular kinetics to describe the processes which contribute to the system
behaviour. An example of a mechanistic model of a feedback ampliﬁer is given
in Example 1.2.
Example 1.2 (Mechanistic Model of a Feedback Ampliﬁer)
Consider the same system as in Example 1.1. When modelling this system
mechanistically, we consider a structural model of the feedback ampliﬁer described
using biochemical terms.
The structure depicted in Figure 1.2 gives more details about the processes
involved in a feedback ampliﬁer system. For example, one can see that the nega-
tive feedback is achieved through the competitive inhibition of the input I by the
output O.
The system of diﬀerential equations which deﬁnes the dynamics of the mech-CHAPTER 1. INTRODUCTION 18
I
Ai
A
Oi
O
Ir
Figure 1.2: Structure of a Feedback Ampliﬁer
anistic feedback ampliﬁer model is the following:

                   
                   
˙ I = −
Vf · I · O
Kf + I
,
˙ Ir =
Vf · I · O
Kf + I
,
˙ Ai = −
Va · Ai · I
Ka + Ai
+
Vd · A
Kd + A
,
˙ A =
Va · Ai · I
Ka + Ai
−
Vd · A
Kd + A
,
˙ Oi = −
Vo · Oi · A
Ko + Oi
+
Vp · O
Kp + O
,
˙ O =
Vo · Oi · A
Ko + Oi
−
Vp · O
Kp + O
.
In this thesis we will mainly use mechanistic biochemical models because
these include more information about the structure of the modelled system, and
consequently are more expressive when used to deﬁne the working hypotheses.
1.3 Reasoning and Inference
Deductive reasoning is a logical framework proposed by Aristotle in the 4th
century B.C. which relies on the application of logical rules such as:
A → B,A ` B,also known as Modus Ponens;
A → B,¬B ` ¬A,also known as Modus Tollens.
For example, if we take A ≡ “It is raining” and B ≡ “The sky is cloudy” the
above logical rules deﬁne the following deductions:CHAPTER 1. INTRODUCTION 19
• The sky is cloudy when it is raining, and it is raining, therefore the sky is
cloudy;
• The sky is cloudy when it is raining, and the sky is not cloudy, therefore
it is not raining.
This kind of reasoning is the most desirable in practise, but unfortunately, we
may not have all the information to apply deductive reasoning.
In the situations when the essential information is not available to perform
deductive reasoning, plausible reasoning can be employed. Consider again the
example above. Deductively, we cannot conclude that it is going to rain if the
sky is cloudy, but we can say that it is more plausible that it will start to rain if
the sky is cloudy. Plausible reasoning relies on a number of logical rules which
allow one to make such conclusions, for instance:
A → B,B ` A becomes more plausible,
A → B,¬A ` B becomes less plausible.
In the ﬁrst case, observing the consequence B makes the reason A more
plausible, when in the second case eliminating one of the reasons for B makes it
less plausible.
We can assign a degree of plausibility to propositions or events using the
Bayesian interpretation of probability. Bayesian theory deﬁnes the concept of
probability as a degree to which a person believes in a proposition. This def-
inition was ﬁrst proposed by Ramsey (1931), and Bayesian theory was later
developed on this foundation.
The name “Bayesian” comes from the use of Bayes’ theorem which takes an
important place in this theory. Bayes’ theorem states how to update or revise
beliefs in light of new evidence:
P(A|B) =
P(B|A)P(A)
P(B)
where
• P(A) is the prior probability of A, which does not take into account any
information about B;
• P(A|B) is the posterior probability of A taking B into account;CHAPTER 1. INTRODUCTION 20
• P(B) is the prior probability of B;
• P(B|A) is the conditional probability of B given A, or in other words the
likelihood of B given A.
Automated inference and reasoning are useful not only for faster decision
making, but also to investigate a large number of almost identical hypotheses.
The goal of this thesis is to introduce automated approaches to assist reasoning
about biological systems.
1.4 Thesis Statement
One of the important challenges in Systems Biology is to enable objective hy-
potheses testing and reasoning about models of biological systems. A major
problem for such reasoning is uncertainty of knowledge and experimental obser-
vations.
We propose that model-based reasoning and inference based on probabilistic
foundations are appropriate for tackling the problem of uncertainty representa-
tion. We demonstrate a novel modelling approach using continuous time Markov
chains which enables quantitative model-based reasoning and develop an imple-
mentation of the Bayesian inferential framework for biological applications.
Both methodologies are applied to case studies in signal transduction path-
ways, thus demonstrating the feasibility of the proposed approaches.
1.5 Thesis Contribution
The problem of consistent reasoning and inference for Systems Biology in un-
certain conditions is investigated.
Mechanistic mathematical models are used to describe the working hypothe-
ses in biological research. A novel modelling approach using continuous time
Markov chains (CTMCs) is proposed that enables deductive derivation of model
behaviours and their properties; a Bayesian inferential methodology allows the
inverse problem of model inference using uncertain knowledge and noisy data to
be solved.
Alternative methods of model deﬁnition are considered in context of mod-
elling using CTMCs, and the population-based approach is selected as the mostCHAPTER 1. INTRODUCTION 21
appropriate for modelling biochemical pathways. We demonstrate that the re-
sulting models approximate the same dynamic system as traditionally deﬁned
using ordinary diﬀerential equations. Probabilistic symbolic model checking is
then applied to derive model behaviours and investigate their properties.
A variety of algorithms which implement Bayesian inference methods are
investigated and critically compared to solve the inverse problem of model infer-
ence and testing of alternative hypotheses. Markov chain Monte Carlo methods
are selected as the “gold standard” as these are based on the least constrained
foundations. Hypotheses testing using noisy experimental data is a challenging
problem which requires the latest developments in applied statistics. We se-
lect path sampling methods to obtain stable results; this is demonstrated with
several case studies in Systems Biology.
1.6 Outline of the Dissertation
The following diagram (see Figure 1.3) depicts the relationship between two
major parts of this thesis.
Modelling Observation
Reasoning: to enable logical analysis of
stochastic models
Inference: to find suitable model parameters
from observed data, and perform model
selection
Figure 1.3: Schematic relationship between two parts of thesis.
From left to right, methods for probabilistic, logical reasoning about stochas-
tic models allow us to analyse and map behaviours of such models to observed,
experimental behaviour. In the opposite direction, inference based on the ob-
served behaviour allows us to ﬁnd suitable model parameters and perform modelCHAPTER 1. INTRODUCTION 22
selection.
In Chapter 2 we give an overview of the state of the art.
In Chapter 3 we describe the methods developed for quantitative reasoning
about the dynamic behaviour of models of biological systems. We give examples
of how this kind of reasoning can be applied to the analysis of signal transduction
pathways.
In Chapter 4 we describe the implementation of Bayesian inference method-
ology in a biological context, considering the problems and solutions for model
identiﬁcation, hypotheses testing, and predictions. Section 4.3 contains two case
studies which demonstrate how the proposed methods and algorithms can be
employed to solve realistic research problems in Systems Biology.
We review our results and achievements and discuss ideas for future work in
Chapter 5.
Summary
We have provided a brief outline of our work and its motivation.Chapter 2
Related Work
Overview
In this chapter we review existing approaches in the areas of mod-
elling, reasoning and inference for biological systems.
2.1 Ordinary Diﬀerential Equations
Modelling with diﬀerential equations is currently the most widely used approach
in Systems Biology (see Voit 2000 de Jong 2003).
Deﬁnition 2.1: An ordinary diﬀerential equation (ODE) is an equation which in-
volves functions of only one independent variable, and one or more of its derivatives.
For example,
˙ y = y
is an ordinary diﬀerential equation, where ˙ y denotes the ﬁrst derivative of the
function y by time. An alternative notation is
dy
dt.
In the context of biological modelling, the independent variable is usually
time, and dependent variables correspond to measurable quantities, e.g. protein
concentrations.
The most common approach to building models of biological systems us-
ing ODEs relies on the use of kinetic laws, such as decay dynamics or binding
dynamics.
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Models deﬁned with ODEs can be used to produce predictions of system
behaviour by solving an initial value problem.
Deﬁnition 2.2 (Initial value problem): An initial value problem consists of a
diﬀerential equation and the initial values which must belong to the solution.
Example 2.1 (A Model of biochemical binding)
Consider a biochemical system of two proteins which can bind each other.
We associate variables x, y, and z with the concentrations of the ﬁrst protein,
the second protein, and their complex respectively. Initially, at time t = 0, the
concentrations of the proteins are x|t=0, y|t=0 and z|t=0. At each instant of time,
there is a chance that a molecule of the ﬁrst protein will bind to a molecule of
the second protein. The speed of protein concentration change depends on these
concentrations at a given time. A system of ordinary diﬀerential equations which
describes how the concentrations of the proteins change over time is

  
  
˙ x = −k · x · y
˙ y = −k · x · y
˙ z = k · x · y
(2.1)
where k ≥ 0 is a model parameter, usually called the binding rate. This type
of chemical kinetics is called the mass action kinetic law (for more details see
Stryer 1995).
Initial value problems are not always solvable analytically due to the struc-
ture of diﬀerential equations. Numerical solution methods can be employed in
such situations. There is a wide range of diﬀerential equation solvers available
at the moment (for an overview see Press et al. 2002). Diﬀerent solvers are
usually specialised for better performance on some classes of ordinary diﬀeren-
tial equations. For example, the Rosenbrock method is an implicit form of the
Runge-Kutta solver that allows stiﬀ1 systems of ordinary diﬀerential equations
1Stiﬀ systems of ordinary diﬀerential equations are those which cannot be solved eﬀectively
by basic adaptive step size solvers. This is mainly due to the fast changes in some dependent
variables which require the step size of the solver to be reduced to very small values. Unfor-
tunately, there is no formal deﬁnition of the stiﬀ system of ODEs, and a system is usually
declared stiﬀ if the Runge-Kutta solver fails.CHAPTER 2. RELATED WORK 25
to be solved eﬀectively in the cases when a Jacobean matrix of the system is
available.
2.2 Petri Nets
Petri nets depict the structure of a distributed system as a directed bipartite
graph with annotations. A Petri net has place nodes (depicted with circles in
Figure 2.1), transition nodes (squares in Figure 2.1), and directed arcs connecting
places with transitions.
At any one time during a Petri net’s execution, each place can hold zero or
more tokens. Unlike more traditional data processing systems that can process
only a single stream of incoming tokens, Petri net transitions can consume tokens
from multiple input places, act on them, and output tokens to multiple output
places. Before acting on input tokens, a transition waits until the required
number of tokens appears in every one of its input places. Transitions act on
input tokens by a process known as ﬁring. When a transition ﬁres, it consumes
the tokens from its input places, performs some processing task, and places a
speciﬁed number of tokens into each of its output places. It does this atomically,
in one step. A set of tokens allocated at the places of Petri net is called marking
of the Petri net.
Petri net representations can be used for qualitative modelling of biochemical
networks (Goss and Peccoud 1998 Pinney et al. 2003 Sackmann et al. 2006 Heiner
et al. 2004). In such applications species in the network are represented with
places of the Petri net, and reactions are represented with transitions. The
marking of this model with tokens represents the presence of some species in the
system at diﬀerent points of time.
Example 2.2 (Petri Net model of a biochemical reaction)
Protein P is activated (to become protein P*) in presence of enzyme E. The
reaction which converts P into P* is possible only when some E is available. The
concentration of enzyme E will not be changed during the reaction.
The initial state of the system is depicted in Figure 2.1(a). The initial mark-
ing (tokens in places P and E) corresponds to the presence of protein P and
enzyme E in the system. As all input places for the transition have tokens, the
transition can be ﬁred and the Petri net will change its state to the one in Fig-CHAPTER 2. RELATED WORK 26
P
P*
E
(a) before ﬁring
P
P*
E
(b) after ﬁring
Figure 2.1: Petri Net representation of an enzymatic activation
ure 2.1(b). In this state P* is present in the system. At the same time, enzyme
E is still present, as it was consumed and then reproduced during the transition.
Above is an example of a catalytic reaction, which can usually be described
with a pair of arcs in the Petri net, corresponding to consuming/producing the
token at the catalyst place.
In general, inhibitory modiﬁcations are more diﬃcult to formalise than cat-
alytic ones. For example, a complementary place can be used to deﬁne a negated
state of the system. Figure 2.2 illustrates Petri net for Kholodenko’s model of the
MAPK cascade (Kholodenko 2000), this model includes an inhibitory (negative)
feedback loop. This system has been formalised using Petri nets (M. Heiner,
private correspondence).
Petri nets enable a number of qualitative logical analysis techniques, such as
automatic detection of loops in the system and checking of general topological
properties. Additionally, some logical properties can be veriﬁed using temporal
logic and model checking algorithms (see Clarke et al. 1999).
A number of extensions of this formalism have been created, such as Petri
nets with inhibitory arcs, coloured Petri nets, stochastic Petri nets, timed Petri
nets, and hybrid functional Petri nets. Using some of these extensions it is
possible to simulate quantitative dynamics of the biochemical networks. We
give a brief overview of a hybrid functional Petri nets approach, focusing on new
capabilities provided and some limitations. Hybrid functional Petri nets extendCHAPTER 2. RELATED WORK 27
Ras/MKKKK
MKKK MKKK-P
MKK MKK-P MKK-PP
MAPK MAPK-P MAPK-PP
No MAPK-PP
Figure 2.2: Petri net model of the MAPK cascade (features a complementary
place for inhibition labelled “No MAPK-PP”)
the basic deﬁnition of Petri nets allowing processing of continuous values on
tokens; real continuous dynamics can be described using special kinds of places
and transitions. This formalism also includes connectivity extensions such as
inhibitory arcs. Another additional connectivity extension is a test arc (drawn
as a dashed arrow) which deﬁnes a requirement for non-zero marking in a given
place to allow a transition to proceed. This arc, however, deﬁnes that performing
a transition does not impact the marking in a place connected to the transition
with a test arc. Hybrid functional Petri nets are useful for illustrating system
behaviour and mature simulation algorithms exist for these models. However
these algorithms have several signiﬁcant drawbacks, which we demonstrate with
examples below. We refer to Cell Illustrator (Doi et al. 2004), which implements
the hybrid functional Petri nets algorithms.CHAPTER 2. RELATED WORK 28
Example 2.3 (Hybrid functional Petri net model of a biochemical reaction)
The enzymatic activation of a protein with the following dynamics (2.2):

     
     
˙ P = −
E · P · 2.7
(E + 0.51) · (P + 0.7)
˙ P
∗ =
E · P · 2.7
(E + 0.51) · (P + 0.7)
˙ E = 0
(2.2)
E|t=0 = 0.05, P|t=0 = 2.5, P
∗|t=0 = 0;
can be described with the hybrid functional Petri net depicted in Figure 2.3.
P
P*
E
2.5
0.0
0.05
(E•P•2.7)/((E+0.51)•(P+0.7))
Figure 2.3: Hybrid functional Petri net model of enzymatic activation
Figure 2.4 shows the simulation results produced with MATLAB’s (Moler
2004) ode15s diﬀerential equation solver (Moler 2004) (Figure 2.4(a)) and Cell
Illustrator (Figure 2.4(b)). This comparison illustrates that the simulation re-
sults are the same.
However, due to the simulation strategy of hybrid functional Petri nets, the
simulation results for some models can be incorrect. To illustrate this we con-
structed the following example. Consider a hypothetical biochemical network
depicted in Figure 2.5(a). This model consists of six species x1, x2, x3, m1, m2,
and m3. There are four reactions. All the reactions have mass action kinetics
with coeﬃcients k1, k2, k3, and k4. For this example the following coeﬃcients
values have been chosen: k1 = 0.013, k2 = 1.0, k3 = 2.5, k4 = 0.087, and theCHAPTER 2. RELATED WORK 29
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(b) Hybrid functional Petri net simula-
tion
Figure 2.4: Enzymatic activation simulation results
initial concentrations for the species are the following: x1|t=0 = 10, x2|t=0 = 10,
x3|t=0 = 1, m1|t=0 = 0, m2|t=0 = 0, m3|t=0 = 0. The network topology is
depicted in Figure 2.5(a). The ODE model for this network is

           
           
˙ x1 = −k1 · x1 · m3 − k2 · x1 · x3,
˙ x2 = −k3 · x2 · x3,
˙ x3 = k1 · x1 · m3 − k2 · x1 · x3 − k3 · x2 · x3,
˙ m1 = k2 · x1 · x3 − k4 · m1 · m2,
˙ m2 = k3 · x2 · x3 − k4 · m1 · m2,
˙ m3 = k4 · m1 · m2 − k1 · x1 · m3,
(2.3)
k1 = 0.013, k2 = 1.0, k3 = 2.5, k4 = 0.087,
x1|t=0 = x2|t=0 = 10.0, x3|t=0 = 1.0, m1|t=0 = m2|t=0 = m3|t=0 = 0.0.
We solved this problem with MATLAB’s ode15s solver and compare it with
the hybrid functional Petri net (HFPN) simulation produced with Cell Illustra-
tor. The results are plotted in Figure 2.5(b). The comparison shows that the
hybrid functional Petri nets approach does not produce the same behaviour as
the ODEs. This is due to the fact that the simulation algorithm for hybrid
functional Petri nets can evaluate a ﬂux through only one reaction at each given
time. The reaction to be performed is chosen randomly. In this case, the reac-
tion x2+x3 → m2 has been chosen ﬁrst, and this reaction consumed all available
x3. This took the model into a deadlock. But, continuous dynamics consume
x3 in both x2 + x3 → m2 and x1 + x3 → m1 reactions simultaneously, which
produces the correct trace. We conclude that hybrid functional Petri nets doCHAPTER 2. RELATED WORK 30
x 1 x 2 x 3
m1 m2
m3
k1
k2 k3
k4
(a) Schematic representation of
model structure. Circles corre-
spond to chemical species and rect-
angles correspond to reactions.
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(b) A comparison of ODE solution result to a hybrid
functional Petri net simulation.
Figure 2.5: An example of a biochemical model for which hybrid functional Petri
nets predict an incorrect behaviour.
not produce correct predictions for this model.
We found that HFPN simulation algorithm also fails when analysing stiﬀ
models. In such a case, the simulation algorithm uses a very small value for the
simulation step size, and the simulation cannot be completed in reasonable time.
On the other hand, ﬁxing the step size on larger values does not give suitable
precision of the simulation results. Thus, hybrid functional Petri nets cannot be
used for modelling stiﬀ systems.
Stochastic Petri Nets can be used for modelling biochemical systems in a way
similar to the approach proposed in Chapter 3. However, such Petri net models
become quite complex to understand when the models become larger.
We conclude that the Petri nets can be quite illustrative for small examples,
but they do not allow any quantitative reasoning and simulation of complex
pathways are often imprecise or incorrect. This motivates the development of
alternative modelling techniques which support structural view of the system,
and also allow quantitative modelling.
2.3 Hybrid Systems
Hybrid systems describe both discrete signals (or variables) and continuous sig-
nals or variables. There have been several attempts to use hybrid systemsCHAPTER 2. RELATED WORK 31
for modelling and analysis of biochemical networks (Alur et al. 2002 Belta
et al. 2004 Lincoln and Tiwari 2004).
The state space of possible variable values can be partitioned into rectangular
domains, in which the ﬂow is qualitatively identical. From this we derive a
qualitative transition system, consisting of the set of all domains, the set of
all transitions between the domains, and a labelling function that associates
the sign of the derivatives of the concentration variables to every domain. A
sequence of states in the qualitative transition system is called a path. A path
describes a possible behaviour of the system. The qualitative transition system is
designed such that it provides an conservative approximation of the dynamics of
the original system, in the sense that to every solution of the model corresponds
a path in the state transition graph. Note, that the converse is not true: some
paths may not correspond to any solution, and therefore represent spurious
behaviours.
The qualitative transition system can be used for model validation with
model checking techniques. As the transition system is labelled with the signs of
the derivatives, model checking queries can only describe trends of the concen-
tration plots. Usually Computational Tree Logic (CTL) (see Clarke et al. 1999)
is used to describe such model properties.
time
x
(a) Possible simulation trace
time
x
(b) Another simulation trace
time
x
˙ x > 0 ˙ x < 0 ˙ x > 0
(c) Derivative sign pattern
Figure 2.6: Qualitative properties for hybrid systems analysis
For example, the following is a property:CHAPTER 2. RELATED WORK 32
EF(dsign x = 1 ∧ EF (dsign x = -1 ∧ EF(dsign x = 1))),
where dsign x is a built-in variable for the sign of the derivative of variable x,
and the EFφ quantiﬁer means that there must exist at least one path on which
φ eventually holds. The expression above deﬁnes a property for the value of x
as depicted in Figure 2.6(c). Note that this property describes both possible
behaviours plotted in Figure 2.6(a) and Figure 2.6(b).
The analysis of realistic models leads to large state transition graphs, which
make veriﬁcation of dynamic properties practically infeasible.
It is possible to implement another approximation of model behaviour, that
conserves the quantitative characteristics of the system. In this case, the state
space of the system is decomposed into a number of hyperrectangles deﬁning
approximation domains. The behaviour of the modelled system is approximated
with a linear behaviour in each of these domains. It is possible to evaluate more
quantitative properties using specialised reasoning algorithms. This approach
can be successfully applied to modelling of small networks, but does not scale
up to larger models. For example, a model of the MAPK cascade proposed by
Schoeberl et al. (2002) consists of 94 species, therefore the state space for this
model will have 94 dimensions. The problem to generate a decomposition of this
space into a number of domains is infeasible by itself. Even an approximation
with three linear segments per specie is described with 394 > 1044 rectangles.
We conclude that due to the complexity of state space decomposition into
multiple domains, this approach cannot be applied eﬀectively to the simulation
and analysis of large biological systems.
2.4 Chemical Master Equation and Stochastic
Simulation
Stochastic simulation involves modelling individual molecules. Most simulations
abstract away from location and motion of individual molecules, which is justiﬁed
if one assumes that the system is well stirred, which means that the molecules
of all kinds are uniformly distributed through the spatial volume. The following
is usually assumed when considering stochastic simulations: the system is in
thermodynamic equilibrium, and the volume is ﬁxed. The state of such system
is described by a vector X(t) = (X1(t),X2(t),...,XN(t)), where Xi(t) is a non-CHAPTER 2. RELATED WORK 33
negative integer which expresses a number of molecules of the ith kind at time
t. X(0) describes the initial state of the system.
At each time when one of the reactions takes place, vector X(t) can change
its value. This leads to the Chemical Master Equation (CME), which is a system
of ODEs, one ODE per each possible state of the system. At time t, the kth
equation deﬁnes the probability that the system is in the kth state. Unlike the
models considered in Section 2.1, the dimensionality of such a system depends
not on the number of chemical species N, but on the number of possible states
of the system X, which in turn depends on the total number of molecules.
Usually, the dimension of the CME is so huge that it is not possible to work
with it either analytically or numerically.
Gillespie (1977) proposed a stochastic simulation algorithm which produces
model behaviours using the CME indirectly. Instead of solving the system of
ODEs to get the probability distribution over the possible states of the system
at each time t, the algorithm produces samples from such distributions.
In spite of the simplicity of the Gillespie’s algorithm, it can be quite ineﬃcient
when some reactions take place frequently. The basic algorithm can be improved
by “lumping together” several reactions, and changing the state vector only when
several reactions took place. This method is called tau-leaping approximation
(see Wilkinson 2006). The error of this approximation is small in the cases where
the system state changes are small.
Several software platforms implement the algorithm (see Kierzek 2002 Adal-
steinsson et al. 2004 Gillespie et al. 2006), but they do not oﬀer additional
reasoning or analysis capabilities (beside simulation).
2.5 Process Algebras and Process Calculi
2.5.1 π-Calculus and Stochastic π-Calculus
The original π-calculus (sometimes referenced as pi-calculus) was developed by
Milner (1999) as a formal language for concurrent computational processes. The
π-calculus provides a framework for representation, simulation, analysis and ver-
iﬁcation of mobile communicating systems. In fact, the π-calculus, just as the
µ-calculus (see Kozen 1983), is so minimal that it does not contain primitives
such as arithmetic (no numbers, no operations), boolean values, ﬂow controlCHAPTER 2. RELATED WORK 34
statements usual for programming languages, data structures, variables or func-
tions.
When modelling biochemical systems with π-calculus, individual molecules
and their domains are treated as computational processes, while their comple-
mentary structural and chemical determinants correspond to communication
channels. Processes can be composed in parallel, which means that they are per-
formed at the same time, and communication between such processes is achieved
through rendezvous. Communication channels between computational processes
express chemical bonds between molecules or molecular domains. Biochemical
interaction and subsequent modiﬁcation is usually expressed with communica-
tion involving channel transmission. Biochemical reactions are modelled by pass-
ing the communication channels from one process to another, thus altering the
communication topology, and therefore describing new bonds between molecules
and molecular domains. For an example of how a model of a signal transduction
pathway can be deﬁned with π-calculus see (Regev et al. 2001).
There exists a number of analysis techniques which can be applied to π-
calculus models of biochemical systems, such as simulation or reachability anal-
ysis.
The basic formulation of π-calculus does not allow quantitative dynamics.
Therefore, only qualitative analysis is possible on such models. However, there
exists a number of extensions which allow association of stochastic time delays
with interactions to be made. One of such extensions is the stochastic π-calculus
(see Priami 1995), and there is a speciﬁc implementation of stochastic π-calculus
tools for modelling and simulation of biochemical networks called BioSPi (see
Priami et al. 2001).
Considering analysis techniques for the stochastic π-calculus, these are lim-
ited to quantitative simulations of model behaviour which is usually achieved
with the Gillespie algorithm (see Section 2.4). Since π-calculus and its stochas-
tic extension consider individual molecules as basic components of a model,
there is a problem of a state-space explosion. These approaches, however, are
suitable for modelling systems with only a few molecules, such as protein-DNA
interactions, transcription and translation modelling.
We conclude that, as no tools for quantitative reasoning or inference are
available at the moment, these modelling formalisms are mostly suitable for
simulation.CHAPTER 2. RELATED WORK 35
2.5.2 Performance Evaluation Process Algebra (PEPA)
PEPA (see Hillston 1996) is a stochastic process algebra which has also been ap-
plied to modelling biochemical systems (see Calder, Gilmore and Hillston 2006).
Unlike π-calculus, the PEPA models do not consider protein structure directly,
but operate on the level of abstract interactions associated with biochemical
reactions. Instead of describing molecular domains and binding them together
using communication channels, PEPA models assign symbolic names to diﬀerent
species involved in a biochemical network.
Semantically, PEPA is diﬀerent to stochastic π-calculus, as the former is a
proper process algebra. This allows a natural comparison of models to be made
(e.g. by bisimulation).
Considering an algorithmic support of modelling using PEPA, there exist
a number of software frameworks which implement steady state and transient
analysis of models, for example with the PEPA workbench (see Gilmore and
Hillston 1994). The PRISM model checker (see Kwiatkowska et al. 2002) also
supports stochastic model checking and Monte-Carlo simulation of such models.
PEPA allows multi-way synchronisation (synchronous actions for more than
two processes at the same time) therefore allowing more abstract modelling
of biochemical reactions which involve multiple reactants. A stochastic rate
can be associated with each event in this process algebra, therefore enabling
quantitative modelling of dynamic systems. In some cases a component can be
passive with respect to some activity. This means that the rate of the activity
will be left unspeciﬁed (denoted >) and is determined upon cooperation, by the
rate of the activity on the other component.
Calder, Gilmore and Hillston (2006) model the RKIP inhibited ERK path-
way using this process algebra. Two diﬀerent models of the system have been
developed: a reagent-centric model and a pathway-centric one. In the former
model, each protein in the system is associated with a computational process,
while the reactions are the actions performed by the processes. The performance
rate is associated with each reaction, which allows the reaction speed to be con-
trolled; all the proteins can have only two states: low concentration and high
concentration. In the low state the protein cannot participate in reactions as a
reagent, but can be a product of a diﬀerent reaction. If the protein is produced,
it changes its state from low to high.
In the pathway-centric model, parts of the pathway are considered as pro-CHAPTER 2. RELATED WORK 36
cesses. Such pathways can be synchronised together to reproduce a behaviour
of the complete network.
Calder, Gilmore and Hillston (2006) provided extensive analysis of these
models. It was shown that both models are bisimilar, and therefore deﬁne the
same observable network behaviour. This could be useful at the stage of building
the model. For example, users can abstract from deﬁning ﬁne-grained players
of the network, concentrating on pathway composition. Particular players can
be deﬁned at the next stage. This approach allows diﬀerent networks to be
compared, and decide whether they simulate each other.
2.6 Pathway Logic
Pathway Logic (Eker et al. 2002) is a qualitative analysis technique based on
term rewriting.
Pathway Logic is currently used for modelling and analysis of signal trans-
duction and metabolic networks. Pathway Logic models are represented using
the Maude term rewriting system (see Clavel et al. 2003). Models can be queried
and computational experiments can be carried out using the execution, search
and model-checking tools of the Maude system. Some current capabilities of
Pathway Logic include:
• Models with diﬀerent levels of detail. This means that a model can be
described either on the scale of species and reaction, or on the scale of
molecular domains. For example, it is also possible to deﬁne cellular com-
partments and therefore model spacial characteristics of the system, and
molecule transport.
• Analysis of models using search and model-checking. This allows one to
verify logical properties of the models in addition to performing simula-
tions. Though, this approach does not allow quantitative modelling, as
the steps of rewriting do not carry the timing information.
• Transformation to Petri nets for analysis and visualisation.
Using Pathway Logic, biological molecules, their states, and their roles in
network elements can be modelled at very diﬀerent levels of abstraction. For
example, a complex signalling protein can be modelled either according to anCHAPTER 2. RELATED WORK 37
overall state or as a collection of functional domains (protein functional domains,
PFDs) and their internal or external interactions (Talcott et al. 2004). The same
hierarchy of organisation levels can be modelled with π-calculus (see Section
2.5.1), but not with, for example, Petri nets.
The main disadvantage of Pathway Logic is that it does not support quanti-
tative modelling, as neither time nor variables can take quantitative values.
2.7 BIOCHAM
BIOCHAM (Chabrier and Fages 2003) is a logical approach which allows classical
model checking algorithms to be applied for biochemical network analysis. In
particular, BIOCHAM translates biological models into model deﬁnitions for the
SMV model checker (see Clarke et al. 1994), which then can be used to perform
property validation.
The basic approach uses qualitative models. Chabrier-Rivier et al. (2004)
propose a number of logical properties, which have biological meaning, using
Computational Tree Logic, CTL (Clarke et al. 1999). Example queries are
• Does the system have a stable state?
• Given an initial state of the system, is there a series of reactions that will
produce some compound P?
• Is state s2 a necessary checkpoint for reaching state s?
The basic approach is extended with quantitative kinetic parameters. The
system behaviour can then be simulated using these parameters. Calzone et al.
(2005) introduce additional features to allow quantitative reasoning. These ex-
tensions enable checking LTL (Linear Temporal Logic) properties on quantitative
simulation traces. Some machine learning techniques are proposed in (Calzone
et al. 2006) which allow model reconstruction and parameter search to ﬁt model
behaviour to the LTL properties.
In the case of quantitative model checking, each time point of the system
trace is represented by a diﬀerent state of a transition system. A simulation
trace is therefore a sequence of states with unlabelled transitions between them,
as depicted in Figure 2.7. The properties can be described using LTL extended
by constraints over variable values and their derivatives.CHAPTER 2. RELATED WORK 38
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...
Figure 2.7: Transition system generated from the model simulation trace. t
denotes time, a and b are model variables, a0 and b0 are their derivatives, respec-
tively.
The parameter search is implemented by iterative scanning through the in-
tervals of possible parameter values.
BIOCHAM implements algorithms for qualitative reasoning about struc-
tural models, and quantitative model checking of properties of model simulation
traces. In Chapter 3 we extend the idea by enabling quantitative model checking
of structural models.
This concludes our review of the approaches for modelling biological systems.
In the following sections we review alternative methods for model identiﬁcation
using experimental data as the main source of information.
2.8 Maximum Likelihood Estimation for Infer-
ence
Maximum likelihood estimation is a method used to make inferences about pa-
rameters of an underlying model from experimental data. The goal is to ﬁnd
parameters that ﬁt the experimental data as closely as possible.
This approach can work with any parametric quantitative model provided
the likelihood function, which deﬁnes the probability that the model reproduces
the experimental data, is deﬁned. We assume that models are formulated using
ODEs, however, the arguments below are relevant to any kind of quantitative
models used within the maximum likelihood estimation framework.
The problem of ﬁnding values of model parameters which maximise the likeli-
hood is not trivial, as many of models of biological systems are nonlinear. There
are numerous algorithms for maximum likelihood estimators, e.g. simulated an-
nealing (Kirkpatrick et al. 1983),, genetic algorithms (Crosby 1973), stochastic
gradient descent (Spall 2003), tabu search (Glover and Laguna 1997).
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estimate” of the model parameters. This is so-called point estimation problem.
Note that, in such formulation, the ﬁnal answer is an element of the parameter
space, with no explicit recognition of the uncertainty involved. Pragmatically, a
point estimate may be motivated as being the simplest possible summary of the
inferences to be drawn from the experimental data about the value of the model
parameters.
There is a number of methods designed for estimation of corresponding un-
certainty for the point estimates. This is achieved either through conﬁdence
limits estimation (see e.g. Cox and Hinkley 1974), through local approximations
to the posterior density (these will be discussed in more detail in Section 4.1.2),
or using Markov chain Monte Carlo to “inﬂate” the modes around the maxi-
mum likelihood point estimate to evaluate the local variance of the posterior
(this method is referred as “ensemble” method and discussed in great detail by
Brown et al. (2004)). The main problem with these methods is that none of
them considers the complete parameter posterior and thus will fail to account
for alternative inferences following from possible multimodal posteriors or pos-
teriors of peculiar shape. Non-trivial posterior distributions are not rare when
considering models of biological systems due to nonlinearities involved.
The hypotheses testing problem and the problem of model comparison are
usually solved with either simple likelihood ratio test (which would prefer more
complex hypotheses over simple ones as long as they provide better ﬁt to data)
or, in an attempt to compensate for that eﬀect, using the Akaike Information
Criterion (see Akaike 1973). We discuss diﬀerent Information Criteria in detail
in Section 4.1.4. The Akaike Information Criterion is well justiﬁed for cases
when predictions of the prior2 are compatible to those of the likelihood, and not
in the more usual situation when prior information is small in comparison to
the information provided by the data. Another major problem with the Akaike
Information Criterion is that it is based on an asymptotic approximation to the
parameter posterior, and therefore it is only valid when the posterior distribution
is approximately multivariate normal.
The latter problem with the Akaike Information Criterion (as well as several
other methods based on the same principle, which are discussed in Section 4.1.4)
is the major drawback of this approach, because nonlinear parameter posteriors
2Knowledge about possible model parameter values available before the experimental data
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are very common in biological modelling3 context.
2.9 Bayesian Networks
Bayesian network inference algorithms (Sachs et al. 2002), (Li and Chan 2004),
(Woolf et al. 2005), (Werhli et al. 2006), (Sachs et al. 2005) construct graphs in
which nodes represent the measured species, and arcs represent statistical rela-
tions and dependencies between species. There are several attractive properties
of Bayesian networks for the inference of signalling pathways from biological data
sets. As emphasised by Sachs et al. (2005), Bayesian networks can represent com-
plex stochastic nonlinear relationships among multiple interacting species, and
their probabilistic nature can accommodate noise that is inherent in biologically
derived data. Such networks can describe direct molecular interactions as well
as indirect inﬂuences that proceed through additional unobserved components.
Therefore, very complex relationships can be modelled and discovered.
The key problem for applying Bayesian networks to signal transduction path-
ways studies (which are considered as case studies in this thesis) is that this ap-
proach requires quantitative data for every player involved in a biological system
(e.g. every specie of a biochemical network) to be available. Bayesian networks
are capable of inferring the models which include only the players which are
observed. Collection of all this data is very diﬃcult in most cases due to the
limitations of current experimental methods. The vast majority of the species
would, therefore, be omitted from the network identiﬁed with the Bayesian net-
works approach, and replaced with arcs which specify statistical dependency of
the observed species. The most discouraging evidence against the application
of Bayesian networks is that, in practice, the amount of available data is very
small, especially when the study of a network is at an early stage.
2.10 Discussion
Some of the modelling approaches considered in this section aim to reproduce
qualitative properties of modelled systems, these are basic Petri nets, original
3As mentioned earlier, nonlinear models are common in biological applications, and very
often such models have peculiar parameter posteriors, and in some cases even multimodal
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(non-stochastic) π-calculus, Pathway logic or the qualitative part of the method-
ology implemented in BIOCHAM. Other approaches are essentially quantitative:
ODEs, hybrid systems and hybrid functional Petri nets, stochastic calculi and
process algebras, and the quantitative methodology in BIOCHAM.
The overview provided in this chapter demonstrates that the majority of the
existing quantitative approaches are aimed primarily for simulation of model
behaviours. In the following chapters, we develop a modelling methodology and
an inference framework which allow reasoning and inference about models of
biological systems.
BIOCHAM supports logical matching of simulation traces to behaviour tem-
plates. However, this kind of logical analysis can hardly be used for deductive or
inferential reasoning about biological models. PEPA supports stochastic descrip-
tions of biological models, and supports some quantitative analysis techniques
(including model simulation/bisimulation checking), we suggest a closely related
modelling approach presented in Chapter 3 which allows logical reasoning about
temporal properties using probabilistic symbolic model checking. In Chapter 3
we build upon the idea of using abstract levels of concentration for quantitative
modelling, and propose to use multiple symbolic intervals of the concentration
for more precise quantitative modelling.
We discussed some drawbacks of the inferential methodology based on maxi-
mum likelihood estimation methods. In Chapter 4 we propose to adopt Bayesian
inferential methodology which overcomes these problems.
Bayesian nets seem to be an interesting approach which allows model infer-
ence from empirical data, but this approach requires large amounts of experi-
mental data. Whilst good quality data is available in some areas of biological
research (such as metabolic networks research), it is very expensive and mostly
unavailable in other areas. The methodology we propose in Chapter 4 operates
on predeﬁned mechanistic models of biochemical pathways, so instead of recon-
structing the models from data, we propose evidence-based hypotheses testing,
treating these models as a description of working hypotheses.
Summary
We have provided an overview of the existing modelling and reason-
ing approaches in Systems Biology. We considered several qualitative
modelling methodologies: Petri Nets, Pathway logic, BIOCHAM,CHAPTER 2. RELATED WORK 42
and π-calculus. We also considered quantitative methodologies, such
as stochastic simulation and the Chemical Master Equation, systems
of ordinary diﬀerential equations, stochastic π-calculus, and PEPA.
We reviewed existing methods for analysis and inference of quanti-
tative models using the methods of maximum likelihood estimation.
We identiﬁed some weaknesses of the existing approaches and suggest
a methodology to tackle those weaknesses in the following chapters.Chapter 3
Model-Based Reasoning
Overview
In this chapter we investigate how the methods of probabilistic model
checking on continuous time Markov chains can be employed to rea-
son about behaviours of biological systems.
3.1 Background
Traditionally, systems of diﬀerential equations are employed for modelling bi-
ological systems; models are usually deﬁned using ordinary diﬀerential equa-
tions or, in some cases, partial diﬀerential equations. In this chapter we con-
sider stochastic modelling approaches, namely those based on continuous time
Markov chains. There exist a number of alternative stochastic approaches, such
as Chemical Master Equation which can be simulated using the Gillespie algo-
rithm (see Gillespie 1977), or stochastic π-calculus (see Priami 1995). The main
problem with these approaches is that they are mainly designed for simulation
of model behaviour and little, if any, logical analysis methods are developed for
them. The approach proposed in this chapter is designed to allow logical analy-
sis of the models. Additionally, it overcomes some of the drawbacks with ODE
modelling, namely
• The structure of the ODE system is ﬂat, thus it is hard to recognise par-
ticular interactions in system behaviour;
• ODEs are mainly suitable for simulation of system behaviours and not for
reasoning;
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• ODEs are deterministic and therefore they may over-specify the knowledge
about biological systems.
The approach described in this chapter resolves these problems; as follows:
1. The structure of a biological system is preserved in a natural way, making
interactions between components clear.
2. There are logical analysis and reasoning methods for stochastic models
described with continuous time Markov chains. We employ probabilistic
model checking of Continuous Stochastic Logic (CSL) for reasoning. CSL
was shown to be decidable (Aziz et al. 1996).
3. It is possible to reason about system behaviours in a semi-quantitative
way, for example, using intervals instead of ﬁxed values.
We start this chapter with a concise overview of the underlying theory of
continuous time Markov chains and Continuous Stochastic Models, and then
demonstrate how these concepts can be applied to modelling and reasoning about
biological systems.
3.1.1 Continuous Time Markov Chains
This section gives a brief introduction to the concept of CTMCs. The deﬁnitions
are taken from (Kwiatkowska 2003).
Deﬁnition 3.1: A continuous time Markov chain (CTMC) is a tuple (S, ¯ s,R,L)
where
1. S is a ﬁnite set of states
2. ¯ s is an initial state
3. R : S × S → R≥0 is the rate matrix, and
4. L : S → 2AP is a labelling with atomic propositions from set AP.
If R(si,sj) > 0 for a pair of states si,sj we say that there is a transition
from state si to state sj. The elements of matrix R are rates for the transitions,
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be taken within time t is 1 − e−R(si,sj)t. If for a pair of states si,sj the rate
R(si,sj) = 0, then we say that there is no direct transition from state si to state
sj.
Note, that these chains have the Markov property, as the exponential distri-
bution used to deﬁne the transition rates is “memoryless” and thus the stochastic
process is conditioned only by its current state.
In the cases when R(si,sj) > 0 for more than one state sj, a race (often
referenced as a racing condition) between the outgoing transitions from s exists.
That is, the probability P(s,s0) of taking a transition from s to s0 in a single
step equals the probability that the delay of going from s to s0 is smaller than
the delays for any other outgoing transition from s.
Deﬁnition 3.2: A path in a CTMC is a non-empty sequence s0t0s1t1s2 ... where
R(si,si+1) > 0 and ti ∈ R≥0 for all i ≥ 0. The value ti represents the amount of
time spent in the state si.
Analysis of CTMCs is based on transient (the state of the CTMC at a par-
ticular time instant) and steady-state (the state of the CTMC in the long run)
behaviour.
Deﬁnition 3.3: The transient probability πs,t(s0) is deﬁned as the probability, hav-
ing started in state s, of being in state s0 at time instant t.
Deﬁnition 3.4: The steady-state probability πs(s0) is deﬁned as limt→∞ πs,t(s0).
An example of a CTMC is given in Example 3.1.
Example 3.1 (A continuous time Markov chain)
Consider a set of states S = {s0,s1,s2,s3,s4,s5}, state s0 is the initial state;CHAPTER 3. MODEL-BASED REASONING 46
transition matrix:
s0 s1 s2 s3 s4 s5
R =
s0
s1
s2
s3
s4
s5





 




0 2 1 0 0 0
0 0 0 2 0 1
0 0 0 0 1 2
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0



 


 


the set of atomic propositions:
AP = {A = 0, A = 1, A = 2, B = 0, B = 1, B = 2, C = 0, C = 1, C = 2}
and labelling:
L =

           
           
s0 → {A = 2,B = 0,C = 0}
s1 → {A = 1,B = 1,C = 0}
s2 → {A = 1,B = 0,C = 1}
s3 → {A = 0,B = 2,C = 0}
s4 → {A = 0,B = 0,C = 2}
s5 → {A = 0,B = 1,C = 1}
The CTMC (S,s0,R,L) is schematically depicted in Figure 3.1.
S0
A = 2
B = 0
C = 0 S4
A = 0
B = 0
C = 2
S1
A = 1
B = 1
C = 0
S2
A = 1
B = 0
C = 1
S5
A = 0
B = 1
C = 1
S3
A = 0
B = 2
C = 0
2
2
2 1
1
1
Figure 3.1: Structure of the CTMC.
Transient probabilities for states s1,s2, and s3 are plotted in Figure 3.2.
Steady-state probabilities for all of the states are:
πs0(s0) = 0 πs0(s3) = 4/9
πs0(s1) = 0 πs0(s4) = 1/9
πs0(s2) = 0 πs0(s5) = 4/9CHAPTER 3. MODEL-BASED REASONING 47
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Figure 3.2: Transient probabilities for some states in the CTMC
3.1.2 Continuous Stochastic Logic
Properties of CTMCs can be described using continuous stochastic logic (CSL,
see Aziz et al. 1996) which is based on computational tree logic (CTL, see
Emerson 1990) and contains probabilistic operators evaluated with respect to
path-based measures on CTMCs. Some deﬁnitions of CSL (e.g. Kwiatkowska
et al. 2005) also include a steady-state operator.
Consider a CTMC M = (S, ¯ s,R,L) with labelling L over atomic propositions
AP. Two types of formulae are used to deﬁne CSL: state formulae (which are
true or false in a speciﬁc state), and path formulae (which are true or false along
a speciﬁc path).
Deﬁnition 3.5: A state formula is deﬁned inductively:
1. a ∈ AP is a state formula,
2. if φ1 and φ2 are state formulae, then so are ¬φ1, φ1 ∧ φ2, φ1 ∨ φ2.
3. if ψ is a path formula, then P≶c(ψ) is a state formula, where c ∈ [0,1], and
≶∈ {<,≤,≥,>},
4. there are no other state formulae.
Deﬁnition 3.6: Path formulae are formulae of the form
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where φ1,φ2,...φn are state formulae, and ∀i ∈ [1...n](ai ∈ R≥0,bi ∈ R≥0).
Deﬁnition 3.7: Continuous stochastic logic is the set of state formulae generated
by the above rules.
Note, that CSL contains only state formulae; path formulae are used only in
deﬁnitions of some state formulae.
The formal semantics for continuous stochastic logic can be found in (Aziz
et al. 1996). The only unusual operator requiring explanation is a time limited
until:
P≶c(φ1U[a,b]φ2). (3.1)
Formula (3.1) holds at a state si if and only if the probability to reach a state
which satisﬁes φ2, from the state si, passing only through states which satisfy
ψ1 within time interval [a,b], is π ≶ c.
3.1.3 Veriﬁcation of CTMCs
Properties of CTMCs expressed in CSL can be veriﬁed using model checking
techniques. Kwiatkowska (2003) argues that the complexity of CSL model check-
ing is linear in the size of the formula, and polynomial in the state space of
CTMC.
Some properties of interest for Example 3.1 are given in Example 3.2.
Example 3.2 (CSL properties for the CTMC deﬁned in Example 3.1)
• A = 2 – all the states of the CTMC have labelling A = 2. This property
does not hold.
• P≥1((true)U[0,+∞](B = 2)) – a state with labelling B = 2 is eventually
reachable in inﬁnite time with probability 1. This property does not hold,
as once a state with C > 0 is reached it is not possible to get to a state
where B = 2 any more.
• P≥0.4((true)U[0,+∞](B = 2)) – a state with labelling B = 2 is reachable in
inﬁnite time with probability greater or equal to 0.4. This property holds
as the probability to reach a state where B = 2 is equal to 4
9, which is
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3.1.4 The PRISM Model Checker
The PRISM model checker is a tool for deﬁning and analysing stochastic mod-
els. It supports a description language to deﬁne models with continuous time
Markov chains. It also supports discrete time Markov chains and Markov deci-
sion processes, however we conﬁne our interest to CTMCs. PRISM allows users
to deﬁne properties of CTMCs in CSL, and check them, employing numerical
solutions of linear equation systems and linear optimisation problems. For a
detailed description see Kwiatkowska et al. (2005).
The PRISM model description language is based on the Reactive Modules
formalism of Alur and Henzinger (1999).
In this section we give a short overview of the PRISM language; the complete
syntax and semantics of this language can be found in the PRISM user’s guide
(see Kwiatkowska et al. 2006).
The fundamental components of the PRISM description language are mod-
ules and variables. A model consists of modules which can interact with each
other. Variables can be either local (in the scope of a module) or global (acces-
sible to all modules in a model). Each variable has a type: boolean, integer or
real. A module contains local variables. The local state of a module is a vector
of values for local variables of this module. The global state of the model is
determined by the global variables together with the local state of all modules.
The behaviour of each module is deﬁned by a set of commands. A command
is deﬁned as:
[a] g → λ : v
0
i = fi(v1,...,vn)&...&v
0
j = fj(v1,...,vn);
The guard g is a predicate over all the variables in the model (including
variables which belong to other modules). a is a symbolic label associated with
this command, it is usually called an action, and is used for synchronisation.
A transition is speciﬁed by giving the new values of the variables in the mod-
ule, possibly as an expression formed from other variables or constants using
assignment expressions:
v
0
i = fi(v1,...,vn),
where v0
i denotes the new value for variable vi, which determines a new local
state of the module which is the destination of the transition deﬁned with such
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The CTMC deﬁned in Example 3.1 can be described using one module with
the following PRISM language deﬁnition (see Example 3.3):
Example 3.3 (CTMC from Example 3.1 deﬁned in PRISM language.)
ctmc
module module1
pA: [0..2] init 2;
pB: [0..2] init 0;
pC: [0..2] init 0;
[] (pA > 0)&(pB < 2) -> 2: (pA’ = pA - 1)&(pB’ = pB + 1);
[] (pA > 0)&(pC < 2) -> 1: (pA’ = pA - 1)&(pC’ = pC + 1);
endmodule
The keyword ctmc speciﬁes that the model is a continuous time Markov chain.
Note, the overlapping guards indicate a racing condition between transitions.
The CTMC generated from the PRISM language description is the parallel
composition of all the modules. PRISM supports multi-way synchronisation in
the style of process algebras. To enable such synchronisation, commands are
labelled with actions given within square brackets. A multi-modular model with
synchronisation is illustrated in Example 3.4:
Example 3.4 (A PRISM model with multiple modules)
The following deﬁnes the CTMC from Example 3.1:
ctmc
const double lambda = 2;
const double gamma = 1;
module module1
pA: [0..2] init 2;
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[action2] (pA > 0) -> gamma: (pA’ = pA - 1);
endmodule
module module2
pB: [0..2] init 0;
[action1] (pB < 2) -> 1: (pB’ = pB + 1);
endmodule
module module3
pC: [0..2] init 0;
[action2] (pC < 2) -> 1: (pC’ = pC + 1);
endmodule
The action1 action in the following command:
[action1] (pA > 0) -> lambda: (pA’ = pA - 1);
is used to force two or more modules to make transitions simultaneously (i.e. to
synchronise). For example, in state (pA = 2, pB = 0, pC = 0), the model can
move to state (pA = 1, pB = 1, pC = 0), synchronising over action1. The
rate of the synchronised transition is the product of the individual rates for the
synchronising action (in this case, lambda · 1 = lambda).
Note that by default all modules are synchronised over all their common ac-
tions.
PRISM also supports deﬁnition and veriﬁcation of properties based on re-
wards, therefore enabling reasoning about expected values. The basic idea is to
associate numerical values with states or transitions of the model. Rewards can
be associated with models using the rewards...endrewards construct. State
rewards can be speciﬁed using multiple reward items, each of the form:
guard : reward;
where guard is a predicate (over any variables of the model) and reward is an
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rewards
x = 0: 100;
x > 0 & x < 10 : 2*x;
x = 10: 100;
endrewards
assigns a reward of 100 to states satisfying x = 0 or x = 10 and a reward of 2∗x
to states satisfying x > 0&x < 10. Any states which do not satisfy the guard of
any reward will have no reward assigned to them. For the states which satisfy
the guards of several rewards, the reward assigned is a sum of the rewards for
all the corresponding reward items. Rewards can also be assigned to transitions
of a model (see Kwiatkowska et al. 2006). We do not use transition rewards for
our analysis.
Properties in PRISM are expressed in a language based on CSL and a number
of additional customisations and extensions are supported. One of the customi-
sations is evaluation of a property to a numeric value. This is achieved by
replacing the probability bounds in CSL properties with “=?” and is illustrated
in the following example:
Example 3.5 (Evaluation of property probabilities using PRISM)
Some probabilities evaluated using PRISM on the CTMC deﬁned in Exam-
ple 3.1:
• P=?((true)U[0,+∞](B = 2)) = 0.444
• probabilities P=?((true)U[t,t](B = 1)) and P=?((C = 0)U[t,t](B = 1)) for
diﬀerent values of t are plotted in Figure 3.3.
Note that the probabilities are evaluated on the paths which start in the initial
state of a CTMC.
The satisfaction of a property (i.e. whether it is true or false) is deﬁned for
a single state of a model. When analysing a property, PRISM considers it to
be true if it is satisﬁed in all the states of the model, and false otherwise. The
satisfaction of a property in a particular state can be veriﬁed by considering
subsets of model states. This is expressed in CSL by formulae of the form:
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Figure 3.3: Property probabilities computed with the PRISM model checker.
Such a formula holds when ψ is satisﬁed at all the states satisfying φ. This is
illustrated by the following example:
Example 3.6 (Verifying properties in a subset of model states)
Consider the model deﬁned in Example 3.1 and the CSL property
P>0.4((true)U[0,+∞](B = 2)).
PRISM evaluates this property to false because when C > 0 no state with B = 2
can be reached, but this property holds at the initial state of the model (as proba-
bility of reaching B = 2 from the initial state is 0.444 as shown in Example 3.5).
The expression above can be extended with an implication to evaluate this prop-
erty only on the initial state thus:
(A = 2) → P>0.4((true)U[0,+∞](B = 2)).
This property is evaluated to be true. Note that
(A = 2) → P>0.5((true)U[0,+∞](B = 2)).
is evaluated to false, since 0.444 is less than 0.5.
The operator S≶c(φ) is used for steady-state properties. In the cases when ≶ c
is substituted with “=?”, the actual steady-state probability will be evaluated.CHAPTER 3. MODEL-BASED REASONING 54
This is illustrated by the following example:
Example 3.7 (Steady-state properties in PRISM)
Consider the CTMC deﬁned in Example 3.1. Some steady-state properties
and their evaluations are as following:
• S=?(B > 0) = 0.888
• S=?(C > 0) = 0.555
• (A = 2) → S>0.75(B > 0) = true
• (A = 2) → S>0.75(C > 0) = false
• (A = 2) → S<0.75(C > 0) = true
Reward-based properties are speciﬁed using the operator R in a similar fash-
ion to the P and S operators. The following are some typical examples:
• R=?[I = 100] – “what is the expected reward value at exactly 100 sec-
onds?”;
• R=?[C ≤ 24] – “what is the expected sum of rewards reachable within 24
seconds?”;
• R<10[S] – “is the expected steady-state reward less than 10?”.
Here I stands for instantaneous, C for cumulative, and S for steady-state reward
value. The time units are, of course, model speciﬁc, and are usually interpreted
in the context of each particular model.
This concludes our overview of PRISM. In Section 3.2 we model one bio-
chemical reaction and evaluate some of the model’s properties using PRISM. In
Section 3.3 we build a stochastic model of a complex signalling pathway and
demonstrate how the analysis can be performed using PRISM.
3.2 Modelling Single Reaction with CTMCs
In this section we demonstrate two approaches to modelling biochemical re-
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molecules while the second one is based on modelling populations. In this sec-
tion we demonstrate both modelling approaches with reference to the following
example of a single biochemical reaction:
Example 3.8 (Single biochemical reaction: protein binding)
Consider a system consisting of one (reversible) biochemical reaction binding
proteins A and B together to form a complex AB:
A + B
k1=1
←→
k2=0.5 AB.
Assume that molecules of proteins A and B are uniformly distributed in one
spatial compartment, the probability of binding proteins to form a complex AB
is proportional to the probability that molecules will meet in the space, and the
proportion factor is some aﬃnity coeﬃcient which corresponds to the likelihood
of binding when molecules meet in space.
The probability that molecules will meet in space is proportional to the number
of molecules. The proportionality coeﬃcient is not usually considered separately
from the aﬃnity coeﬃcient: they are both combined in a common kinetic rate.
There is also a probability that complex AB will decompose producing proteins
A and B. The probability of this event is proportional to the likelihood of such
an unbinding event.
The mean dynamic behaviour of a (reversible) binding reaction is traditionally
modelled using the following system of diﬀerential equations:

  
  
˙ A = −k1 · A · B + k2 · AB,
˙ B = −k1 · A · B + k2 · AB,
˙ AB = k1 · A · B − k2 · AB.
(3.2)
Assume that initially we have an equal concentration of proteins A and B,
both 10 millimolars1 (10 mmol/L), the compartment size is 1 millilitre. No
complexes AB are present initially.
Solving the initial value problem, we obtain the simulation trace depicted in
Figure 3.4.
1The Molar (M) is a unit of concentration, or molarity, of solution equal to 1 mol/L.CHAPTER 3. MODEL-BASED REASONING 56
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Figure 3.4: Simulation of a reversible binding reaction. A|t=0 = 10, B|t=0 = 10,
AB|t=0 = 0.
3.2.1 Modelling Individual Molecules
Heath et al. (2006) propose the following approach for modelling interactions of
individual molecules with CTMCs. In the case of modelling individual molecules,
stochastic eﬀects of individual molecule-molecule interactions form the basis of
the model.
Consider Example 3.8 above. To model this system the following atomic
propositions are deﬁned:
• A = 1 – a molecule of protein A present,
• A = 0 – no molecules of A present,
• B = 1 – a molecule of protein B present,
• B = 0 – no molecules of B present,
• AB = 1 – a molecule of a complex AB present,
• AB = 0 – no complexes.
The system described in Example 3.8 can be modelled as individual molecu-
les, with a CTMC consisting of two states: s1 and s2. The labelling for these
states is the following:
• L(s1) = {A = 1,B = 1,AB = 0},CHAPTER 3. MODEL-BASED REASONING 57
• L(s2) = {A = 0,B = 0,AB = 1}.
Below is the PRISM model for this system. The rate of protein binding is
λ1; the rate of unbinding is λ2. The variables A, B and AB denote the pres-
ence/absence of a molecule of A, B or the complex AB respectively. Initially,
there is one molecule each of A and B, and none of AB.
ctmc
rate k1 = λ1;
rate k2 = λ2;
module binding
A: [0..1] init 1;
B: [0..1] init 1;
AB:[0..1] init 0;
[bind] (A = 1)&(B = 1) -> k1: (A’ = 0)&(B’ = 0)&(AB’ = 1);
[unbind] (AB = 1) -> k2: (A’ = 1)&(B’ = 1)&(AB’ = 0);
endmodule
Assume that constants λ1 and λ2 are the kinetic rates deﬁned in the original
example (i.e. λ1 = 1, and λ2 = 0.5). This assumption is sound if we consider the
system within a ﬁxed volume of uniform size. Adjustments for system volume
are required otherwise.
To calculate the probability that there will be a molecule of AB at time point
t, we check the following property:
P=?(trueU[t,t](AB = 1))
The result of this formula over the range of t [0,10] is depicted in Figure 3.5.
We also employ rewards to evaluate the probability that there is molecule
AB at time t. To do so we deﬁne the following reward:
rewards
(AB > 0) : 1;
endrewardsCHAPTER 3. MODEL-BASED REASONING 58
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Figure 3.5: Probability that there is complex AB at time t
thus assigning a reward of 1 point to each state where AB > 0 (only s2 in
this case). The expected value for this reward is evaluated using the following
property:
R=?[I = t].
The result obtained with this experiment is precisely equivalent to the one de-
picted in Figure 3.5. Thus we can employ any of the methods to compute such
probabilities.
Figure 3.5 suggests that the probability that there is a molecule of the com-
plex initially rises, and then stays at the same level. This suggests that the
system reaches an equilibrium state, which is indeed one of the features of this
system.
The concentrations of proteins and complexes can be determined from the
model of individual molecules using the following rewards (by scaling the num-
ber of molecules to concentrations with a factor of 10, because the maximal
concentration possible is the model is 10 M.):
• true:(A*10); for protein A,
• true:(B*10); for protein B,
• true:(AB*10); for complex AB.
The concentration of complex AB is compared to the one found by simulation of
the ODEs in Figure 3.6. Notice, however, that the concentration produced with
these rewards does not match the behaviour simulated with the ODE modelCHAPTER 3. MODEL-BASED REASONING 59
 0
 2
 4
 6
 8
 10
 0  2  4  6  8  10
E
x
p
e
c
t
e
d
 
c
o
n
c
e
n
t
r
a
t
i
o
n
,
 
m
M
Time, s
PRISM: E(AB)
ODEs: E(AB)
Figure 3.6: Predicted concentration of complex AB.
(introduced in Example 3.8 and originally depicted in Figure 3.4). We propose
that this is due to the lack of the population dynamics in the molecule-based
model. Namely, the rates of actions do not take the numbers of molecules into
account.
A B
A1
A2
B1
B2
bind11
bind12
bind21
bind22
Figure 3.7: Possible binding events for two molecules of protein A and B.
Below, we demonstrate how to represent population dynamics in the case of
a small number of molecules. Consider the case of two molecules. Each molecule
of protein A can bind to any of the molecules of protein B, thus we consider
four possible binding events (see Figure 3.7). Initially, all four binding events are
enabled, thus a racing condition exists in the corresponding CTMC; reﬂecting
the impact of population size onto the dynamics of this reaction. Example 3.9
deﬁnes a model with two molecules of A, B and AB each:
Example 3.9 (PRISM model of a small population of individual molecules)
ctmc
rate k1 = λ1;
rate k2 = λ2;CHAPTER 3. MODEL-BASED REASONING 60
module A1
A1:[0..1] init 1;
[bind11] (A1=1) -> k1:(A1’=0);
[bind12] (A1=1) -> k1:(A1’=0);
[unbind11] (A1=0) -> 1:(A1’=1);
[unbind12] (A1=0) -> 1:(A1’=1);
endmodule
module A2
A2:[0..1] init 1;
[bind21] (A2=1) -> k1:(A2’=0);
[bind22] (A2=1) -> k1:(A2’=0);
[unbind21] (A2=0) -> 1:(A2’=1);
[unbind22] (A2=0) -> 1:(A2’=1);
endmodule
module B1
B1:[0..1] init 1;
[bind11] (B1=1) -> 1:(B1’=0);
[bind21] (B1=1) -> 1:(B1’=0);
[unbind11] (B1=0) -> 1:(B1’=1);
[unbind21] (B1=0) -> 1:(B1’=1);
endmodule
module B2
B2:[0..1] init 1;
[bind12] (B2=1) -> 1:(B2’=0);
[bind22] (B2=1) -> 1:(B2’=0);
[unbind12] (B2=0) -> 1:(B2’=1);
[unbind22] (B2=0) -> 1:(B2’=1);
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module A1B1
A1B1:[0..1] init 0;
[bind11](A1B1=0) -> 1:(A1B1’=1);
[unbind11](A1B1=1) -> k2:(A1B1’=0);
endmodule
module A1B2
A1B2:[0..1] init 0;
[bind12](A1B2=0) -> 1:(A1B2’=1);
[unbind12](A1B2=1) -> k2:(A1B2’=0);
endmodule
module A2B1
A2B1:[0..1] init 0;
[bind21](A2B1=0) -> 1:(A2B1’=1);
[unbind21](A2B1=1) -> k2:(A2B1’=0);
endmodule
module A2B2
A2B2:[0..1] init 0;
[bind22](A2B2=0) -> 1:(A2B2’=1);
[unbind22](A2B2=1) -> k2:(A2B2’=0);
endmodule
We can analyse the transient probabilities concerning quantities of molecules
A, B or AB at any given time using the following CSL properties:
• P=?((true)U[t,t](A1 = 1)|(A2 = 1)) - at least one molecule of A is present
at time t;
• P=?((true)U[t,t](B1 = 1)|(B2 = 1)) - at least one molecule of B is present
at time t;CHAPTER 3. MODEL-BASED REASONING 62
• P=?((true)U[t,t](A1B1 = 1)|(A1B2 = 1)|(A2B1 = 1)|(A2B2 = 1)) - at least
one molecule of AB is present at time t;
The evaluation results for these properties are depicted in Figure 3.8.
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Figure 3.8: Transient probabilities for a CTMC model of individual molecules.
The solid line corresponds to the probability that at least one molecule of A and
B (out of two available) is present at a certain time. Initially, this probability
equals 1, but then the probability decreases, until stabilising between 0.5 and
0.6. The dashed line corresponds to the analogous property for complex AB.
Initially, probability equals 0, and then it increases and stabilises between 0.9
and 1.
We can also compute the concentrations of proteins using rewards. For ex-
ample, for AB such a reward is
rewards
(true):(A1B1 + A1B2 + A2B1 + A2B2)*5;
endrewards
Now, we use the scaling factor of 5 in order to map the maximal amount of
complex molecules (2 in this case) on to the allowed range of concentrations
(0 to 10 Molars). The computed (PRISM) concentration plot is depicted in
Figure 3.9. This time the result is closer to the simulation trace produced with
ODEs (introduced in Example 3.8 and originally depicted in Figure 3.4), but
there is still a signiﬁcant diﬀerence as the population dynamics is simulated
by the racing condition between parallel binding events. The quality of this
approximation will improve if a model with a larger population of molecules is
used. We investigated how the results change when using larger populations ofCHAPTER 3. MODEL-BASED REASONING 63
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Figure 3.9: Comparison of protein concentrations obtained with a model of
individuals using PRISM rewards with ODE results.
molecules by building a programme which generates individual-based models for
a given size of molecules population.
Figure 3.10 demonstrates how the result for the concentration of AB ap-
proaches the simulation trace generated with the ODE model as the number of
molecules increases.
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Figure 3.10: Estimates generated from CTMC models with diﬀerent number of
molecules.
The size of the CTMCs, however, increases dramatically when modelling
larger populations. Table 3.1 lists sizes of CTMCs for diﬀerent models of Exam-
ple 3.8. Notice that models of 6 or 7 molecules per species ﬁtted into computer’s
memory, however, we could not calculate the estimated concentrations as reward
computations became intractable (e.g. took more than 3 days on a state of art
desktop computer).CHAPTER 3. MODEL-BASED REASONING 64
Number of Molecules
per species
States Transitions
1 2 2
2 7 16
3 34 126
4 209 1088
5 1546 10450
6 13327 111312
7 130922 1306046
8 Does not ﬁt to computer’s memory
Table 3.1: Sizes of CTMCs for models of individual molecules.
Models of larger populations are intractable for both the description (because
a separate variable, or a module is required for each molecule, and a separate
command is required for each possible binding event) and computational exper-
iments.
We conclude that due to complexity limitations (state space and time) it is
problematic to employ the individual-based modelling approach of Heath et al.
(2006) for systems with large populations of molecules when population dy-
namics plays an important role. However, this approach may be suitable when
modelling systems consisting of few molecules, where population dynamics does
not serve an important role in shaping the system behaviour.
We propose that the scalability problem can be resolved by adopting a
population-based approach as deﬁned in the following section (see Section 3.2.2).
3.2.2 Population-Based Modelling
To resolve the scalability problem demonstrated in the previous section we pro-
pose an approach which takes the population dynamics directly into account.
This means considering concentrations rather than individual molecules. We
extend an approach published in (Calder, Gilmore and Hillston 2006) which was
implemented in PEPA. Instead of considering two symbolic levels of concen-
tration (“high” and “low” in (Calder, Gilmore and Hillston 2006)) we propose
to use multiple intervals of the concentration. Additionally, we propose a new
form of analysis of such models using probabilistic symbolic model checking. We
reported some of this work in (Calder, Vyshemirsky, Gilbert and Orton 2006).
The key concept is the introduction of discrete concentrations for each bio-CHAPTER 3. MODEL-BASED REASONING 65
chemical species.
Each species has a concentration which changes with time, i.e. m = f(t),
where m is a concentration of the species and t is time. We make discrete
abstractions as follows. When the maximum concentration is M, then for a
given N, the abstract values 0...N represent the concentration intervals [0,1 ∗
M/N),[1 ∗ M/N,2 ∗ M/N),...[(N − 1) ∗ M/N,N ∗ M/N]. We refer to 0...N
as levels of concentration. We note that we could deﬁne a diﬀerent N for each
species but in this chapter, without loss of generality, we assume the same N,
for all species.
To model a biochemical system we associate a concurrent, computational
process with each of the proteins in the network and deﬁne these processes by
PRISM modules. We note that this description could be produced automatically
from a topological description of the pathway. Consider a model of a binding
reaction (Example 3.10) described in Example 3.8.
Example 3.10 (Population model for Example 3.8.)
ctmc
const double M=10.0;
const int N=3;
const double L=M/N;
rate k1=1.0;
rate k2=0.5;
module A
A: [0..N] init N;
[bind] (A>0) -> A*L: (A’ = A - 1);
[unbind] (A<N) -> 1: (A’ = A + 1);
endmodule
module B
B: [0..N] init N;
[bind] (B>0) -> B*L: (B’ = B - 1);
[unbind] (B<N) -> 1: (B’ = B + 1);CHAPTER 3. MODEL-BASED REASONING 66
endmodule
module AB
AB: [0..N] init 0;
[bind] (AB < N) -> 1: (AB’ = AB + 1);
[unbind] (AB > 0) -> AB*L: (AB’ = AB - 1);
endmodule
module Constants
x: bool init true;
[bind] (x) -> k1/L: (x’=true);
[unbind] (x) -> k2/L: (x’=true);
endmodule
rewards
(true) : AB*L;
endrewards
The model begins with the keyword ctmc, consists of some preliminary con-
stants:
• M – the maximal (continuous) concentration of any species,
• N – the number of discrete abstract concentration levels,
• L – the length of each interval, an abbreviation for M/N;
and four modules: A, B, AB, and Constants. Consider the ﬁrst three modules,
representing species A, B, and AB. Each module has the form: a state variable
which denotes the species concentration (we use the same name for process and
variable, the type can be deduced from the context) followed by commands with
actions [bind] and [unbind].
In order to deﬁne the rates of the transitions, we distinguish species which
are spent in a reaction (reactants) from species which are produced in a reaction
(products). Since the transitions are synchronised on common actions, the rate
of each transition will be a product of rates deﬁned in individual modules. We
assign these rates to the concentration of reactants (in corresponding modules)CHAPTER 3. MODEL-BASED REASONING 67
multiplied by the scaling coeﬃcient L, which corresponds to the length of the
discrete interval. The rates in modules which correspond to products are set to
1.
There is a fourth module, Constants. This module simply deﬁnes the coef-
ﬁcients for reaction kinetics. This module uses a “dummy” state variable called
x, and (two) always enabled transitions with actions bind and unbind.
The assignments for the transitions of reactants decrease the value of corre-
sponding variables by 1, thus decreasing corresponding species’ concentration.
The assignments for products increase corresponding variables by 1.
All the transitions with the same action are synchronised. For example, the
resulting transition from the initial state for action bind has rate:
λ =
N · L · N · L · k1
L
= 30. (3.3)
The resulting CTMC consists of 4 states and 6 transitions. The schematic
representation of this CTMC is depicted in Figure 3.11.
S0
A = 3
B = 3
AB = 0
X
S1
A = 2
B = 2
AB = 1
X
S2
A = 1
B = 1
AB = 2
X
S3
A = 0
B = 0
AB = 3
X
30 13.3333 3.3333
0.5 1 1.5
Figure 3.11: CTMC for model from Example 3.10.
Consider the soundness of this modelling approach. The crucial question
is how do the transition rates compare with, or relate to, the binding kinetics
explained in Example 3.8?
First, consider how the variables relate to each other: the system of diﬀeren-
tial equations (3.2) in Example 3.8 refers to continuous concentrations, whereas
the PRISM model operates on discrete natural concentration levels. Let mi be
a continuous variable (e.g. m1 = A, m2 = B and m3 = AB in (3.2)). and let
md
i be the corresponding PRISM variable (e.g. A, B, AB). Then
mi = m
d
i · L = m
d
i ·
M
N
(3.4)
Second, derive a rate expressed in terms of the PRISM variables. From theCHAPTER 3. MODEL-BASED REASONING 68
continuous rate:
dm3
dt
= k1 · m1 · m2 (3.5)
the simplest way to derive a new concentration m0
3 from m3 is by Euler’s method
thus:
m
0
3 = m3 + (k · m1 · m2 · ∆t) (3.6)
But the discrete (PRISM) concentrations can only increase in units of 1 level of
concentration, or M
N molars, so the time to perform such concentration change
is:
∆t =
M
k1 · m1 · m2 · N
(3.7)
PRISM implements rates as “memoryless” negative exponential, that is for given
rate λ, P(t) = 1−e−λt is the probability that the transition will be taken before
time t. Taking λ as 1
∆t, in this example we have
λ =
k1 · m1 · m2 · N
M
(3.8)
Replacing the continuous variables by their discrete forms, we have
λ =
k1 · (md
1 · M
N ) · (md
2 · M
N ) · N
M
(3.9)
or
λ =
md
1 · L · md
2 · L · k1
L
(3.10)
which in an initial state of Example 3.10 is
λ =
N · L · N · L · k1
L
= 30, (3.11)
which is exactly the rate given in (3.3).
Now consider simulation of behaviour predictions using these population-
based models. In Example 3.10, we included the factor (/L) in the Constants
module, and multiply the concentrations by the scaling factor L in the protein
processes. The following reward
(true) : AB*L;
can be used to determine the expected concentration of complex AB. The
scaling factor L is used again to convert the discrete concentration to the scaleCHAPTER 3. MODEL-BASED REASONING 69
of continuous concentrations. The estimated concentration of AB for diﬀerent
values of N are compared with the simulation trace produced with ODEs in
Figure 3.12.
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Figure 3.12: Model behaviour predictions for diﬀerent values of N. Note, that
in comparison to Figure 3.10, the predicted behaviours here provide better ap-
proximations to the behaviour simulated with ODEs.
The size of CTMCs when using this approach depends linearly on the number
of intervals employed. Table 3.2 lists sizes of CTMCs for diﬀerent population-
based models of Example 3.8.
N States Transitions
1 2 2
2 3 4
3 4 6
4 5 8
7 8 14
10 11 20
50 51 100
200 201 400
Table 3.2: Sizes of CTMCs for population-based models.
This illustrates how, using a population-based approach, we have overcome
the problem of model complexity. At the same time we have managed to achieve
a more precise simulation of population dynamics. In the next section (see Sec-
tion 3.3) we apply this methodology to a more complex biochemical pathway.CHAPTER 3. MODEL-BASED REASONING 70
3.3 Modelling a Pathway with CTMCs
In this section we consider modelling and analysing the RKIP inhibited ERK
pathway. Here we give only a brief overview of the pathway structure, further
details are presented in (Cho et al. 2003).
This pathway is a ubiquitous pathway that conveys mitogenic and diﬀeren-
tiation signals from the cell membrane to the nucleus.
The kinase inhibitor protein RKIP inhibits activation of Raf and we conjec-
ture that it can reduce the strength of the signal passing through the pathway.
m1
Raf-1*
m2
RKIP
m3
Raf-1*/RKIP
k1/k2
k3/k4
k9/k10
k6/k7
k5
k11
k8
m4
Raf-1*/RKIP/ERK-PP
m5
ERK
m7
MEK-PP
m8
MEK-PP/ERK
m6
RKIP-P
m10
RP
m11
RKIP-P/RP
m9
ERK-PP
Figure 3.13: The RKIP inhibited ERK pathway
We consider the pathway as given in the graphical representation of Fig-
ure 3.13. This ﬁgure is taken from (Cho et al. 2003), where a number of nonlin-
ear ordinary diﬀerential equations (ODEs) representing the kinetics are given.
We take Figure 3.13 as our starting point, and explain informally, its meaning.
Each node is labelled by a protein (or species). For example, Raf-1*, RKIP and
Raf-1*/RKIP are proteins, the last being a complex built up from the ﬁrst two.
A suﬃx -P or -PP denotes a (single or double, resp.) phosphorylated protein, for
example RKIP-P and ERK-PP. Each protein has an associated concentration,
given by m1, m2 etc. Reactions deﬁne how proteins are built up and broken
down. Propagation of a signal corresponds to the “wave” of binding/unbindingCHAPTER 3. MODEL-BASED REASONING 71
events. In Figure 3.13, bidirectional arrows correspond to both forward and
backward reactions; unidirectional arrows to forward reactions. Each reaction
has a rate given by the rate constants k1, k2, etc. These are given in the rect-
angles, with kn/kn + 1 denoting that kn is the forward rate and kn + 1 the
backward rate. Initially, all concentrations are equal to zero, except for m1, m2,
m7, m9, and m10 (Cho et al. 2003). The dynamic behaviour of the pathway
is quite complex, because proteins are involved in more than one reaction and
there are several feedbacks. We note that the example system is part of a larger
pathway which can be found elsewhere (e.g Kholodenko et al. 1999 Schoeberl
et al. 2002).
ERK-PP is a protein which is capable of entering the cell nucleus, and for
this reason is usually considered the “output” of the signalling pathway.
We model this biochemical pathway employing the population-based ap-
proach described in Section 3.2.2.
Example 3.11 (PRISM model of the RKIP inhibited ERK pathway.)
ctmc
const double M=3.0;
const int N=12;
const int I1=floor((2.5*N)/3.0);
const int I2=N;
const double L=M/N;
rate k1=0.53;
rate k2=0.0072;
rate k3=0.625;
rate k4=0.00245;
rate k5=0.0315;
rate k6=0.8;
rate k7=0.0075;
rate k8=0.071;
rate k9=0.92;
rate k10=0.00122;
rate k11=0.87;CHAPTER 3. MODEL-BASED REASONING 72
module RAF1
RAF1: [0..I1] init I1;
[r1] (RAF1 > 0) -> RAF1*L: (RAF1’ = RAF1 - 1);
[r2] (RAF1 < I1) -> 1: (RAF1’ = RAF1 + 1);
[r5] (RAF1 < I1) -> 1: (RAF1’ = RAF1 + 1);
endmodule
module RKIP
RKIP: [0..I1] init I1;
[r1] (RKIP > 0) -> RKIP*L: (RKIP’ = RKIP - 1);
[r2] (RKIP < I1) -> 1: (RKIP’ = RKIP + 1);
[r11] (RKIP < I1) -> 1: (RKIP’ = RKIP + 1);
endmodule
module RAF1RKIP
RAF1RKIP: [0..I1] init 0;
[r1] (RAF1RKIP < I1) -> 1: (RAF1RKIP’ = RAF1RKIP + 1);
[r2] (RAF1RKIP > 0) -> RAF1RKIP*L:(RAF1RKIP’ = RAF1RKIP - 1);
[r3] (RAF1RKIP > 0) -> RAF1RKIP*L:(RAF1RKIP’ = RAF1RKIP - 1);
[r4] (RAF1RKIP < I1) -> 1: (RAF1RKIP’ = RAF1RKIP + 1);
endmodule
module ERKPP
ERKPP: [0..I1] init I1;
[r3] (ERKPP > 0) -> ERKPP*L: (ERKPP’ = ERKPP - 1);
[r4] (ERKPP < I1) -> 1: (ERKPP’ = ERKPP + 1);
[r8] (ERKPP < I1) -> 1: (ERKPP’ = ERKPP + 1);
endmodule
module RAF1RKIPERKPP
RAF1RKIPERKPP: [0..I1] init 0;
[r3] (RAF1RKIPERKPP < I1) -> 1:(RAF1RKIPERKPP’ = RAF1RKIPERKPP + 1);
[r4] (RAF1RKIPERKPP > 0) ->RAF1RKIPERKPP*L:
(RAF1RKIPERKPP’ = RAF1RKIPERKPP - 1);
[r5] (RAF1RKIPERKPP > 0) ->RAF1RKIPERKPP*L:
(RAF1RKIPERKPP’ = RAF1RKIPERKPP - 1);CHAPTER 3. MODEL-BASED REASONING 73
endmodule
module ERK
ERK: [0..I1] init 0;
[r5] (ERK < I1) -> 1: (ERK’ = ERK + 1);
[r6] (ERK > 0) -> ERK*L: (ERK’ = ERK - 1);
[r7] (ERK < I1) -> 1: (ERK’ = ERK + 1);
endmodule
module RKIPP
RKIPP: [0..I1] init 0;
[r5] (RKIPP < I1) -> 1: (RKIPP’ =RKIPP + 1);
[r9] (RKIPP > 0) -> RKIPP*L: (RKIPP’ =RKIPP - 1);
[r10] (RKIPP < I1) -> 1: (RKIPP’ =RKIPP + 1);
endmodule
module RP
RP: [0..I2] init I2;
[r9] (RP > 0) -> RP*L: (RP’ = RP - 1);
[r10] (RP < I2) -> 1: (RP’ = RP + 1);
[r11] (RP < I2) -> 1: (RP’ = RP + 1);
endmodule
module MEKPP
MEKPP: [0..I1] init I1;
[r6] (MEKPP > 0) -> MEKPP*L: (MEKPP’ = MEKPP - 1);
[r7] (MEKPP < I1) -> 1: (MEKPP’ = MEKPP + 1);
[r8] (MEKPP < I1) -> 1: (MEKPP’ = MEKPP + 1);
endmodule
module MEKPPERK
MEKPPERK: [0..I1] init 0;
[r6] (MEKPPERK < I1) -> 1: (MEKPPERK’ = MEKPPERK + 1);
[r7] (MEKPPERK > 0) -> MEKPPERK*L:(MEKPPERK’ = MEKPPERK - 1);
[r8] (MEKPPERK > 0) -> MEKPPERK*L:(MEKPPERK’ = MEKPPERK - 1);
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module RKIPPRP
RKIPPRP: [0..I1] init 0;
[r9] (RKIPPRP < I1) -> 1: (RKIPPRP’ = RKIPPRP + 1);
[r10] (RKIPPRP > 0) -> RKIPPRP*L: (RKIPPRP’ = RKIPPRP - 1);
[r11] (RKIPPRP > 0) -> RKIPPRP*L: (RKIPPRP’ = RKIPPRP - 1);
endmodule
module Constants
x: bool init true;
[r1] (x) -> k1/L: (x’ = true);
[r2] (x) -> k2/L: (x’ = true);
[r3] (x) -> k3/L: (x’ = true);
[r4] (x) -> k4/L: (x’ = true);
[r5] (x) -> k5/L: (x’ = true);
[r6] (x) -> k6/L: (x’ = true);
[r7] (x) -> k7/L: (x’ = true);
[r8] (x) -> k8/L: (x’ = true);
[r9] (x) -> k9/L: (x’ = true);
[r10] (x) -> k10/L: (x’ = true);
[r11] (x) -> k11/L: (x’ = true);
endmodule
The model deﬁned in Example 3.11 uses special constants I1 and I2 to tackle
diﬀerent maximal concentration for diﬀerent species. For example, the original
model (see Cho et al. 2003) of this pathway states that the initial concentration
for RP is 3.0 Molars, while the initial concentrations for Raf-1*, RKIP, ERK-
PP and MEK-PP are 2.5 Molars. Thus, we deﬁne I1 as an integer part of 2.5·N
3.0
which is the discrete value for 2.5 Molars, and I2 equal to N which is the discrete
value for 3.0 Molars.
We use PRISM rewards to evaluate the estimates for protein concentrations.
The following reward:
rewards
true: ERKPP*L;
endrewards
produces the estimate for the MEK-PP concentration. To compare simulation
results between this stochastic model and the deterministic model deﬁned by theCHAPTER 3. MODEL-BASED REASONING 75
system of diﬀerential equations (3.2), consider the concentration of MEK-PP,
over the time interval [0...100]. Concentration is the vertical axis. Figure 3.14
demonstrates the results, using the ODE model and two instances of our stochas-
tic model, with N = 6 and N = 12. The “upper” curve is the ODE simulation,
the “lower” curve is the stochastic simulation, when N = 3; the curve in between
the two is the stochastic behaviour when N = 7. As N increases, the closer the
plots; with N = 12 the diﬀerence is barely discernible.
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Figure 3.14: Concentration estimates for ERK-PP
In this model the size of the CTMCs depends entirely on the number of
abstract concentration levels. This is due to concurrency and interleaving in this
model, e.g. binding of Raf-1* to RKIP can either precede or succeed binding
of RKIP-P to RP. The sizes of CTMCs for diﬀerent numbers of concentration
levels are given in Table 3.3.
While it is very interesting to see that a stochastic model produces the be-
haviour very similar to the one produced with the deterministic ODE model,
even when employing quite a small number of concentration levels, the primary
motivation for this methodology is logical analysis, with respect to temporal
logic properties.CHAPTER 3. MODEL-BASED REASONING 76
N States Transitions
2 13 30
3 73 276
6 1974 12236
8 4326 28896
10 16071 118932
12 47047 372372
16 175644 1485848
Table 3.3: Sizes of CTMCs for models of the RKIP inhibited ERK pathway.
Temporal logics are powerful tools for expressing temporal queries which may
be generic (e.g. state reachability, deadlock) or application speciﬁc (e.g. refer-
ring to variables representing application characteristics). Whereas simulation
is the exploration of a single behaviour over a given time interval, model check-
ing allows us to investigate the truth (or otherwise) of temporal queries over
(possibly inﬁnite) sets of behaviours over (possibly) unbounded time intervals.
For this example, we consider three diﬀerent kinds of temporal property:
1. steady state analysis of stability of a protein, i.e. a protein reaches a level
and then remains there, within certain bounds,
2. steady state analysis of protein stability when varying reaction rates, i.e.
a protein is more likely to be stable for certain reaction rates,
3. transient analysis of protein activation sequence, i.e. concentration peak
ordering.
3.3.1 Stability of Protein in Steady State
This type of property is particularly applicable to the analysis of networks where
temporary and sustained signal responses can produce markedly diﬀerent cel-
lular outcomes. For example, a transient signal could lead to cell proliferation,
whereas a sustained signal would result in diﬀerentiation.
Consider the concentration of Raf-1*. Stability for this protein (at level D)
is expressed by the CSL formula:
S=?[(RAF1 = D)] (3.12)CHAPTER 3. MODEL-BASED REASONING 77
The results are given Figure 3.15, with D ranging over 0...12 (N = 12).
They illustrate that Raf-1* is most likely to be stable at level 1, with a relatively
high probability of stability at levels 0, 2 or 3. It is unlikely to be stable at levels
4 or more.
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Figure 3.15: Stability of Raf-1* at level D in steady state.
3.3.2 Protein Stability in Steady State while Varying Rates
This type of property is particularly useful during model ﬁtting, i.e. ﬁtting the
model to experimental data. As an example, consider evaluating the probability
that Raf-1* is stable in concentrations interval [0.25...0.5] mM (discrete level
2) in the steady state, whilst varying the rate of the reaction r1 (the reaction
which binds Raf-1* and RKIP). We vary the parameter k1 (which determines
the rate of r1) over the interval [0...1]. The stability property is expressed by:
S=?[RAF1 = 2] (3.13)
Consider also the probability that Raf-1* is stable at level 1 ([0...0.25] mM);
the formula for this is:
S=?[RAF1 = 1] (3.14)
Figure 3.16 depicts results for both these properties, when N = 12. The
probability density of property (3.13) (solid line) peaks at k1 = 0.2 and then
decreases; the probability density of property (3.14) (dashed line) increases dra-
matically, reaching a maximum when k1 > 0.6.CHAPTER 3. MODEL-BASED REASONING 78
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Figure 3.16: Stability of Raf-1* for diﬀerent values of rate k1
3.3.3 Activation Sequence Analysis
The last example illustrates queries over several proteins: sequences of protein
activations. Consider two complexes: Raf-1*/RKIP and Raf-1*/RKIP/ERK-
PP. Is it possible that the (concentration of the) former “peaks” before the
latter?
Let M be the peak level of Raf-1*/RKIP/ERK-PP, and D be the level of
Raf-1*/RKIP. The formula for this property is:
P=?[(RAF1RKIPERKPP < M)U(RAF1RKIP = D)] (3.15)
This property expresses “What is the probability that the concentration of
Raf-1*/RKIP/ERK-PP does not exceed level M, until Raf-1*/RKIP reaches
concentration level D?” The results of this query, for N = 6, D ranging
over {1,2} and M ranging over {1,2,3,4,5} are given in Table 3.4. For ex-
ample, the probability Raf-1*/RKIP reaches concentration level 2 before Raf-
1*/RKIP/ERK-PP reaches concentration level 5 is 98.7%, the probability Raf-
1*/RKIP reaches concentration level 2 before Raf-1*/RKIP/ERK-PP reaches
concentration level 2 is 90.9%.
To conﬁrm these results, we conducted the inverse experiment – is it possibleCHAPTER 3. MODEL-BASED REASONING 79
M = 1 M = 2 M = 3 M = 4 M = 5
D = 1 100% 100% 100% 100% 100%
D = 2 73.1% 90.9% 95.9% 97.5% 98.7%
Table 3.4: Protein activation sequence (Property (3.15)).
for Raf-1*/RKIP/ERK-PP to reach concentration level 5 before Raf-1*/RKIP
reaches concentration level 2 with N = 6? The property is:
P=?[(RAF1RKIP < D)U(RAF1RKIPERKPP = M)] (3.16)
This property expresses “What is the probability that the concentration of Raf-
1*/RKIP is less than level D until Raf-1*/RKIP/ERK-PP reaches concentra-
tion level M?” The results are given in Table 3.5 which is complementary to
Table 3.4: for example, the probability Raf-1*/RKIP/ERK-PP reaches concen-
tration level 5 before Raf-1*/RKIP reaches concentration level 2 is 1.39%. This
conﬁrms the results obtained with property (3.15).
M = 1 M = 2 M = 3 M = 4 M = 5
D = 1 0% 0% 0% 0% 0%
D = 2 26.9% 9.1% 4.1% 2.5% 1.3%
Table 3.5: Inverse protein activation sequence (Property (3.16)).
3.4 Discussion: Population-Based Modelling and
Deductive Reasoning
We have described a new population-based modelling and quantitative deduc-
tive analysis approach for signal transduction networks. We model the dynamics
of networks by continuous time Markov chains, making discrete approximations
to concentrations. We describe the models in the high level PRISM modelling
language: proteins are synchronous processes and concentrations are state vari-
ables. We have illustrated our approach with an example, the RKIP inhibited
ERK pathway, a pathway previously modelled by ODEs (Cho et al. 2003).
The PRISM model checker has been a useful tool for model checking, ex-
perimentation, and even simulation. All computations have been tractable on a
single standard processor (the times are trivial and have been omitted).CHAPTER 3. MODEL-BASED REASONING 80
The main advantage of our approach is that using a continuous time stochas-
tic logic and the PRISM model checker, we can perform quantitative analysis
such as what is the probability that a protein reaches a stable concentration level?
and how does varying a reaction rate aﬀect that probability? The approach oﬀers
considerably more expressive power than simulation or qualitative analysis. We
can also perform standard simulations and we have compared our results with
traditional ordinary diﬀerential equation-based (simulation) methods. An inter-
esting and useful result is that in the example pathway, only a small number
of discrete data values is required to render the simulations practically indistin-
guishable.
In Section 3.2.2 we showed how our population based PRISM model relates
to mass action kinetics as deﬁned by ODEs. While simulation is not the pri-
mary goal of our approach, in Section 3.3 we demonstrated that with small N,
our model provides (more than) suﬃcient simulation accuracy, for the example
system. This is because the example pathway has reactions which are all on a
similar scale. If we were to apply our approach to a pathway where the changes
of concentrations are on diﬀerent scales, i.e. the corresponding ODE model is
a set of stiﬀ equations, then we could still reason about the stochastic model
using temporal logic queries. However, simulations would not be as accurate,
for small N. If more accuracy of simulation was required, then we would have
to increase N.
We demonstrated how deductive reasoning using temporal logic properties
can be performed to show that the pathway model considered in Section 3.3
reaches the steady state, and to verify that one of the proteins (Raf-1*/RKIP)
is likely to “peak” earlier than another one (Raf-1*/RKIP/ERK-PP).
3.5 Model Analysis: from Reasoning to Infer-
ence
In this chapter we have developed a deductive reasoning approach to analyse
model behaviour. We have assumed that the structure of a model and partic-
ular quantitative kinetic parameters are known: the aim of the reasoning is to
derive model behaviours and deduce properties of such behaviours. We formu-
lated models using Continuous Time Markov Chains (deﬁned with a high level
language), and expressed properties using CSL.CHAPTER 3. MODEL-BASED REASONING 81
In the next chapter we consider an inferential approach which solves the
inverse problem: given observed behaviour, we search for suitable model pa-
rameters and compare alternative model topologies. Models will be formulated
using ODEs, since these are traditional models for time course data.
Summary
In this chapter we considered two modelling approaches for quan-
titative reasoning about biological systems. Both approaches use
continuous time Markov chains. Initially, we considered an approach
proposed by Heath et al. (2006) that is based on modelling individ-
ual molecules. We have demonstrated that while being suitable for
some cases when only a few molecules are involved in a model (such
as Protein-DNA interaction models) this approach is inadequate for
modelling systems where any impact of population dynamics is im-
portant. We tried to ﬁx this ﬂaw by explicitly deﬁning small popu-
lations of molecules. We have shown how several molecules can be
modelled using this approach, however this solution does not appear
to be practical, as it leads to a well known state space explosion
problem.
To resolve these problems, we proposed a novel population-based
modelling approach which employs abstract discrete concentration
levels. These provide approximations for continuous concentration
values. We compared the simulated model behaviours to the solu-
tions of the traditional ODE models, and found that even a small
number of abstract concentration levels can be suﬃcient for a satis-
factory simulation of biochemical system dynamics.
The main advantage of the proposed modelling approach is the ability
to apply model checking techniques to enable logical reasoning. We
have demonstrated how this can be done on a case study of the
RKIP inhibited ERK pathway by proposing and verifying a number
of logical properties described with Continuous Stochastic Logic.Chapter 4
Model-Based Inference
Overview
In this chapter we consider a problem of model inference and test-
ing of alternative hypotheses, when models are deﬁned by non-linear
ordinary diﬀerential equations and the experimental data is noisy
and sparse. We compare and evaluate a number of statistical tech-
niques, and implement an eﬃcient Bayesian inferential framework for
Systems Biology based on Markov chain Monte Carlo methods and
estimation of marginal likelihoods by annealing-melting integration.
We illustrate the application of this framework with two case studies,
one of which involves an open problem concerning the mediation of
ERK phosphorylation in the ERK signal transduction pathway.
4.1 Background
In this chapter we develop an inferential framework for Systems Biology. The
inferential framework consists of methods to perform inference and hypotheses
testing tasks. It requires alternative hypotheses to be deﬁned with paramet-
ric statistical models. The initial knowledge and beliefs have to be deﬁned as
prior distributions of model parameters. The likelihood function which com-
pares behaviour produced by a model to the experimental data allows us to
infer plausible posterior distributions of the model parameters that explain the
observed data. Alternative models can be ranked by the degree of their support
by experimental data. The main contribution of this chapter is the selection of
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methods that perform well with nontrivial models used in modelling biochemical
systems.
As we base the inferential framework for Systems Biology on the founda-
tions of Bayesian theory, we begin this chapter with an introduction of the main
concepts of Bayesian analysis, and practical methods for Bayesian inference.
This overview should be considered as a general one, though suﬃcient to under-
stand the work described in this chapter. A complete overview of the Bayesian
inference philosophy, background and methods can be found in, for example,
(Lindley 1965 Box et al. 1983 Bernardo and Smith 1994 Jaynes 2003).
4.1.1 Bayesian Inference
(Bernardo and Smith 1994) demonstrate how Bayesian theory is built on the
foundation of axiomatic utility theory, and therefore is conceptually sound. In
this section we introduce the main concepts for Bayesian inference, and provide
an overview of the methods which can be used to perform such inference.
Formally, Bayesian inference is statistical inference in which evidence or ob-
servations are used to update or to infer the probability that a hypothesis may
be true. To perform such inference we need to deﬁne a way to express our initial
beliefs and describe the process by which some evidence or observations can be
used to update these beliefs.
Applying Bayesian inference methods requires formal representation of the
available knowledge. This should include the statistical model for the problem,
and a priori information about the model parameters, as we assume that the
statistical model is parametric.
In the cases when we have several competing hypotheses about some phe-
nomenon, and therefore several competing models of it, we also associate an a
priori probability p(Mi) to each model, which describes the degree of initial be-
lief that a particular model is the most appropriate one to describe the observed
phenomenon.
Our initial beliefs (initial state of information) about the values of parameters
of each available statistical model of the system are, most often, uncertain and
therefore distributed according to some probability density function p(θi|Mi).
This probability distribution function is called “a prior distribution of model
parameters”.
When some new information D about the modelled phenomenon is acquired,CHAPTER 4. MODEL-BASED INFERENCE 84
we update our beliefs according to Bayes’ theorem. The updated distribution
of our beliefs is called “a posterior distribution of model parameters”. D can
correspond to the data from a newly performed experiment, or new information
published in a recent paper. Bayes’ theorem deﬁnes how the posterior can be
obtained from the prior, generally:
p(θi|Mi,D) =
p(D|Mi,θi) · p(θi|Mi) R
p(D|Mi,θi) · p(θi|Mi)dθi
.
Here the probability p(D|Mi,θi) to produce data D with model Mi given parame-
ters θi is called “the likelihood” (see, for example, Cox and Hinkley 1974 Gelman
et al. 1995).
Consider Example 4.1 as an illustration of a consistent beliefs update using
this methodology:
Example 4.1 (Inference about a genetic probability)
This example is proposed by Gelman et al. (1995) to illustrate how inference
can be performed using Bayes’ theorem.
Human males have one X-chromosome and one Y-chromosome, whereas fe-
males have two X-chromosomes, each chromosome being inherited from one par-
ent. Haemophilia is a disease that inhibits X-chromosome-linked recessive inher-
itance, meaning that a male who inherits the gene which causes the disease on
the X-chromosome is aﬀected, whereas a female carrying the gene on only one
of her two X-chromosomes is not aﬀected. The disease is generally fatal for
women who inherit two such genes, and this is very rare, since the frequency of
occurrence of the gene is low in human populations.
Consider a woman who has an aﬀected brother, which implies that her mo-
ther must be a carrier of the haemophilia gene with one “good” and one “bad”
X-chromosome. We are also told that her father is not aﬀected; thus the woman
herself has a ﬁfty-ﬁfty chance of having the gene. The unknown quantity of
interest, the state of the woman, has only two possible values: the woman is a
carrier of the gene (θ = 1) or not (θ = 0). Based on the information provided
thus far, the prior distribution for the unknown θ can be expressed as: p(θ =
1) = p(θ = 0) = 1
2.
The new information which is used for inference is the status of the woman’s
sons. Suppose she has two sons, neither of whom is aﬀected. Let di = 1 orCHAPTER 4. MODEL-BASED INFERENCE 85
0 mean aﬀected or unaﬀected son, respectively. We assume that sons are not
identical twins, therefore the outcomes are independent. The likelihood takes the
following form:
p(d1 = 0,d2 = 0|θ = 1) = (0.5)(0.5) = 0.25
p(d1 = 0,d2 = 0|θ = 0) = (1)(1) = 1.
Bayes’ theorem can now be used to update our beliefs in whether the woman
is a carrier of a haemophilia gene. Using D to denote the joint data (d1,d2), the
posterior probability that the woman is a carrier is:
p(θ = 1|D) =
p(D|θ = 1)p(θ = 1)
p(D|θ = 1)p(θ = 1) + p(D|θ = 0)p(θ = 0)
=
(0.25)(0.5)
(0.25)(0.5) + (1.0)(0.5)
=
0.125
0.625
= 0.20.
Intuitively it is clear that if a woman has unaﬀected children, it is less proba-
ble that she is a carrier, and Bayes’ theorem provides a formal mechanism for
determining the extent of the correction.
In Example 4.1 we were in a (very rare) position, when we were able to iterate
through the ﬁnite space of the available options, and compute the likelihoods
and the priors by simple enumeration of possible outcomes.
Analytical inference of parameter posteriors is also possible in some spe-
cial cases when the likelihood belongs to the exponential family, e.g. Normal,
Bernoulli, Poisson) and a conjugate prior is used. This approach is not consid-
ered in this thesis as it is not applicable to the class of models used. A detailed
description of the conjugate priors approach can be found in (Bernardo and
Smith 1994).
In this chapter we consider several complex models as our case studies. These
are formulated using non-linear ordinary diﬀerential equations. We argue that, in
the majority of realistic applications within Systems Biology, it is not possible to
perform inference analytically due to the complexity of the integrals involved. In
such cases we need some numerical methods to be able to evaluate the posteriors.
A large family of such numerical methods is called Monte Carlo methods, which
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4.1.2 Deterministic Approximations to the Posterior
In this section we consider an analytical method of inferring parameter posteriors
using a Taylor series expansion of the likelihood around the maximal likelihood
estimate of the parameter.
This approach is justiﬁed for the cases when the posterior is almost multivari-
ate normal. This, however, is rare when the models are deﬁned using nonlinear
diﬀerential equations, and only a few variables can be observed.
In some cases, analytical methods cannot be applied for inference mainly due
to complexity of evaluating an integral of the form:
E [g(θ)|D] =
Z
θ∈Θ
g(θ)p(θ|D)dθ, (4.1)
where p(θ|D) is derived from a predictive model, and g(θ) is some real-valued
function of interest. Often, g(θ) is a ﬁrst or second moment, and p(θ|D) is given
by
p(θ|D) =
p(D|θ)p(θ) R
θ∈Θ p(D|θ)p(θ)dθ
.
In order to evaluate (4.1) using Laplace’s method (see Tierney and Kadane 1986)
we ﬁrst express the integrand in the form exp{log(g(θ)p(θ|D))} and then expand
log(g(θ)p(θ|D)) as a function of θ in a quadratic Taylor series around its mode
θ0:
log(g(θ)p(θ|D)) ≈ log(g(θ0)p(θ0|D)) −
1
2
(θ − θ0)
TA(θ − θ0) + ...,
where
A = − ∇
2 log(g(θ)p(θ|D))


θ=θ0 , (4.2)
Aij = −
∂2
∂θi∂θj
log(g(θ)p(θ|D))

 

θ=θ0
. (4.3)
This method assumes that θ0, as a mode of a multivariate Gaussian distribution,
is the maximum a posteriori estimate of the model parameters.
g(θ)p(θ|D) can then be approximated by an unnormalised Gaussian
q
∗(θ) = g(θ0)p(θ0|D)exp

−
1
2
(θ − θ0)
TA(θ − θ0)

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and the normalising constant Zq for this Gaussian is
Zq = g(θ0)p(θ0|D)
r
(2π)n
detA
, (4.5)
where n is the dimensionality of the parameter space.
For the cases when matrix A cannot be evaluated analytically, numerical
derivation methods can be used. Though, this approximation is valid, as already
mentioned, it is only valid in the cases when the posterior is unimodal and almost
multivariate normal. For more complex cases, for example, when the likelihood
is multimodal or diﬀers signiﬁcantly from a normal distribution (as in the case
studies considered in Sections 4.3.1 and 4.3.2), the Laplace approximations are
not valid. In more complex cases, other methods, for example, Monte Carlo
methods, must be applied.
4.1.3 Monte Carlo Methods
As we stated above, we need to evaluate complex probability distributions when
performing inference over model parameters from observed data. A straightfor-
ward evaluation of these probabilities is problematic, as the likelihood function
can involve complex nonlinear forms. Monte Carlo methods are computational
techniques developed to generate samples from a desired probability distribution
p(x) and to compute integrals of the form (4.1). The generated samples can be
used to estimate the probability densities of interest. We start with a concise
introduction to Monte Carlo integration, and then consider three Monte Carlo
methods in this chapter: rejection sampling, Metropolis-Hastings sampling and
Gibbs sampling.
Monte Carlo Integration
Monte Carlo methods are computational techniques developed to generate sam-
ples

θ(r)	R
r=1 from a desired probability distribution p(θ|D) and to compute
integrals of the form (4.1):
E [g(θ)|D] =
Z
θ∈Θ
g(θ)p(θ|D)dθ,
The probability distribution p(θ|D), which in this case is called target den-CHAPTER 4. MODEL-BASED INFERENCE 88
sity, might be a distribution of model parameters arising in biological modelling,
for example, the posterior distribution of model parameters given some observed
data.
If the ﬁrst part of the problem, generating a sample from the target density,
is solved, then the value of the integral can be estimated as
E [g(θ)|D] =
Z
θ∈Θ
g(θ)p(θ|D)dθ,≈
1
R
R X
r=1
g(θ
(r)). (4.6)
As the number of samples R increases, the variance of this estimate will decrease
as σ2/R, where σ2 is the variance of g(θ),
σ
2 =
Z
θ∈Θ
p(θ|D)(g(θ) − E [g(θ)|D])
2dθ.
An important property of Monte Carlo integration methods is that the ac-
curacy of the Monte Carlo estimate (4.6) depends only on the variance of g(θ)
and not on the dimensionality of the space sampled. So, regardless of the di-
mensionality of the parameter space, it may be that as few as a dozen samples

θ(r)	
suﬃce to estimate E [g(θ)|D] satisfactorily.
We consider three popular Monte Carlo methods of generating a sample from
a target density: rejection sampling, the Metropolis-Hastings method and Gibbs
sampling.
Rejection Sampling
The general background for this method is described in (Robert and Casella
2004) and (MacKay 2003) as the following:
Assume that we need to generate a sample from a univariate probability
density p(x) = p∗(x)/Z, and it is diﬃcult to sample from such distribution
directly. We assume that we have a simpler proposal density q(x) which we can
evaluate (within some multiplicative factor Zq, such that q(x) = q∗(x)/Zq), and
from which we can generate samples. We further assume that we know the value
of a constant c such that
∀x(cq
∗(x) > p
∗(x)). (4.7)
A schematic picture of such functions is depicted in Figure 4.1.
To produce a sample from p(x) we generate two random numbers. The ﬁrst,CHAPTER 4. MODEL-BASED INFERENCE 89
x
p*(x)
cq*(x)
Figure 4.1: The functions involved in rejection sampling. p∗(x) is too complex
to sample from directly, so some simple distribution cq∗(x) is chosen in a way
that its density is always larger than p∗(x).
x, is generated from the proposal density q(x). We then evaluate cq∗(x) and
generate the second random number, u, from a uniform distribution over the
interval [0,cq∗(x)]. At the next stage we evaluate p∗(x) and accept or reject
sample x by comparing the value of u with the value of p∗(x). If u > p∗(x), then
the sample x is rejected; otherwise it is accepted, which means that we add x to
our set of samples

x(r)	
.
This procedure generates samples from p(x) because the proposed point (x,u)
comes uniformly from the area underneath the curve cq∗(x) (see Figure 4.1), and
the rejection rule rejects all the points that lie above the curve p∗(x). So the
points (x,u) which are accepted are uniformly distributed in the area under
the curve p∗(x). This implies that the probability density of the x-coordinates
of the accepted points must be proportional to p∗(x), so the samples must be
independent samples from p(x).
Rejection sampling will work best if the proposal distribution q(x) is close
to p(x). However, in the cases when q(x) is signiﬁcantly larger (in terms of the
area under the curve cq∗(x)) than p(x), then rejection sampling will be very
ineﬃcient, as the majority of the proposed points (x,u) will be rejected. This
problem becomes a signiﬁcant drawback when applying this method to sampling
from multidimensional distributions, as the acceptances become very rare indeed.CHAPTER 4. MODEL-BASED INFERENCE 90
The Metropolis-Hastings Method
We stated that rejection sampling is very ineﬃcient when sampling from complex
multidimensional distributions. The Metropolis-Hastings algorithm employs a
diﬀerent approach which overcomes the eﬃciency problems of rejection sampling.
This algorithm originates in statistical physics (see Metropolis et al. 1953) where
it is used to investigate properties of large two- and three-dimensional systems of
interacting particles. Later, this method was employed as a Bayesian inference
machine by Grenander (1983) and Geman and Geman (1984) in the context of
image analysis.
The Metropolis-Hastings algorithm uses a proposal density Q which depends
on the current sample x(r). This proposal density q(x0,x(r)) can be any ﬁxed
density from which we can draw samples.
As before, we assume that we can evaluate p∗(x) for any proposed x. A
tentative new x0 is generated from the proposal density q(x0,x(r)), to decide
whether to accept this value into our sample, we have to compute the value:
a =
p∗(x0)
p∗(x(r))
·
q(x(r),x0)
q(x0,x(r))
. (4.8)
If a ≥ 1 then x0 is accepted into the sample. Otherwise, x0 has to be accepted
with probability a. If x0 is accepted into the sample, then it will be taken as
the base for the proposal distribution of x(r+1) at the next sampling iteration.
Otherwise, the last accepted value x(r) has to be duplicated: x(r+1) = x(r).
The Metropolis-Hastings algorithm is an example of the Markov Chain Monte
Carlo (MCMC) method (see Gilks et al. 1995 Robert and Casella 2004 Gamer-
man 2006). In contrast to rejection sampling where the accepted values

x(r)	
are independent samples from the desired distribution, MCMC methods use a
partial realisation

x(r)	N
r=0 from a Markov chain with stationary distribution
p(x) (see below for deﬁnitions).
We now give some basic background from the theory of Markov chains rele-
vant to MCMC.
Deﬁnition 4.1 (Markov chain): A Markov chain is a sequence of random variables
X0,X1,... taking values in X with the Markov property:
Pr
 
X
t+1 = x

X
t = xt,...X
1 = x1,X
0 = x0

= Pr
 
X
t+1 = x

X
t = xt

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X is called the state space of a Markov chain.
For simplicity, we focus on Markov chains with countable state space X.
For a deeper theoretical background, especially with regard to continuous state
spaces, see, for example, (Tierney 1994) or (Athreya et al. 1992).
Deﬁnition 4.2: A Markov chain is called time homogeneous if
Pr
 
X
t+1 = x

X
t = y

= Pr
 
X
t = x

X
t−1 = y

for all t.
While considering MCMC methods we use time homogeneous Markov chains,
thus we assume this property for all the subsequent deﬁnitions.
Deﬁnition 4.3: The transition kernel p(x → x0) of a Markov chain is deﬁned by
p(x → x
0) = Pr
 
X
t+1 = x
0 
X
t = x

.
Deﬁnition 4.4: The n-step transition kernel pn(x → x0) of a Markov chain is
deﬁned by
p
n(x → x
0) = Pr
 
X
t+n = x
0 
X
t = x

.
Deﬁnition 4.5: A Markov chain is irreducible if there is a positive probability to
get from any state to any state.
Deﬁnition 4.6: A period dx of the state x is
dx = gcd{n ≥ 0 : p
n(x → x
0) > 0}.
A Markov chain is aperiodic if ∀x ∈ X (dx = 1).
Deﬁnition 4.7: π(x) is a stationary distribution of a Markov chain if
∀x
0 ∈ X
 
X
x∈X
π(x)p(x → x
0) = π(x
0)
!
.
Deﬁnition 4.8: Let Tx = inf {t ≥ 1 : Xt = x|X0 = x}, a Markov chain is calledCHAPTER 4. MODEL-BASED INFERENCE 92
positive recurrent if, and only if, ∀x ∈ X(E[Tx] < ∞), where E[Tx] is the expected
value of Tx.
Theorem 4.1 (Ergodic theorem): A Markov chain which is aperiodic, irreducible,
and positive recurrent has a unique stationary distribution.
More details about ergodicity and the ergodic theorem can be found in (Feller
1968) or (Iosifescu 1980).
The key feature of the Markov chain theory for MCMC is that the empir-
ical distribution of an aperiodic, irreducible, positive recurrent Markov chain
converges to its stationary distribution (see Levental 1988).
It was demonstrated (see e.g. Hastings 1970 Neal 1993) that the Metropolis-
Hastings algorithm builds an aperiodic, irreducible, positive recurrent Markov
chain with the stationary distribution p(x) (or more precisely, performs a random
walk in such Markov chain), which means that after a large number of initial
steps it produces a sample from p(x).
Example 4.2 (Demonstration of the Metropolis-Hastings algorithm.)
The Metropolis-Hastings algorithm is often used for multidimensional prob-
lems, as it avoids the common problems of rejection samplers. Many imple-
mentations of this algorithm employ a proposal distribution with a length scale 
which is short relative to the scale L of the desired distribution (see Figure 4.2).
The reason for such choice is that for multivariate problems a large random step
from a typical point is very likely to end in a state which has very low probability;
such steps are unlikely to be accepted.
Figure 4.2: Traditional proposal density for a Metropolis-Hastings algorithm in
two dimensions (see MacKay 2003).CHAPTER 4. MODEL-BASED INFERENCE 93
For a demonstration we use the Metropolis-Hastings algorithm to draw sam-
ples from a two-dimensional normal distribution:
N
 
x

 


µ = (3,2),Λ =
"
1 0.9
0.9 1
#!
.
We use
N
 
x
(r+1)
 



µ = x
(r),Λ =
"
0.15 0
0 0.15
#!
as the proposal distribution. Figure 4.3 depicts a comparison of samples gener-
ated using Metropolis-Hastings algorithm to the samples drawn directly from the
target distribution.
The smaller sample produced with the Metropolis-Hastings algorithm (see Fig-
ure 4.3(a)) has not converged enough to the target; as a result the initial random
walk (a trail in the left part of Figure 4.3(a)) signiﬁcantly distorts the sample.
At the same time the larger sample produced with Metropolis-Hastings algorithm
with the same parameters (see Figure 4.3(c)) is much closer to the target.
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(a) Metropolis-Hastings, N = 1000
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(b) Direct, N = 1000
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(c) Metropolis-Hastings, N = 10000
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(d) Direct, N = 10000
Figure 4.3: Metropolis-Hastings sampling for a toy problem. Samples (a) and
(c) were produced with the Metropolis-Hastings algorithm, while samples (b)
and (d) were drawn directly from the target distribution.CHAPTER 4. MODEL-BASED INFERENCE 94
Gibbs Sampling
Gibbs sampling (see e.g. MacKay 2003 Thomas et al. 1992) is a method of sam-
pling from distributions of at least two dimensions. This method is used when
conditional distributions of the joint target distribution can be easily evaluated.
It is assumed that, while p(x) is too complex to draw samples from directly, its
conditional distributions P

xi

 {xj}j6=i

are tractable to work with. This holds
for many simple statistical models, but is generally not applicable to models of
most biological systems described with nonlinear diﬀerential equations, since the
likelihood function in such cases cannot be reduced to conditional probabilities.
The iterative procedure of the Gibbs sampler is similar to the Metropolis-
Hastings algorithm described above, the only diﬀerence is how the proposal step
is performed. In a general case of a system with K parameters, a single proposal
step is performed by sampling each parameter separately, conditioned on the
values of the rest of parameters:
x
(r+1)
1 ∼ P

x1
 
x
(r)
2 ,x
(r)
3 ,...x
(r)
K

x
(r+1)
2 ∼ P

x2


x
(r+1)
1 ,x
(r)
3 ,...x
(r)
K

···
x
(r+1)
K ∼ P

x1
 
x
(r+1)
1 ,x
(r+1)
2 ,...x
(r+1)
K−1

(4.9)
The convergence of the Gibbs sampler to the target distribution follows from
the fact that this sampler is a special case of the Metropolis-Hastings algorithm,
and therefore the probability distribution of x(r) tends to p(x) as t → ∞.
Both the basic Metropolis-Hastings algorithm and the Gibbs sampler suﬀer
from the same defect that the state space is explored by a slow random walk.
This can be easily observed when some of the parameters are strongly correlated,
in such cases the acceptance rate of both algorithms reduces usually to very small
values (only few proposed steps become accepted).
Adaptive Proposals
To overcome the problem with ineﬃcient proposals in a general Metropolis-
Hastings algorithm, Gelman et al. (1995) proposes to use an adaptive proposal
distribution, resetting the Markov chain several times until a good acceptance
rate is achieved.CHAPTER 4. MODEL-BASED INFERENCE 95
Suppose there is a model with K parameters, and the posterior distribu-
tion of the parameters θ = (θ1,...,θK). Gelman et al. (1995) propose to take
draws using the Metropolis-Hastings algorithm with a symmetric normal pro-
posal distribution of the same shape as the current approximation of the target
distribution: that is
Q
 
θ
(r)  θ
(r−1)
= N
 
θ
(r) 
µ = θ
(r−1) ,Λ = c
2Σ

,
where Σ is an estimate of the posterior’s variance-covariance matrix. In practice,
among this class of proposal distributions, the most eﬃcient1 has scale c ≈
2.4/
√
K (see Gelman et al. 1995). The optimal acceptance rate for multivariate
problems is about 0.23. This improved proposal suggests the following adaptive
sampling algorithm:
1. Start the simulation with a ﬁxed proposal distribution using a standard
version of the Metropolis-Hastings or Gibbs algorithm.
2. After some number of iterations, update the proposal distribution as fol-
lows:
(a) Adjust the covariance of the proposal distribution to be proportional
to the posterior covariance matrix estimated from the simulated sam-
ple.
(b) Increase or decrease the scale of the jumping distribution if the ac-
ceptance rate of the simulations is much too high or low, respectively.
The goal is to bring this acceptance rate to the approximate optimal
value between 0.44 and 0.23.
Note, that when using this adaptive algorithm, the simulation of the Markov
chain has to be restarted when the proposal distribution is updated, the sample
can be expected to converge to the target distribution only once the proposal is
ﬁxed after a number of updates.
Convergence monitoring
As we already stated in the overview of Markov chain theory, the chains built
with MCMC algorithms converge to some stationary distribution, and the Metropolis-
1Gelman et al. (1995) justify this choice by their practical experience with many statistical
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Hastings algorithm builds the chains in a way that the desired parameter poste-
rior is this stationary distribution. We immediately can see the main technical
problem for MCMC sampling: how many samples are required to be sure that
the sample is produced from the stationary distribution?
The actual number of required “burn-in”2 samples can not be precisely de-
ﬁned. Some methods, however, have been developed to detect whether the
sampler reached a stationary distribution. In our practice, we use a method
published by Gelman et al. (1995). This method suggests running several simi-
lar Markov Chains in parallel, and assessing the level of mixing3 of the samples
produced by them.
The method of Gelman et al. (1995) is used to monitor the mixing of param-
eter samples by computing a mixing statistic for each parameter separately, and
when the values of this statistic is small enough for each of the parameters, we
assume that the Markov chains have converged.
For each scalar parameter p, we label the draws from J parallel samplers
of length n as pij (i = 1,...,n;j = 1,...,J). For each scalar parameter we
compute its between- and within-sequence variances, B and W correspondingly.
B =
n
J − 1
J X
j=1
(¯ p·j − ¯ p··)
2, W =
1
J
J X
j=1
s
2
j,
where
¯ p·j =
1
n
n X
i=1
pij, ¯ p·· =
1
J
J X
j=1
¯ p·j, s
2
j =
1
n − 1
n X
i=1
(pij − ¯ p·j)
2.
The between-sequence variance, B, contains a factor of n because it is based on
the variance of the within-sequence means, ¯ p·j, each of which is an average of n
values pij. If only one sequence is simulated, B cannot be calculated.
The marginal posterior variance of parameter p can be estimated by a weighted
average of W and B:
d var(p|D) =
n − 1
n
W +
1
n
B,
which overestimates the marginal posterior variance assuming the starting dis-
2Burn-in is an initial part of the sample which is discarded to give the Markov chain some
time to converge to the target distribution.
3Mixing of samples means that the samples are produced from the same probability distri-
bution.CHAPTER 4. MODEL-BASED INFERENCE 97
tribution is overdispersed4.
For any ﬁnite n, the within-sequence variance W should be an underestimate
of var(p|D) because the individual sequences have not had time to range over
all the target distribution and, as a result, will have less variability; in the limit
as n → ∞, the expectation of W approaches var(p|D).
Gelman et al. (1995) propose to monitor convergence of the iterative simu-
lation by estimating the factor by which the scale of the current distribution for
p might be reduced if the simulations were continued in the limit n → ∞. This
potential scale reduction is estimated by
ˆ R =
r
d var(p|D)
W
,
which declines to 1 as n → ∞. If the potential scale reduction is high, then
we have reason to believe that proceeding with further simulations may improve
our sample from the target distribution.
4.1.4 Model Comparison and Bayes Factors
The methodology presented in this section allows one to rank competing hy-
potheses by the evidential support from experimental data, and therefore eval-
uate relative conﬁdence values for such hypotheses. A complete comprehensive
overview of Bayes factors and model comparison can be found in e.g. (Kass and
Raftery 1995).
In the cases when a discrete set of competing hypotheses is considered, the
hypotheses can be ranked by the ratio of their posterior probabilities. For a pair
of hypotheses H1 and H2 represented with models M1 and M2 the ratio is
p(M1|D)
p(M2|D)
. (4.10)
Taking a prior distribution of beliefs in preference of each hypotheses π into
account, and in the case when hypotheses are represented by parametric models,
this ratio is:
p(M1|D)
p(M2|D)
=
π (M1)
π (M2)
×
p(D|M1)
p(D|M2)
=
π (M1)
π (M2)
×
R
p(D|M1,θ1) · p(θ1|M1)dθ1 R
p(D|M2,θ2) · p(θ2|M2)dθ2
(4.11)
4Overdispersion in this context means that the variance of the initial population of parallel
chains is signiﬁcantly higher than the variance of the posterior distribution.CHAPTER 4. MODEL-BASED INFERENCE 98
Deﬁnition 4.9: The ratio of the marginal likelihoods for two competing hypothe-
ses: R
p(D|M1,θ1) · p(θ1|M1)dθ1 R
p(D|M2,θ2) · p(θ2|M2)dθ2
is called the Bayes factor.
Bayes factors are used to test competing hypotheses, and update correspond-
ing beliefs using formula (4.11).
Example 4.3 (Bayes factors applied to Example 4.1.)
The genetics example given as Example 4.1 can be reintroduced in terms of
Bayes factors, considering two competing hypotheses:
H1: the woman is aﬀected,
H2: the woman is not aﬀected.
That is θ = 1 and θ = 0 in terms of Example 4.1. The prior odds are
π(H2)
π(H1)
= 1,
as we consider both hypotheses to be equally probable: π(H1) = π(H2).
The Bayes factor of data that the woman has two unaﬀected sons is
p(y|H2)
p(y|H1)
=
1.0
0.25
.
The posterior odds are thus
p(H2|y)
p(H1|y)
= 4.
Which means that it is four times more likely that the woman is unaﬀected if
she has two unaﬀected sons. This result matches the one obtained by applying
Bayes’ theorem directly in Example 4.1.
We propose that reasoning employing Bayes factors is much more compre-
hensible and more natural than that given in Example 4.1.
Example 4.3 demonstrates how Bayes factors are calculated when only dis-
crete options are considered. When using models with continuous parameter
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ated by integration. In the vast majority of practical problems these integrals
cannot be evaluated analytically, and therefore numerical methods are required
to estimate them. These integrals are called marginal likelihoods, and we give a
brief overview of some numerical methods to estimate them in the next section
(see Section 4.1.5).
The Bayes factor is a summary of the evidence provided by the data in favour
of one hypothesis, represented by a model, as opposed to another. Jeﬀreys (1961)
suggested interpreting Bayes factors in half-units on the log10 scale. Pooling two
of his categories together for simpliﬁcation we demonstrate his scale in Table 4.1.
log10(B) B Evidence support
0 to 1/2 1 to 3.2 Not worth more than a bare mention
1/2 to 1 3.2 to 10 Substantial
1 to 2 10 to 100 Strong
> 2 > 100 Decisive
Table 4.1: Interpretation of the Bayes factor as evidence support categories
according to Jeﬀreys (1961)
These categories are not a calibration of the Bayes factor, as it already pro-
vides a meaningful interpretation as probability, but rather a rough descriptive
statement about standards of evidence in scientiﬁc investigation.
Kass and Raftery (1995) propose a slight modiﬁcation to this scale, and use
natural logarithms instead. This modiﬁed scale is demonstrated in Table 4.2.
2loge(B) B Evidence support
0 to 2 1 to 3 Not worth more than a bare mention
2 to 6 3 to 20 Positive
6 to 10 20 to 150 Strong
> 10 > 150 Very strong
Table 4.2: Interpretation of the Bayes factor as evidence support categories
according to Kass and Raftery (1995)
There are a number of publications on the controversy between Bayesian and
non-Bayesian testing procedures. The following four issues are usually consid-
ered:
1. P values used in non-Bayesian signiﬁcance testing are not similar to the
posterior probability that the null hypotheses is correct. Jeﬀreys (1961)CHAPTER 4. MODEL-BASED INFERENCE 100
demonstrates this problem and considers the results obtained with both
approaches.
2. Non-Bayesian tests tend to reject null hypotheses in very large samples,
whereas Bayes factors do not. This has been a problem in sociology, where
the data sets can contain thousands of cases. Facing this problem, sociolo-
gists have taken to ignoring signiﬁcance tests and using other criteria and
informal methods when comparing models. An example with number of
samples n = 113,566 was discussed by Raftery (1986), where a meaningful
model that explained 99.7% of the deviance was rejected by a standard chi-
squared test with a P value of about 10−120 but was nevertheless favoured
by the Bayes factor. Bayes factors are now widely used in sociology, usually
with BIC (Bayesian Information Criterion) as an approximation.
3. Bayes factors can be applied to both nested5 and non-nested models, while
application of non-Bayesian signiﬁcance tests to non-nested models is dif-
ﬁcult. This problem is brieﬂy discussed in (Kass and Raftery 1995).
4. Non-Bayesian signiﬁcance tests were designed for comparison of two mod-
els, but practical data analysis often involves more than two models, at
least implicitly. In such a case, performing multiple signiﬁcance tests to
guide a search for the best model can give very misleading results (e.g.
Freedman 1983). This problem can be avoided by taking model uncer-
tainty into account and employing Bayes factors (e.g. Raftery et al. 1993).
Arkinson (1978) has noted some examples when Bayes factors favoured the
simpler model H0 even when a more complex model H1 was correct. Smith and
Spiegelhalter (1980) demonstrated that this occurs only when the models are
so close that there is almost no loss in predictive power when cutting back to
the simpler model, so that Bayes factors can be considered as a fully automatic
Occam’s razor6.
Akaike (1973) proposed yet another criterion for model comparison, which
also takes the complexity of the models into account. This criterion suggests to
5Nested models are statistical models with model parameters arranged in a hierarchical
structure.
6Occam’s razor is a principle which states that the explanation of any phenomenon should
make as few assumptions as possible. Thus, the simplest model which explains the evidence
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choose the model which minimises AIC (Akaike information criterion):
AIC = −2(log maximum likelihood) + 2(number of parameters). (4.12)
There are two main justiﬁcations for this criterion. The ﬁrst one is based on
the predictive argument. Suppose that, given current data and a set of possible
models, we are seeking for a predictive distribution of a future datum. Then, if
the predictive distribution is conditional on a single model and on its estimated
parameters, the AIC picks the model that gives the best approximation, asymp-
totically, in the Kullback-Leibler sense. AIC tends to overestimate the number
of parameters needed, even asymptotically. The second main justiﬁcation for
the AIC is Bayesian. Akaike (1983) claimed that model comparisons based on
the AIC are asymptotically equivalent to those made with Bayes factors. But
this is true only in the situations when predictions of the prior are compatible
to those of the likelihood, and not in the more usual situation when prior infor-
mation is small in comparison to the information provided by the data. In the
latter (and more usual situation) the Bayesian Information Criterion (BIC), also
known as Schwartz criterion, indicates that the model with the highest posterior
probability is the one which minimises
BIC = −2(log maximum likelihood) + (logN)(number of parameters), (4.13)
where N is a number of observations.
Comparing Equations (4.12) and (4.13) indicates that BIC tends to favour
simpler models than those chosen by the AIC criterion.
The deviance information criterion (DIC) (see Spiegelhalter et al. 2002) is
sometimes used for model comparison when parameter posteriors were obtained
with Markov chain Monte Carlo simulation. This criterion allows one to avoid
marginal likelihood estimation and is more convenient than AIC and BIC as it
does not require maximum likelihood estimation. Like AIC and BIC it is an
asymptotic approximation. It is only valid when the posterior distribution is
approximately multivariate normal. DIC indicates that the model which min-
imises
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should be preferred over the rest. In Equation (4.14)
D(¯ θ) = −2log(p(D|M, ¯ θ)),
where ¯ θ is the expectation of the parameter posterior; and
¯ D = Ep(θ|D,M)[−2log(p(D|M,θ))]
is the expectation of −2log(p(D|M,θ)) on the posterior sample.
Using hypotheses testing approaches based on asymptotic approximations
(AIC, BIC, DIC) sometimes provides unreliable results, as these methods are
justiﬁed only for the cases when parameter posteriors are unimodal and almost
multivariate normal. This is a very rare case in modelling biological systems,
as the majority of the involved models are nonlinear. Employing asymptotic
methods with such models often provides confusing and incorrect results. For
example, the deﬁnition of DIC assumes that the likelihood estimate of the aver-
age parameter value produces the maximum likelihood value, which is incorrect
in the case of multimodal or nonlinearly shaped posteriors.
In our Case Studies we rely on the hypotheses testing results obtained with
Bayes factors. However, computing such Bayes factors is a challenging problem,
as the marginal likelihoods for nonlinear models have to be evaluated to obtain
these. In the following section we discuss alternative methods for estimation of
the marginal likelihoods.
4.1.5 Estimation of the Marginal Likelihoods
Evaluation of marginal likelihoods can be successfully avoided in estimation of
the posterior parameter distribution by employing Metropolis-Hastings sampling
algorithm. However, in Section 4.1.4 we demonstrated that marginal likelihoods
are required to perform hypotheses testing and model comparison with Bayes
factors. A review of diﬀerent methods for evaluating marginal likelihoods can
be found in (Newton and Raftery 1994 Kass and Raftery 1995 Chib 1995).
The main problem is that the marginal likelihood
p(D|M) =
Z
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can be evaluated analytically only in very special cases, e.g. when the likelihood
belongs to the exponential family, and conjugate priors are used. The majority
of the mechanistic biological models considered in this thesis are based on non-
linear ordinary diﬀerential equations that contribute to the likelihood. In such
cases analytical integration of the marginal likelihood is impossible, and there-
fore we will not consider this method in our case studies. Brute force numerical
integration can be applied to low-dimensional problems. This approach, how-
ever, becomes computationally intractable for more complicated applications
(this estimate becomes impractical in more than two-dimensional case, as its
computational complexity depends exponentially on the dimensionality of the
parameter space). The artiﬁcially constructed models considered in Case Study
1 are deﬁned in 5 to 8 dimensions, and the realistic models from Case Study 2 are
deﬁned in over 100 dimensions each. Brute force numerical integration cannot
be performed eﬀectively in such parameter spaces, and therefore this method
will not be considered.
The reasons of complexity discussed above leave us with the only practical
option of considering methods for approximate evaluation of marginal likeli-
hoods. Many of these approximate methods are limited by very strong condi-
tions. For example, Laplace approximations or DIC are large sample approxima-
tions around the maximum a posteriori estimate, which can be diﬃcult to ﬁnd
in some cases of complex problems. Moreover, such asymptotic approximations
rely on almost-normality of the target distribution, which is often wrong for non-
linear problems. For example, see Figure 4.14(b) from Case Study 1 (page 132),
strong interaction of the model parameters causes signiﬁcant curvature of the
posterior distribution density.
The reversible Jump MCMC approach (Green 1995), where Markov chains
are constructed in a special way, allow jumps between alternative models in
accordance with Metropolis-Hastings ratio, and in principle, can be tuned for
any problem. Such an approach, however, creates signiﬁcant technical diﬃcul-
ties, as the rate of jumps between alternative models has to be maintained at
some acceptable level, to obtain a satisfactory result. Friel and Pettitt (2006)
investigated the problem of estimates stability for the Reversible Jump MCMC
approach, they suggested to introduce a correction to the relative prior pref-
erence between the alternative models to achieve acceptable precision. Such
correction sacriﬁces the possibility to use uneven priors over alternative models,CHAPTER 4. MODEL-BASED INFERENCE 104
and consequently limits the analysis possibilities.
Two more methods which can be applied in a general case are importance
sampling estimators (Newton and Raftery 1994) and thermodynamic integration
or path sampling (Ogata 1989 Gelman 1998).
In this section, we give a detailed description and practical comparison of
three estimators from the above classes: the prior arithmetic mean estimator,
the posterior harmonic mean estimator, and annealing-melting integration.
Importance Sampling Estimators
Importance sampling estimation consists of generating a sample

θ
(i);i = 1,...,m
	
from an unnormalised density π∗(θ). Under quite general conditions, an estimate
of integral
I =
Z
p(D|M,θ)p(θ|M)dθ
is
ˆ I =
Pm
i=1 ωi · p(D|M,θ(i))
Pm
i=1 ωi
, (4.15)
where ωi = p(θ(i)|M)

π∗(θ(i)); the function π∗(θ) is known as the importance
sampling function.
The simplest application of this method is to use the prior as the importance
sampling function π∗(θ) = p(θ|M), in which case (4.15) produces the prior
arithmetic mean estimator (see McCulloch and Rossi 1991):
p(D|M) '
1
m
m X
i=1
p(D|M,θ
(i)); θ
(i) ∼ p(θ|M). (4.16)
A well known problem with this estimator is that the high-likelihood region
can be very small. Therefore, unless m is very large, the sample drawn from the
prior will contain virtually no points from the high-likelihood region, resulting
in a very poor estimate of the marginal likelihood. Lewis and Raftery (1997)
reference a study in which to reduce the standard error to an acceptable level, it
was necessary to use a sample of roughly 50 million draws from the prior distri-
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models in Example 4.4. The relative error of the Bayes factor, which relies on
two marginal likelihood estimates, when using 500,000 samples from the prior
is 25%, is signiﬁcantly worse than the estimates achieved with thermodynamic
integration methods.
An alternative application of importance sampling estimation, proposed by
Newton and Raftery (1994), is to use the parameter posterior as the importance
sampling function π∗(θ) = p(θ|D,M). A sample from the parameter posterior
can be obtained using MCMC sampling. Such a sample should be signiﬁcantly
better in covering the high-likelihood region. Substituting the parameter poste-
rior into (4.15) results in the posterior harmonic mean estimator, we obtain:
p(D|M) ' ˆ I =
Pm
i=1 ωi · p(D|M,θ(i))
Pm
i=1 ωi
=
Pm
i=1
p(θ(i)|M)
π∗(θ(i)) · p(D|M,θ(i))
Pm
i=1
p(θ(i)|M)
π∗(θ(i))
=
Pm
i=1
p(θ(i)|M)p(D|M)
p(D|M,θ(i))p(θ(i)|M) · p(D|M,θ(i))
Pm
i=1
p(θ(i)|M)p(D|M)
p(D|M,θ(i))p(θ(i)|M)
=
Pm
i=1 p(D|M)
Pm
i=1
p(D|M)
p(D|M,θ(i))
=
m · p(D|M)
p(D|M) ·
Pm
i=1
1
p(D|M,θ(i))
=
m
Pm
i=1
1
p(D|M,θ(i))
=
 
1
m
m X
i=1
1
p(D|M,θ(i))
!−1
; θ
(i) ∼ p(θ|D,M). (4.17)
The main problem with this estimate is that, in many practical situations, its
variance is inﬁnite, because of the occasional occurrence of a value of θ(i) with a
small likelihood and hence a large eﬀect on the ﬁnal result. As we demonstrate in
Example 4.4 on simple regression models, this estimate is very unstable because
of the reasons described above.
There exists a number of modiﬁcations of this approach proposed by New-
ton and Raftery (1994) which propose to combine sampling from the posterior
with sampling from the prior, for example, by using a mixture δp(θ|M) + (1 −
δ)p(θ|D,M) as the importance sampling function, where δ is small. The forms
for an estimate for this case can be found in (Newton and Raftery 1994).
Thermodynamic Integration
The method of thermodynamic integration originates in Statistical Physics (for
an overview see Neal 1993), where the marginal likelihood is equivalent to theCHAPTER 4. MODEL-BASED INFERENCE 106
so-called partition function and its logarithm to the free energy. The computa-
tions required to perform thermodynamic integration are computationally more
intensive, but the results are usually more stable (Gelman 1998).
This method is based on the following principles: suppose that there are two
unnormalised distributions q0(θ) and q1(θ), deﬁned on the same parameter space
Θ. We can normalise these densities dividing them by normalisation constants.
pi(θ) =
1
Zi
qi(θ), i = 0,1,
where
Zi =
Z
Θ
qi(θ)dθ, i = 0,1
To perform the evaluation of log-ratio
µ = ln

Z1
Z0

= lnZ1 − lnZ0
a continuous and diﬀerentiable path (qβ)0≤β≤1 can be deﬁned in the space of
unnormalised densities, joining q0 and q1. Similarly,
pβ(θ) =
1
Zβ
qβ(θ),
Zβ =
Z
Θ
qβ(θ)dθ.
Taking the derivative of lnZβ with respect to β:
∂ lnZβ
∂β
=
1
Zβ
∂Zβ
∂β
=
1
Zβ
∂
∂β
Z
Θ
qβ(θ)dθ
=
1
Zβ
Z
Θ
∂qβ(θ)
∂β
dθ =
Z
Θ
1
qβ(θ)
∂qβ(θ)
∂β
qβ(θ)
Zβ
dθ
=
Z
Θ
∂ lnqβ(θ)
∂β
pβ(θ)dθ = Epβ(θ)

∂ lnqβ(θ)
∂β

, (4.18)
where Epβ(θ) [···] is the expectation with respect to pβ(θ). Deﬁning the potential
U(θ) =
∂ lnqβ(θ)
∂β
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we obtain
∂ lnZβ
∂β
= Epβ(θ) [U].
Integrating over [0,1] yields the log-ratio µ:
µ = lnZ1 − lnZ0 =
Z 1
0
∂ lnZβ
∂β
dβ =
Z 1
0
Epβ(θ) [U]dβ.
To compute this integral, a Markov chain Monte Carlo simulation is usually
run for particular values of β, in which qβ is used as an unnormalised density
in the Metropolis-Hastings ratio. By deﬁnition, this produces a sample from pβ.
Expectations of the potential can then be estimated as averages on this sample.
This computation is repeated for a series of values of β spaces between 0 and 1,
which implies running a separate chain for each value of β.
The log-ratio µ can then be estimated by numerical integration using trape-
zoidal (as in Friel and Pettitt 2006) or Simpson’s scheme (as in Lartillot and
Philippe 2006).
A particular integration scheme employed in this thesis is called annealing-
melting integration according to Lartillot and Philippe (2006) or power-posteriors
integration according to Friel and Pettitt (2006).
Assuming that q0(θ) above is the prior p(θ|M), and q1(θ) is the unnormalised
posterior p(D|M,θ)p(θ|M), and the corresponding normalisation constants are
Z0 = 1 (as the prior is already normalised) and Z1 = p(D|M), the resulting
log-ratio µ is the logarithm of the marginal likelihood.
Deﬁning qβ(θ) as a path in the probability densities space which connects
the prior and the posterior:
qβ(θ) = p(D|M,θ)
βp(θ|M),
the potential takes a simple form:
U(θ) =
∂ lnqβ(θ)
∂β
= lnp(D|M,θ).
And the logarithm of the marginal likelihood we are seeking an estimate for
is
lnp(D|M) = µ = lnZ1 − lnZ0 =
Z 1
0
Epβ(θ) [lnp(D|M,θ)]dβ.CHAPTER 4. MODEL-BASED INFERENCE 108
The stability improvement was explained by Gelman (1998) by using “bridge”
densities to eﬀectively shorten the distances between target densities Z0 and Z1,
distances that are responsible for large errors with the standard importance
sampling methods.
There are a number of ways to select a schedule for β to estimate this integral.
In the case studies considered in this chapter, we use the schedule proposed by
Friel and Pettitt (2006), and select these values as
βi = a
c
i, ai =
i
N
, i = 0,...,N.
Good results can usually be achieved with N ∈ [20,100] and c = 4 or c = 5.
In Example 4.4 we compare four methods of estimating the marginal likeli-
hoods by calculating the error of the Bayes factor estimate for two simple linear
regression models.
Example 4.4 (Model comparison for linear regression models.)
Williams (1959) described a linear regression example which has traditionally
been used as a benchmark for model comparison approaches. Table 4.3 describes
the maximum compression strength parallel to the grain yi, the density xi, and
the resin-adjusted density zi for 42 specimens of radiata pine. This dataset has
been examined in (Han and Carlin 2001), (Carlin and Chib 1995), (Bartolucci
and Scaccia 2004) and (Friel and Pettitt 2006), where they compared several
methods to estimate the Bayes factor between two non-nested competing models.
Two competing models are the following:
M1 : yi = α + β(xi − ¯ x) + i, i ∼ N(0,σ
2).
M2 : yi = γ + δ(zi − ¯ z) + ηi, ηi ∼ N(0,τ
2).
The following priors have been used in the above studies: N(3000,106) for
α and γ, N(185,104) for β and δ, and IG(3,1/(2 · 3002)) for σ2 and τ2, where
IG(a,b) is an inverse Gamma distribution with density
f(x) =
1
exp(1/bx)Γ(a)baxa+1.
Green and O’Hagan (1998) computed the Bayes factor B21 = 4862 by brute
force numerical integration.CHAPTER 4. MODEL-BASED INFERENCE 109
i yi xi zi i yi xi zi i yi xi zi
1 3040 29.2 25.4 15 2250 27.5 23.8 29 1670 22.1 21.3
2 2470 24.7 22.2 16 2650 25.6 25.3 30 3310 29.2 28.5
3 3610 32.3 32.2 17 4970 34.5 34.2 31 3450 30.1 29.2
4 3480 31.3 31.0 18 2620 26.2 25.7 32 3600 31.4 31.4
5 3810 31.5 30.9 19 2900 26.7 26.4 33 2850 26.7 25.9
6 2330 24.5 23.9 20 1670 21.1 20.0 34 1590 22.1 21.4
7 1800 19.9 19.2 21 2540 24.1 23.9 35 3770 30.3 29.8
8 3110 27.3 27.2 22 3840 30.7 30.7 36 3850 32.0 30.6
9 3160 27.1 26.3 23 3800 32.7 32.6 37 2480 23.2 22.6
10 2310 24.0 23.9 24 4600 32.6 32.5 38 3570 30.3 30.3
11 4360 33.8 33.2 25 1900 22.1 20.8 39 2620 29.9 23.8
12 1880 21.5 21.0 26 2530 25.3 23.1 40 1890 20.8 18.4
13 3670 32.2 29.0 27 2920 30.8 29.8 41 3030 33.2 29.4
14 1740 22.5 22.0 28 4990 38.9 38.1 42 3030 28.2 28.2
Table 4.3: Radiata pine dataset from (Williams 1959): yi – maximum pine wood
compression strength parallel to the grain, xi – wood density, zi – resin-adjusted
wood density.
In this example we compare four marginal likelihood estimators on the exam-
ple described above. We estimated the marginal likelihoods for alternative mod-
els M1 and M2 and computed the Bayes factor B21 using the prior arithmetic
mean estimator, the posterior harmonic mean estimator, the annealing-melting
integration and the Laplace approximation based estimator. Each estimate was
evaluated 100 times, so the standard and relative errors of the estimates can be
computed.
Mean = ˆ B21 =
1
100
100 X
i=1
ˆ B21,i
Standard error =
v u
u
t 1
100
100 X
i=1
( ˆ B21,i − B21)2
Relative error =
1
B21
v u
u
t 1
100
100 X
i=1
( ˆ B21,i − B21)2
where B21 is the true value of the Bayes factor. The comparative overview of the
estimates is demonstrated in Table 4.4.
MCMC sampling was performed in all of the compared estimators by the
Metropolis-Hastings algorithm. The initial burn-in period was 1,000,000 sam-
ples. The length of the utilised sample was 500,000 samples.CHAPTER 4. MODEL-BASED INFERENCE 110
True value for B21 4862
Prior arithmetic mean ˆ B21 estimate
mean: 5052.58
standard error: 1229.93
relative error: 25.30%
Posterior harmonic mean ˆ B21 estimate
mean: 6412.43
standard error: 6094.93
relative error: 125.36%
Annealing-Melting integration ˆ B21 estimate
mean: 5007.63
standard error: 203.86
relative error: 4.19%
Laplace approximation ˆ B21 estimate
mean: 3215.17
standard error: 2568.55
relative error: 52.83%
Table 4.4: Error comparison for diﬀerent marginal likelihood estimators.
For the annealing-melting estimator we used 101 diﬀerent values of βi dis-
tributed within [0,1] as the following:
βi = a
5
i, ai =
i
100
, i = 0,1,...,100.
The true Bayes factor value (4862) lies within the error for each of the com-
pared estimates, however using the annealing-melting integration provides signif-
icantly smaller estimate error.
We also computed AIC, BIC and DIC values for both of the alternative re-
gression models to demonstrate that in this case the results achieved using large
sample based criteria are consistent with the results obtained using Bayes factors:CHAPTER 4. MODEL-BASED INFERENCE 111
AIC(M1) = 612.58064 ± 5.5 × 10−4
BIC(M1) = 617.79365 ± 5.5 × 10−4
DIC(M1) = 1522.8535 ± 3.01 × 10−2
AIC(M2) = 595.52311 ± 6.7 × 10−4
BIC(M2) = 600.73612 ± 6.7 × 10−4
DIC(M2) = 1480.5757 ± 3.27 × 10−2
Table 4.5: AIC, BIC and DIC values for the comparison of regression models.
The values of all the information criterions listed in Table 4.5 suggest pre-
ferring the second model over the ﬁrst one, which is consistent with the result
obtained using Bayes factor. The success of applying AIC, BIC and DIC is
caused by the fact that the parameter posteriors for both of the alternative mod-
els are distributed almost normally.
This example justiﬁes the use of the annealing-melting integration in the case
studies.
In this section we presented the fundamental concepts of Bayesian theory
and introduced main methods that will be employed to implement an inferential
framework for Systems Biology. In the next section we describe how such a
framework can be built by making certain practical decisions on model imple-
mentation and MCMC sampling methods.
4.2 A Bayesian Inference Framework for Sys-
tems Biology
The Bayesian inferential methodology can be applied to model identiﬁcation and
model comparison (and therefore hypotheses testing) of any kind of models, as
long as the likelihood function is provided.
Evaluating the likelihood is crucial for parameter inference and it is also
required for estimation of marginal (integrated over parameter space) likeli-
hoods for model comparison. The likelihood functions can be provided in a
quite straightforward way for ODE models by using a normalised metric which
provides the distance from the predicted behaviour to the observed data. For
example, consider Figure 4.4. The solid line in Figure 4.4 (a) depicts a system
behaviour predicted with a model, while points (depicted with crosses) corre-CHAPTER 4. MODEL-BASED INFERENCE 112
(a) The simulated behaviour depicted with a solid line 
      is matched against the experimental data depicted
      with crosses.
(b) A crossection made along x=1 line. A gaussian is put
      centered at the value predicted by the model; L1 and
      L2 correspond to probabilities that the experimental 
      data belongs to the gaussian.
(c) Analogous to (b), for x=3, L3 and L4 correspond to 
     the probabilities that the experimental data belongs
     to the gaussian.
Figure 4.4: Likelihood evaluation. The predicted behaviour is compared to the
experimental data by putting a Gaussian centred at the predicted value at each
time point and then evaluating the probability for the experimental data points
under this Gaussian. L1, L2, L3, and L4 are such probabilities for four data
points in this example. Multiplying these values together produces the overall
likelihood value L1 · L2 · L3 · L4 = 0.1343.
spond to the measured data. At each of the time points, where the experimental
data is available, we put a Gaussian centred at the value predicted with the
model and measure probabilities of the corresponding experimental data under
this Gaussian. In Figures 4.4 (b) and (c) these probabilities are marked L1, L2,
L3, L4. Multiplying these values together produces the overall likelihood value.
For the general case a deﬁnition of such likelihood function for N data points is:
p(D|M,θ) =
N Y
i=1
NDi(φ(M,θ,xi),σi), (4.19)
where xi is the time when Di was measured, σi is the variation of experimental
error, and φ(M,θ,xi) produces the value predicted with model M using param-
eters θ for time point xi where Di was measured.
The likelihood function in Equation 4.19 assumes a normal distribution of
errors. In some cases, e.g. when data is produced using microarrays, when
the measurement error is not normally distributed, this distribution has to be
replaced with a diﬀerent probability distribution. Khanin et al. (2007) proposed
to use the log-normal distribution to deﬁne likelihood function in the cases when
experimental data were produced using microarrays. This decision was made toCHAPTER 4. MODEL-BASED INFERENCE 113
model the microarray saturation eﬀect which causes larger experimental errors
when larger data values are observed.
Example 4.5 (The likelihood based on Equation (4.19))
Consider an example depicted in Figure 4.4. The experimental data is mea-
sured at two time points, when x = 1 and x = 3. For each of the time points we
have two data:
x = 1 x = 3
D1 : y(x) = 0.6 D3 : y(x) = 0.05
D2 : y(x) = 1.4 D4 : y(x) = 0.4
We model the observed system with function
y(x) = 2e
−x. (4.20)
Our model M is deﬁned using equation 4.20 which has no parameters, so the
set of model parameters θ is empty. The overall statistical model has four noise
parameters σ1,σ2,σ3,σ4. The likelihood, according to (4.19), is:
p(D|M,θ) =
4 Y
i=1
NDi(φ(M,θ,xi),σi)
We chose σi = 0.5 for all i ∈ {1,2,3,4}. And therefore:
p(D|M,θ) = ND1(2e
−1,0.5) · ND2(2e
−1,0.5) · ND3(2e
−3,0.5) · ND4(2e
−3,0.5) =
= L1 · L2 · L3 · L4 = 0.7690 · 0.3302 · 0.7940 · 0.6661 = 0.1343,
where L1, L2, L3, L4 are the values deﬁned in Figures 4.4 (b) and (c).
Such a likelihood function can be deﬁned for any models which are capable
of producing deterministic quantitative system behaviour predictions, e.g. mod-
els based on ordinary or partial diﬀerential equations. Without restricting the
generality of the approach, in this thesis we consider case studies which employ
systems of ordinary diﬀerential equations (see Section 2.1) as models of biolog-
ical systems. We discuss the technical problems experienced with ODE models
of biological systems, and the solutions to tackle these problems in Section 4.2.2.CHAPTER 4. MODEL-BASED INFERENCE 114
4.2.1 Biochemical Data Interpretation
The next problem is how the experimental data is interpreted, and how it can
be used in a form suitable to formulate a likelihood function as in (4.19). The
solution to this problem largely depends on a technique used to acquire the
experimental data. We suggest that each particular case study has to include a
dedicated discussion on how the laboratory measurements are interpreted. For
some common techniques there already exist traditional ways of quantifying and
interpreting the data.
In the case studies we consider in this chapter, the experimental technique
employed is Western blotting (see Voet and Voet 1995). This technique is used
to measure protein concentrations in studied cells. The main characteristics of
this technique are:
• It only provides a relative measure of concentration of interest within a
range of experiments. For example, if a range of experiments corresponds
to diﬀerent time points (e.g. 1 min, 2 min, 5 min after cells stimulation)
it will only be possible to say the relative concentrations of the measured
protein y, e.g. y(2)/y(1), y(5)/y(1), etc.
• It is only possible to compare the concentrations for the same protein, as
for diﬀerent proteins diﬀerent antibodies with diﬀerent aﬃnity are used,
and the results cannot be compared properly.
• It is diﬃcult to compare the values from diﬀerent experimental runs (diﬀer-
ent gels), as environmental conditions and experimental protocols can be
slightly diﬀerent. Measurement scaling is usually performed in such a case.
The same experiment is performed in both experimental runs (alongside
other experiments), assuming that it should provide the same outcome,
the measured values are then scaled in a way that both results (from dif-
ferent runs) are matched. However, it introduces a signiﬁcant degree of
imprecision and uncertainty in the experimental data.
• Despite the fact that quantiﬁed values of the blots can be obtained with
very high precision, the blots usually contain signiﬁcant experimental er-
rors. So, the data produced using this technique usually demonstrate sig-
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• This experimental technique is a low throughput one: production of the
data is slow and expensive. Therefore, we cannot expect large amounts of
data to be available.
In our main case study (Case Study 2, Section 4.3.2) the methods for an
appropriate data quantiﬁcation were discussed with biologists. Starting with
a table of relative values for protein concentration (concentrations of only one
protein were measured in the laboratory) in diﬀerent experimental conditions
for diﬀerent time points, all the relative values were scaled in the way that the
biggest one became a 100% of the available protein, while the rest were expressed
as a smaller percentage. When the models for the studied systems were built
using ODEs, we introduced a likelihood function based on such relative values.
E.g. if the model predicts that a concentration of the measured protein is 1
Molar out of 10 Molars theoretically achievable, we assign a value of 10% to the
model variable used as a predictive output.
4.2.2 Technical Problems and Solutions
We experienced a number of technical problems while investigating the appli-
cations of Bayesian inference to ODE models of biological systems. All these
problems are mainly due to the performance of initial value problem solvers.
MCMC sampling requires the likelihood to be evaluated many times. In our
case studies it was required to perform likelihood evaluations several million
times. As a result, solving the initial value problems became a bottleneck of the
sampling process.
The performance problems can be separated into two general classes:
1. Performance problems due to stiﬀness of a model.
2. Performance problems due to the number of initial value problems.
Consider both performance problem classes with possible technical solutions.
Stiﬀness
As soon as one deals with more than one ﬁrst-order diﬀerential equation, the
possibility of a stiﬀ set of equations arise.CHAPTER 4. MODEL-BASED INFERENCE 116
Deﬁnition 4.10: An initial value problem is called stiﬀ, if it causes numerical
problems while solving it using non-specialised solvers.
This deﬁnition is very vague, but there is no better deﬁnition. Stiﬀness occurs
in a problem where there are two or more very diﬀerent scales of the independent
variable on which the dependent variables are changing. A conventional solver
(such as Runge-Kutta method, see Press et al. (2002)) will require the integration
step size to be reduced to very small values, therefore making very little progress
through the large time intervals required for the solution. Since this problem
was discovered, a number of specialised solvers have been developed to overcome
the performance issues with stiﬀ problems. The most widely used ones are
Rosenbrock methods (see Press et al. 2002), and Bader-Deuﬂhard method (see
Bader and Deuﬂhard 1983).
We use a specialised solver for stiﬀ problems developed in the Lawrence-
Livermore National Laboratory, USA (see Hindmarsh et al. 2005). This solver
is publicly available and demonstrates performance compatible with proprietary
patented algorithms (e.g. ones implemented in Matlab).
Number of Initial Value Problems
While computing the likelihood as in (4.19), it is sometimes possible to com-
pute the predicted values φ(M,θ,xi) for diﬀerent experimental conditions xi in
parallel.
For the model M and the set of model parameters θ, the values of φ(M,θ,xi)
can be computed independently for diﬀerent values of xi. For the case studies
presented in this chapter, we compute such predictions simultaneously using a
distributed computing cluster. The results for separate values of xi are then
combined to produce the overall value of the likelihood function.
Our distributed algorithm runs a number of initial value problem solvers in
parallel on a cluster, submitting the parameter values θ, the models M, and
experimental conditions xi to each of the solvers (see Figure 4.5). The results
from the solvers are then substituted into equation (4.19) to compute the value
of the likelihood.
In a case study considered in Section 4.3.2 this distributed computations
algorithm allowed us to produce the inference results within reasonable time,
while a single threaded version of the inference algorithm was too slow. ForCHAPTER 4. MODEL-BASED INFERENCE 117
Figure 4.5: Distributed algorithm for the likelihood evaluation. The central
sampler submits a proposed set of model parameters to several initial value
problem solvers to evaluate the likelihood in diﬀerent experimental conditions.
The results are then returned to the central sampler where they are multiplied
to produce the overall likelihood. Ri = NDi(φ(M,θ,xi),σi)
each proposed value of model parameters we had to solve eleven initial value
problems to compute the likelihood function. The distributed algorithm allowed
us to solve these initial value problems in parallel. The required communication
overhead, however, impacts the theoretical speedup factor and the practical
beneﬁt of this distributed algorithm is slightly lower than eleven times. In the
case study in Section 4.3.2, the MCMC sampling took about three weeks on a
distributed cluster of 42 workstations able to sustain the average performance
of 5.267 GFLOP/s7.
4.2.3 Parameter Inference
The ﬁrst and core application of the Bayesian inferential methodology is the
inference of model parameters from observed data. Given a parametric model M
with parameters θ, and a set of experimental observations D = {d1,d2,...,dn} in
experimental conditions X = {x1,x2,...,xn}, the goal is to infer the distribution
of parameters θ to reproduce the experimental observations.
We start with the prior distribution of the parameter values p(M,θ). Then
we employ MCMC sampling to produce a sample from the parameter posterior.
The posterior is a parameter distribution learned from the experimental data
taking into account, and updating the prior knowledge.
Consider the details of the inference process:
7A GFLOP/s is a measure of computational system performance equal to a billion ﬂoating
point arithmetical operations per second.CHAPTER 4. MODEL-BASED INFERENCE 118
Prior Probabilities
In the absence of any experimental evidence we note that there is a large amount
of existing literature and subjective knowledge based around studied systems.
This information can be employed in deﬁning the prior probabilities for the
models and the associated parameter values. In the case when the priors are
deﬁned by p(M,θ), we can assume that the choice of the model structure or
systems of equations describing the physical process will not aﬀect a priori the
range of feasible values, and thus the prior, on the associated parameters in this
case p(M,θ) = p(M)p(θ).
Structured priors can now be designed to best reﬂect the levels of subjective
knowledge and uncertainty in the prior beliefs regarding the parameter values.
In many cases such structured priors can be suggested based on the physical
laws involved. In our case studies, we use Gamma distributions to deﬁne the
priors of model parameters, as the laws employed in our models do not allow
negative parameter values. Moreover, these distributions have non-zero density
on all R+, which corresponds to our ignorance about the parameter values.
Posterior Distributions and Predictions
Having made our experimental observations and collected data D, we are in a
position to update our strength of belief in the values of the model parameters a
posteriori. Bayes’ theorem provides us with the required posterior distribution
in terms of our likelihood and prior distributions
p(θ|X,D,M) =
p(D|X,M,θ)p(Mi,θ) R
p(D|X,M,θ)p(Mi,θ)dθ
. (4.21)
This is an important level of inference as now the distribution p(θ|X,D,M)
will provide us with valuable insights into the plausible range of the parame-
ter values within the model. This improves vastly on the maximum likelihood
estimates (see Section 2.8) as the posterior distribution over parameter values
indicates how informative the experimental data has been in reducing our un-
certainty in parameter values.
It also means that predictions on new experimental conditions can be made
from model M, and again we can now integrate over our levels of posteriorCHAPTER 4. MODEL-BASED INFERENCE 119
uncertainty such that
p(Dnew|Xnew,M) =
Z
p(Dnew|Xnew,M,θ)p(θ|X,D,M)dθ '
'
1
N
N X
i=1
p(Dnew|Xnew,M,θi) θi ∼ p(θ|X,D,M).
(4.22)
Now we have a distribution for the predictions and thus consistent levels
of conﬁdence can be assigned based on the above distribution with takes into
account the prior beliefs and how these have been updated in the light of exper-
imental evidence {X,D}.
The problem with multidimensional integrals can be resolved by employing
MCMC sampling from the posterior distributions (see Section 4.1.3).
Parameter Identiﬁability Issues
Non-linear models are motivated by the laws of chemical kinetics, but the in-
creased complexity means that such models, in some cases, become overparam-
eterised. In such situations, some parameters of the model are unidentiﬁable.
In other words, diﬀerent combinations of unidentiﬁable parameters lead to the
same likelihood, making it impossible to select single maximum likelihood esti-
mates of the parameter values. This, however, does not cause a methodological
problem for the Bayesian inferential approach, as all alternative combinations of
non identiﬁable parameters are considered as a part of the parameter posterior.
Considering the hypotheses testing methodology, a consistent framework of
Bayesian inference, as introduced in this chapter, demonstrates a signiﬁcant ad-
vantage over maximum likelihood ratio methods due to considering such alter-
native combinations of parameter values. The identiﬁability issues are properly
addressed when marginal likelihoods are evaluated, as information about the
whole parameter distribution is taken into account. This contributes to the
capability of Bayes factors to implement Occam’s razor concept, as simple mod-
els with less unidentiﬁable parameters will be preferred to unnecessarily more
complex models.
MCMC convergence problems, which are often observed when sampling from
parameter posteriors of non identiﬁable models, can be resolved by adopting an
adaptive proposal distribution idea as discussed in Section 4.1.3.
We conclude that all identiﬁability issues are naturally addressed in theCHAPTER 4. MODEL-BASED INFERENCE 120
Bayesian inferential framework by considering full distributions of parameter
posteriors. The corresponding uncertainty is naturally carried through Bayesian
analysis methods, and can be resolved at the ﬁnal stage if proper informative
prior on all the parameters is speciﬁed. For detailed discussion of this issue, see
(Hills 1987) and (Section 4.5 of Florens et al. 1990).
4.2.4 Hypotheses Testing
Consider the case where there are two competing hypotheses described by models
M1 and M2. We employ Bayes factors (see Section 4.1.4) for model comparison,
i.e.
p(M1|D,X)
p(M2|D,X)
=
p(D|X,M1)p(M1)
p(D|X,M2)p(M2)
(4.23)
In the case when no preference over competing hypotheses is suggested, we
assign equal prior probabilities for both of the alternative models considered
p(M1) = p(M2). These probabilities can, however, be diﬀerent, if the prior
knowledge suggests preference of one hypothesis over another.
Now we can see that to compare our models the marginal likelihood under
each model is required, i.e. for a kth indexed model
p(D|X,Mk) =
Z
θk∈Θ
p(D|X,Mk,θk)p(Mk,θk)dθk. (4.24)
Diﬀerent methods of computing these marginal likelihoods are discussed in Sec-
tion 4.1.5. We will demonstrate some of them in the case studies considered in
Section 4.3.
4.3 Applications to Signal Transduction Path-
ways
In this section we develop our contribution with two case studies which demon-
strate the applications of the Bayesian inference framework implementation. The
ﬁrst case study (Section 4.3.1) investigates alternative hypotheses formulated
with artiﬁcially generated models and uses simulated data for parameter infer-
ence. This case study demonstrates how the Bayesian inference methods can be
applied to ODE models. The second case study (Section 4.3.2) investigates theCHAPTER 4. MODEL-BASED INFERENCE 121
complex problem of testing hypotheses about the structure of a realistic signal
transduction pathway.
4.3.1 Case Study 1: Artiﬁcial Biochemical Networks
In this case study we consider four alternative models of a biochemical sys-
tem. The models are artiﬁcially constructed to demonstrate the essence of the
proposed methodology and demonstrate its main points and advantages on an
example with a known result.
The schematic diagrams for the models are depicted in Figure 4.6. The
entities in circles represent proteins involved in a biochemical network, while
arrows correspond to biochemical reactions. Enzymatic behaviour is indicated
by an arrow with a circle as head. For example, see Figure 4.6(b) where S in an
enzyme for activation of R. Kinetic parameters of the reactions are depicted as
text beside the arrows e.g. k1,V1. These networks represent realistic networks,
and they all have a structure which is very common in nature.
Model 1 This model deﬁnes a common motif of signalling pathways that is
a stage in a signal transduction cascade. The input signal is represented by
the concentration of protein S depicted in the top left of the diagram (see Fig-
ure 4.6(a)). This protein activates the next stage of the cascade by binding to
protein R forming complex RS, and activating R into its phosphorylated form
Rpp. Protein Rpp can then be deactivated. Model 1 also deﬁnes input signal
degradation by converting protein S into its degraded form dS. This is added to
demonstrate a nontrivial quantitative behaviour of the cascade stage.
To perform quantitative analysis of this system we formally describe a model
using ordinary diﬀerential equations. All the proteins used in this model (de-
picted with ellipses in Figure 4.6(a)) will be represented as dependent variables
in our ODE model. As we are interested in modelling and analysis of temporal
behaviour, the independent variable is time.
The dephosphorylation reaction Rpp → R is deﬁned using the Michaelis-
Menten kinetic law, while the rest of the reactions (arrows in Figure 4.6(a)) are
deﬁned using the Mass Action kinetic law with parameters depicted as textual
remarks beside the arrows in model diagram (e.g. k1, k4). The following systemCHAPTER 4. MODEL-BASED INFERENCE 122
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(a) Model 1: A model of a signal trans-
duction cascade. Protein S represents the
input signal. S can degrade to dS. At
the same time S activates protein R from
its inactive state, to an active state Rpp
by binding and activation. Protein Rpp
can then be deactivated. This model was
used to generate the experimental data.
(b) Model 2: A simpliﬁed version of a sig-
nal transduction cascade. It represents
the same process as described by Model
1, but a mechanistic description of the ac-
tivation process is omitted and replaced
with more general functions.
(c) Model 3: A model of a signalling cas-
cade which is signiﬁcantly diﬀerent to the
rest of the models in this case study. This
model does not describe degradation of
protein S. Our goal is to demonstrate that
this model will gain much smaller evi-
dential support at the hypotheses testing
stage.
S dS
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(d) Model 4: An overcomplicated version of
Model 1. This model mechanistically describes
how protein Rpp is deactivated by phosphotase
PhA.
Figure 4.6: Models constructed for Case Study 1.CHAPTER 4. MODEL-BASED INFERENCE 123
of ODEs deﬁnes this model:

           
           
˙ S = −k1 · S − k2 · S · R + k3 · RS + k4 · RS
˙ dS = k1 · S
˙ R = −k2 · S · R + k3 · RS +
V · Rpp
Km + Rpp
˙ RS = k2 · S · R − k3 · RS − k4 · RS
˙ Rpp = k4 · RS −
V · Rpp
Km + Rpp
We ﬁx the initial values for the variables in this model. We could have added
these initial values as additional parameters of our model if inferring these was
required. For demonstration purposes we avoid introducing these as additional
parameters, and deﬁne them as the following:
S|t=0 = 1 dS|t=0 = 0 Rpp|t=0 = 0
R|t=0 = 1 RS|t=0 = 0
This model has six kinetic parameters: k1 ...k4,V,Km.
Model 2 The model depicted in Figure 4.6(b) was constructed as a simpliﬁed
representation of the signal transduction cascade stage. It essentially represents
the same system as deﬁned with Model 1, but uses diﬀerent kinetic laws to deﬁne
reactions.
The system of ODEs used in this model is

        
        
˙ S = −k1 · S
˙ dS = k1 · S
˙ R = −
V1 · R · S
k2 + R
+
V2 · Rpp
k3 + Rpp
˙ Rpp =
V1 · R · S
k2 + R
−
V2 · Rpp
k3 + Rpp
The following initial values were chosen for this model
S|t=0 = 1 R|t=0 = 1
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The model has ﬁve kinetic parameters: k1, k2, k3, V1, V2.
Model 3 The model depicted in Figure 4.6(c) is a version of Model 2 with
degradation of protein S removed. As protein S cannot degrade, we would not
observe any signal decrease in system behaviours, and therefore we would expect
to see behaviours which are signiﬁcantly diﬀerent to the ones produced with other
models in this case study. Our goal for this model is to demonstrate through
hypotheses testing, that this model gains signiﬁcantly smaller evidential support
from data than the rest of the models.
The system of ODEs used in this model is

     
     
˙ S = 0
˙ R = −
V1 · R · S
k1 + R
+
V2 · Rpp
k2 + Rpp
˙ Rpp =
V1 · R · S
k1 + R
−
V2 · Rpp
k2 + Rpp
The following initial values were chosen for this model
S|t=0 = 1 R|t=0 = 1 Rpp|t=0 = 0.
The model has four kinetic parameters: k1, k2, V1, V2.
Model 4 The model depicted in Figure 4.6(d) is an overcomplicated version of
Model 1. Phosphatase PhA depicted in the bottom of the diagram deactivates
protein R. This model was constructed to demonstrate how it would be penalised
for complexity according to Occam’s razor concept in Bayesian hypotheses test-
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The system of ODEs used in this model is

              
              
˙ S = −k1 · S − k2 · S · R + k3 · RS + k4 · RS
˙ dS = k1 · S
˙ R = −k2 · S · R + k3 · RS + k7 · RppPhA
˙ RS = k2 · S · R − k3 · RS − k4 · RS
˙ Rpp = k4 · RS − k5 · Rpp · PhA + k6 · RppPhA
˙ PhA = −k5 · Rpp · PhA + k6 · RppPhA + k7 · RppPhA
˙ RppPhA = k5 · Rpp · PhA − k6 · RppPhA − k7 · RppPhA
The following initial values were chosen for this model
S|t=0 = 1 dS|t=0 = 0 Rpp|t=0 = 0
R|t=0 = 1 RS|t=0 = 0 PhA|t=0 = 1
RppPhA|t=0 = 0
This model has seven kinetic parameters: k1 ...k7.
Data Generation
In this case study we use data artiﬁcially generated from Model 1. To generate
the data we simulated the behaviour of Model 1 with the following values for
kinetic parameters:
k1 = 0.07 k2 = 0.6 k3 = 0.05
k4 = 0.3 V = 0.017 Km = 0.3
by solving an initial value problem, and generated the time series of variable
values (protein concentrations).
We decided to generate a data set for further experiments as a time series of
Rpp values measured at the following time points: t ∈ {2s,5s,10s, 20s,40s, 60s,
100s}. We added observation noise with variance 0.01 to the simulated values
at each of the time points. The data set D contains twenty one samples. The
obtained values are depicted in Figure 4.7.CHAPTER 4. MODEL-BASED INFERENCE 126
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Figure 4.7: Data set generated from Model 1.
Overall Statistical Models
Performing Bayesian inference of model parameters and testing corresponding
hypotheses involves likelihood estimation as deﬁned in Section 4.2. We added
only one additional noise parameter σ to each of the models, because we used
the same noise value when the data was generated. The same noise parameter
will be substituted to the normal distributions placed at each of the time points
when evaluating the likelihood (4.19). The resulting statistical models contain
the parameters given in Table 4.6.
Model Number of Parameters Parameters
Model 1 7 σ, k1 ...k4, V,Km
Model 2 6 σ, k1 ...k3, V1,V2
Model 3 5 σ, k1,k2, V1,V2
Model 4 8 σ, k1 ...k7
Table 4.6: Parameters used in models for Case Study 1.
We discarded any information about the parameter values used to generate
data for our experiments with Model 1; and deﬁned the prior for model parame-
ters. As none of the parameters can take a negative value, we deﬁned the priors
for all of the parameters of all the models to be distributed according to Gamma
distribution Γ(1,3). This prior is depicted in Figure 4.8.CHAPTER 4. MODEL-BASED INFERENCE 127
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Figure 4.8: The shape of the prior distribution density used for all the parameters
in Case Study 1.
Parameter Inference
MCMC sampling from parameter posteriors for all the models was performed.
We used 20 instances of the Metropolis-Hastings sampler in parallel to ensure
that the chains have mixed well before producing the actual sample for the pa-
rameter posteriors. Chain mixing was assessed using a method proposed by Gel-
man et al. (1995)8. An adaptive proposal distribution referenced in Section 4.1.3
was used to achieve faster convergence of Markov chains to the posterior distri-
bution.
200,000 samples were generated from parameter posteriors after convergence
of the chains was achieved9. The posterior for parameters of Model 1 is plotted
in Figure 4.9. The parameter values used for data generation are also indicated
in Figure 4.9, this demonstrates that the parameter posteriors were inferred
correctly.
We can see that the posterior has diverged from the prior, which corresponds
to the fact that some new information has been extracted from the experimental
evidence. This additional information allowed us to update our beliefs, quanti-
tative characteristics of which are expressed with these distributions.
Notice, that the identiﬁed amount of observational noise was somewhat un-
derestimated (posterior mean is at about 0.005, while the value used for data
generation is 0.01). This, however, is not an inference problem, but a charac-
teristic of this particular data set. As at each time point we generated only
8See Section 4.1.3 for more details.
9Convergence of the chains was achieved after about 1,400,000 burn-in samples.CHAPTER 4. MODEL-BASED INFERENCE 128
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(b) Parameter k1 of Model 1
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(c) Parameter k2 of Model 1
 0
 2
 4
 6
 8
 10
 12
 14
 16
 0.15  0.1  0.05  0
p
(
k
3
|
M
1
,
D
)
k3
Posterior
Parameter value used
to generate data
(d) Parameter k3 of Model 1
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(e) Parameter k4 of Model 1
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(f) Parameter V of Model 1
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(g) Parameter Km of Model 1
Figure 4.9: Posterior distribution for kinetic parameters of Model 1.CHAPTER 4. MODEL-BASED INFERENCE 129
three experimental values, the amount of real noise is not necessary equal to the
true standard deviation of the noise generator due to the small sample size. To
prove this we computed the amount of the observational noise, and our results
are listed in Table 4.7. The average amount of the true observational noise is
0.005394 which agrees well with the infered results depicted in Figure 4.9(a).
Time Point Computed standard deviation of the dataset
2 0.0075045
5 0.007388366
10 0.003265294
20 0.005031623
40 0.004247883
60 0.004336995
100 0.005981922
Table 4.7: The true amount of the observational noise in our dataset.
The distributions for parameters in Figure 4.9 are marginalised posterior dis-
tributions, and do not demonstrate the complete picture about the full posterior.
In our case with 7 parameters for Model 110, the full posterior is a distribution
in 7 dimensions. Nevertheless, we can investigate some properties of this poste-
rior, such as its correlation. The resulting correlation matrix indicates possible
dependencies between diﬀerent model parameters. Correlation matrixes11 for all
four of our models are depicted with heat maps in Figures 4.10 – 4.13.
In Figure 4.10 one can see that parameters V and Km, and also k2 and k4 of
Model 1 have high covariance values, and are likely to be dependent. We have
plotted their joint posterior distributions (marginalised from the rest of model
parameters) in Figure 4.14. Indeed, parameters V and Km are two parameters
of the same reaction, and the found dependency is a well known characteristic
of the Michaelis-Menten kinetic law. In the second case, for smaller values of k2
larger values of k4 have been proposed and vice versa. Consider the diagram for
Model 1 in Figure 4.6(a). Parameter k2 is the forward rate of binding protein R
to S to form complex RS, and parameter k4 is the rate of dissociation reaction
for complex RS that produces Rpp and S. Maintaining the inferred dependency
between parameter values allows the system to maintain the same ﬂux from R
10The number of parameters for other models can be found in Table 4.6.
11Absolute values of the correlation coeﬃcients were taken for these matrices, as we are not
interested in the sign of correlation.CHAPTER 4. MODEL-BASED INFERENCE 130
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Figure 4.10: A heat map of the correlation matrix of the parameter posterior
for Model 1.
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Figure 4.11: A heat map of the correlation matrix of the parameter posterior
for Model 2.
to Rpp, that means the inferred dependency can be explained by the laws of
chemical kinetics.
Note that the values for these parameters used for data generation:
k2 = 0.4 k4 = 0.4 V = 0.017 Km = 0.3
lie within the area of high posterior probability density in Figure 4.14.CHAPTER 4. MODEL-BASED INFERENCE 131
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Figure 4.12: A heat map of the correlation matrix of the parameter posterior
for Model 3.
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Figure 4.13: A heat map of the correlation matrix of the parameter posterior
for Model 4.
Predictions
Having obtained samples from the posterior distribution of model parameters
we now can generate predictions for the system behaviour. We consider two
initial conditions for our prediction experiments. The ﬁrst one is exactly the
same condition which was used for data generation. Using the initial values for
variables as deﬁned in model description and parameter values from the identiﬁedCHAPTER 4. MODEL-BASED INFERENCE 132
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Figure 4.14: Joint posterior distribution for parameters of Model 1 inferred from
simulated data.
parameter posterior we produce a family of solutions for the concentration of
Rpp, as we consider it to be the output of the models. The family of predicted
behaviours is depicted in Figure 4.15. The solid line in the middle of each plot
corresponds to the mean of the predicted behaviours family, while two bounding
lines correspond to the standard deviation of the identiﬁed observation noise.
Note, that diﬀerent models predict diﬀerent amounts of such noise.
The predictions made with Models 1, 2 and 4 (see Figures 4.15(a), 4.15(b)
and 4.15(d)) match the data well, while the predictions made with the incorrect
model (Model 3) in Figure 4.15(c) are not capable of reproducing the data
properly. We will perform model comparison using Bayes factors in Section 4.3.1
to decide which one of the models is necessary for faithful modelling.
Additionally, we produce system behaviour predictions for a new experimen-
tal condition. Assume, we are interested in how the system behaves in the case
when we use double the concentration of protein S is used, which corresponds
to two times stronger input signal into our system. To perform these prediction
experiments, we substituted a new initial value for variable S in our initial value
problem:
S|t=0 = 2,
took the parameter values from the identiﬁed parameter posterior, and solved
the new initial value problem 200,000 times producing the predictions for the
concentrations of Rpp. The results of this prediction experiment is depicted inCHAPTER 4. MODEL-BASED INFERENCE 133
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(a) Predictions made with Model 1 (originally used for data generation)
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(b) Predictions made with Model 2 (simpliﬁed one)
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(c) Predictions made with Model 3 (incorrect one)
 0
 0.2
 0.4
 0.6
 0.8
 1
 0  20  40  60  80  100
[
R
p
p
]
Time
(d) Predictions made with Model 4 (overcomplicated one)
Figure 4.15: Predictions for the original experiment used to produce data set D
plotted against original data from data set D.CHAPTER 4. MODEL-BASED INFERENCE 134
Figure 4.16.
Model Comparison
In the ﬁnal stage of our case study, we compute estimates for marginal likeli-
hoods of each of our models, and perform model comparison (and corresponding
hypotheses testing) using Bayes factors.
We compare diﬀerent estimators for marginal likelihoods by computing re-
quired Bayes factors using posterior harmonic means estimator, prior arithmetic
means estimator, Laplace approximations and the annealing-melting integration
(see Section 4.1.5). We use large (about 600,000 each) samples from each dis-
tribution qβ(θ). The chosen schedule for β in annealing-melting integration is
deﬁned as
βi = a
4
i, ai =
i
40
, i = 0...40.
The obtained estimates for the marginal likelihoods for each of the models
using each of the methods are given in Table 4.8.
Once again, an estimator based on annealing-melting integration principles
demonstrates signiﬁcant superiority in the stability of obtained estimates. These
estimates produce the following pairwise Bayes factors for model comparison:
p(M1|D)
p(M2|D)
= 1.636 × 10
7 p(M2|D)
p(M1|D)
= 6.114 × 10
−8
p(M1|D)
p(M3|D)
= 2.377 × 10
20 p(M2|D)
p(M3|D)
= 1.454 × 10
13
p(M1|D)
p(M4|D)
= 5.862 × 10
4 p(M2|D)
p(M4|D)
= 3.584 × 10
−3
p(M3|D)
p(M1|D)
= 4.206 × 10
−21 p(M4|D)
p(M1|D)
= 1.706 × 10
−5
p(M3|D)
p(M2|D)
= 6.880 × 10
−14 p(M4|D)
p(M2|D)
= 2.790 × 10
2
p(M3|D)
p(M4|D)
= 2.466 × 10
−16 p(M4|D)
p(M3|D)
= 4.056 × 10
15
these correspond to the following relative ranking of the four competing models:
p(M1|D) > p(M4|D) > p(M2|D) > p(M3|D)CHAPTER 4. MODEL-BASED INFERENCE 135
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(c) Predictions made with Model 3 (incorrect one)
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(d) Predictions made with Model 4 (overcomplicated one)
Figure 4.16: Predictions for a new experimental condition.CHAPTER 4. MODEL-BASED INFERENCE 136
Prior arithmetic means estimator
Model Estimate mean Standard deviation of the estimate
Model 1 2.89 × 106 5.64 × 106
Model 2 2.40 × 106 3.78 × 106
Model 3 3.35 × 10−1 3.21 × 10−2
Model 4 2.68 × 1010 7.11 × 1010
Posterior harmonic means estimator
Model Estimate mean Standard deviation of the estimate
Model 1 2.03 × 1031 2.46 × 1031
Model 2 2.80 × 1019 1.70 × 1019
Model 3 8.11 4.46
Model 4 1.64 × 1024 1.29 × 1024
Annealing-melting integration
Model Estimate mean Standard deviation of the estimate
Model 1 7.98 × 1019 1.49 × 1019
Model 2 4.87 × 1012 2.82 × 1011
Model 3 3.36 × 10−1 4.47 × 10−3
Model 4 1.36 × 1015 1.27 × 1014
Laplace approximations
Model Estimate mean Standard deviation of the estimate
Model 1 5.85 × 1018 1.91 × 1018
Model 2 1.14 × 1011 2.30 × 1010
Model 3 1.76 × 10−3 1.12 × 10−4
Model 4 4.67 × 1013 4.69 × 1013
Table 4.8: Estimated marginal likelihoods for models in Case Study 1.
The incorrect model (Model 3) gained the smallest evidential support and
its marginal likelihood is dwarfed by the marginal likelihoods of other models.
Model 1, which was used for data generation, has the maximal marginal likeli-
hood, and therefore should be preferred over the rest of the models. Model 4,
which was constructed to be an overcomplicated version of Model 1, has a smaller
marginal likelihood value, and therefore is rated second. This demonstrates that
Bayesian hypotheses testing accounts for the complexity of models, and imple-
ments Occam’s razor principle.
According to the evidence support categories by Kass and Raftery (1995) de-
ﬁned in Table 4.2, the evidence suggests “very strong” preference of the original
Model 1 over the rest of the models.CHAPTER 4. MODEL-BASED INFERENCE 137
An interesting detail is that Laplace approximations based estimate produces
the correct ordering of the models while maintaining second best relative error.
The error, however, grows with the complexity of the model which corresponds
to the known limitations of this estimator.
Applying information criteria approach for hypotheses testing in this case
study produces correct model order when using AIC or BIC. However, DIC fails
dramatically (producing completely inconsistent results with inﬁnite variance of
DIC score) due to the fact that posterior distributions are not normal. DIC
is designed using an assumption that the mode of the posterior distribution
matches its mean, which does not hold in this case.
Summary of Case Study 1
In the ﬁrst case study we considered four alternative models. All the models
were artiﬁcially constructed to allow testing of the proposed methodology on
an example with a known result. We generated the “experimental” data used
for parameter inference from one of the suggested models; selecting the original
model as the most probable one on the model comparison stage, was a crucial
result to demonstrate the correctness of our approach. We demonstrated how
the principle of Occam’s razor works in this framework, as the more complicated
model was not preferred to the original one despite it being capable of reproduc-
ing the experimental data precisely enough. At the same time, the framework
does not blindly select the simplest model, as the simpliﬁed alternative model
was not preferred to the original due to poor likelihood of reproducing the ex-
perimental data. The control experiment using a structurally diﬀerent model
which was not capable of reproducing the general trends of system behaviour
was also successful, as we demonstrated that this model was rated signiﬁcantly
lower than the rest of the alternatives.
Additionally to model comparison (and the underlying hypotheses testing)
we performed parameter inference and behaviour predictions using all of the al-
ternative models. Precisely as we expected, the parameter values used for initial
data simulation were identiﬁed to belong to the high probability parts of the
parameter posterior. The predictions made with the models using the inferred
parameter posteriors demonstrate how model simulation traces reproduce the
experimental data, but at the same time allow us to make predictions and plans
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In the next case study, we apply this inferential approach to a systems biology
problem. The topic is a current problem in signal transduction pathways study
about the structure of the ERK signalling network.
4.3.2 Case Study 2: The ERK Signal Transduction Path-
way
In the second case study we consider an application of Bayesian inference to
an ongoing research investigation. For this research we collaborated with the
research group of Professor M. D. Houslay. Members of Prof. Houslay’s group
performed biochemical experiments in a laboratory, while we conducted the
analysis of the experimental data and assessment of competing hypotheses.
The aim of this case study is to analyse the ERK signal transduction pathway
using diﬀerent biochemical interventions to decide which of the alternative hy-
potheses (presented below) about the pathway topology is better supported by
the experimental evidence. This will allow us to test the alternative hypotheses
about the pathway structure, make better predictions for future experiments,
and will contribute to a better understanding of the underlying pathway.
Biological Background and Pathway Description
Epidermal Growth Factor (EGF) and Nerve Growth Factor (NGF) mediate the
diﬀerent biological processes of cellular proliferation and diﬀerentiation (Marshall
1995). It is known that NGF stimulation produces long term activation of Ex-
tracellular Signal-Regulated Kinase (ERK) whilst EGF provides a transient ac-
tivation of ERK and both eﬀects are mediated through the same ERK pathway
(Marshall 1995 Kao et al. 2001). Both growth factors clearly employ ERK in
a diﬀerent manner to produce either cell diﬀerentiation or proliferation but the
biochemical mechanisms underlying this diversity are unknown. The receptors
for NGF and EGF are diﬀerent and thus may explain why NGF and EGF medi-
ate diﬀerent biological responses. Indeed there are various Ras and Raf isoforms
which may also lead to the observed diﬀerences in response and as both MEK
and ERK are well conserved, they do not contribute to this diﬀerence. We are
motivated to consider the role that the isoforms of Ras and Raf play in these
diﬀerent responses.
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vates B-Raf (York et al. 1998 Wang et al. 2005), each of which directly activates
MEK and subsequently ERK. In (Dhillon et al. 2002) it is observed that c-Raf
is transiently active whilst B-Raf is constantly active. To explain the diﬀerence
between NGF and EGF responses, our hypothesis is that NGF employs c-Raf
and B-Raf to sustain the activation of ERK, whilst EGF employs only c-Raf.
Therefore, if c-Raf is inhibited then we would be able to conﬁrm this hypothesis.
It is known that Protein Kinase A (PKA), which is activated by cyclic adenosine
monophosphate (cAMP), inhibits c-Raf (Wu et al. 1993 Dhillon et al. 2002).
To investigate the ERK pathway our collaborators performed experiments
on PC12 cells generated by Greene and Tischler (1976) from a transplantable
rat adrenal pheochromocytoma line.
It is now appreciated that regulation of degradation of cAMP by cAMP
phosphodiesterases (PDEs) plays a pivotal role in controlling intracellular cAMP
concentrations and crosstalk with signalling pathways such as ERK (Houslay
and Kolch 2000). Eight PDE families are involved in cAMP regulation, with
the PDE3 and PDE4 families performing a dominant role in many cell types.
Here we use cilostamide, a speciﬁc inhibitor of PDE3, to evaluate the eﬀect of
inhibiting cAMP degradation in PC12 cells by PDE3 on the activity status of
ERK.
For this case study, we focused our interest on the activation of the ERK
pathway by EGF which triggers speciﬁcally the proliferation of the cell. The
mechanisms through which EGF activates cell proliferation are not fully under-
stood and other pathways may also be responsible for such regulation. In this
context we consider the cAMP pathway, which activates molecules that have
been shown to be involved in ERK pathway regulation (Houslay and Kolch 2000).
These molecules are PKA and a guanine nucleotide exchange factor (EPAC or
cAMP-GEF). The biologists used a crosstalk between the ERK and the cAMP
pathways to introduce biochemical interventions into the pathway dynamic be-
haviour, and thus were able to collect data which might be useful for model
inference of the ERK signalling pathway.
Working Hypotheses
There are two alternative hypotheses on how the ERK pathway mediates the
phosphorylation of ERK. The ﬁrst one, supported by Brown et al. (2004) and
Schoeberl et al. (2002), considers a single path of ERK activation by EGF sig-CHAPTER 4. MODEL-BASED INFERENCE 140
nalling (see Figure 4.17(a)): EGF → EGFR → Grb2 → SOS → Ras → c-Raf
→ MEK → ERK. An alternative hypothesis, proposed in the paper by Kao
et al. (2001), considers two ways of ERK activation by EGF signalling (see Fig-
ure 4.17(b)). This second hypothesis consider the second way of ERK activation
through the EGF → EGFR → Crk → C3G → Rap1 → B-Raf → MEK → ERK
cascade (right hand path in Figure 4.17(b)). Kao et al. (2001), Brown et al.
(2004), and Schoeberl et al. (2002), we also consider the possibility that Ras
activates B-Raf, as it was demonstrated by Marais et al. (1997).
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(a) Pathway model supported by Brown
et al. (2004) and Schoeberl et al. (2002).
ERK (Extracellular Signal-Regulated Ki-
nase) is at the bottom of the diagram. We
study regulation of this kinase activity by the
pathway depicted above it. EGF (Epidermal
Growth Factor) is at the top of the diagram,
as it initiates the activation of this particular
pathway. This model (and the corresponding
hypothesis) considers only one way of pass-
ing the signal – through the left and only
branch (EGF, EGFR, Grb2, Sos, Ras, c-Raf
or BRaf, MEK and ERK).
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(b) Pathway model supported by Kao et al.
(2001). As in Figure 4.17(a) ERK is at
the bottom of the diagram, and EGF is
at the top. There are two ways of pass-
ing the signal from EGF down to ERK: the
ﬁrst one is through the left branch (EGF,
EGFR, Grb2, Sos, Ras, c-Raf or BRaf, MEK
and ERK) and the second one is through
the right branch (EGF, EGFR, CRK, C3G,
Rap1, BRaf, MEK and ERK).
Figure 4.17: Hypotheses about the topology of the ERK signalling pathway
Crosstalk of the EGF signalling pathway with the cAMP pathway is achieved
through small molecules activated by cAMP. These molecules are PKA and
EPAC (Houslay and Kolch 2000 Baillie and Houslay 2005), and the structure of
the crosstalk is depicted in Figure 4.18. The nature of this crosstalk can take a
variety of diﬀerent forms that are selectively utilised in diﬀerent cell types andCHAPTER 4. MODEL-BASED INFERENCE 141
may lead to cAMP either activating or inhibiting the ERK signalling or both.
Here we model both inhibitory and stimulatory cAMP inputs that are mediated
through c-Raf and B-Raf respectively. Experimentally, biologists demonstrated
that PDE3 activity regulates cAMP input into the ERK signalling pathway in
PC12 cells.
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Figure 4.18: Other processes taking place in the cell can impact signalling
through the ERK pathway. We particularly consider a case when another net-
work of biochemical reactions, called the cAMP pathway, interacts with the
signalling processes in the ERK pathway. cAMP (cyclic adenosine monophos-
phate) is an important second messenger involved in many biological processes.
If the cell is stimulated with speciﬁc drugs targeted to regulate the levels of
cAMP then the dynamics of signalling through the ERK pathway changes. We
use three of such drugs: cilostamide, EPAC agonist and PKA agonist. The
schematic interactions of these drugs with cAMP and the ERK pathway are
depicted in this diagram.
A series of experiments have then been designed to assess the validity of
the single and dual path hypotheses and the experimental data measured is
then employed in devising single and dual path models to objectively assess the
support of each hypothesis.CHAPTER 4. MODEL-BASED INFERENCE 142
Experimental Data
The biologists performed a number of experiments using PC12 cells generated
by Greene and Tischler (1976) from a transplantable rat adrenal pheochromocy-
toma line to investigate the dynamic behaviour of the ERK pathway. To do so,
they measured the activation of ERK by quantifying the phosphorylation of this
molecule using the Western blotting technique (see Voet and Voet 1995). Cells
were starved for 3 hours in serum-free medium prior to any of the experiments.
Then they were pre-treated for 10 minutes with cAMP analogues that activate
speciﬁcally EPAC or PKA. Cilostamide was also used, which is a phosphodi-
esterase inhibitor that increases the level of cAMP within the cell. Next, the
cells were stimulated with EGF for 0, 2, 5, 10, 20 and 40 minutes to activate
the ERK signalling pathway. At the next stage the cells were lysed in lysis
buﬀer containing protease and phosphatase inhibitors. Cell debris was removed
by centrifugation. The protein concentration of each cell lysate was measured
and normalised to the same concentration in each experiment to load the same
amount of protein in each gel. Proteins were separated by NuPAGE R Novex
4-12% Bis-Tris gels electrophoresis and transferred on nitrocellulose membranes
to perform Western blots. The membranes were immunoblotted with speciﬁc
antibody directed against phosphorylated or non-phosphorylated ERK. These
primary antibodies were detected using ﬂuorescent secondary antibodies that
emit at diﬀerent wavelengths. The membranes were analysed using an infrared
scanner (Licor, ODYSSEY) that detects the ﬂuorescent secondary antibodies.
As the infrared scanner is able to scan two bands of the spectrum at the same
time, two diﬀerent antibodies were used on the same gel. The ﬁrst scanned
band (green) corresponds to the total amount of ERK in the cell lysade, and
the second one (red) corresponds to the amount of the phosphorylated from of
ERK. Consequently, the ratio of the phosphorylated form to the total amount
of ERK can be calculated.
EGF stimulation A number of experiments was performed by stimulating
PC12 cells with EGF only. The cells were stimulated for 0, 2, 5, 10, 20 and
40 minutes after being starved for 3 hours in serum-free medium. 100 ng/ml of
EGF was used for stimulation. This experiment was replicated 4 times. The
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Time Experiment 1 Experiment 2 Experiment 3 Experiment 4
0 9.03% 3.78% 3.29% 3.34%
2 7.03% 4.77% 3.78% 2.75%
5 34.49% 34.49% 30.66% 24.31%
10 23.71% 20.26% 34.49% 34.49%
20 9.03% 6.67% 7.41% 5.09%
40 7.90% 5.10% 4.85% 3.91%
Table 4.9: Data for Case Study 2: control set, stimulation with EGF only.
Cilostamide stimulation PC12 cells were used after being starved for 3 hours
in serum-free medium. The cells were then stimulated with Cilostamide (10 µM)
for ten minutes. At the second stage the cells were stimulated with EGF (100
ng/ml) for 0, 2, 5, 10, 20, and 40 minutes. This experiment was replicated 3
times. The results are given in Table 4.10.
Time Experiment 1 Experiment 2 Experiment 3
0 5.04% 4.47% 3.74%
2 6.72% 3.63% 2.22%
5 61.72% 77.92% 52.82%
10 45.93% 87.52% 54.62%
20 16.96% 18.48% 11.11%
40 6.04% 5.96% 4.39%
Table 4.10: Data for Case Study 2: stimulation with Cilostamide and EGF.
A similar experiment was performed when no EGF stimulation was provided,
and only Cilostamide (10 µM) was used. This experiment has shown no activa-
tion of ERK at all.
EPAC agonist stimulation The cells were stimulated with EPAC agonist
(10 µM) for ten minutes. In the second stage the cells were stimulated with
EGF (100 ng/ml) for 0, 2, 5, 10, 20, and 40 minutes. This experiment was
replicated 3 times. The results are given in Table 4.11.
An experiment when no EGF stimulation was provided was also performed,
and only EPAC agonist (10 µM) was used. This experiment has shown no
activation of ERK at all.
PKA agonist stimulation The cells were stimulated with PKA agonist (10
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Time Experiment 1 Experiment 2 Experiment 3
0 3.96% 2.84% 3.92%
2 7.63% 7.57% 6.60%
5 61.12% 56.63% 56.75%
10 39.83% 49.63% 51.54%
20 10.33% 9.00% 6.94%
40 5.40% 4.91% 4.14%
Table 4.11: Data for Case Study 2: stimulation with EPAC agonist and EGF.
(100 ng/ml) for 0, 2, 5, 10, 20, and 40 minutes. This experiment was replicated
3 times. The results are given in Table 4.12.
Time Experiment 1 Experiment 2 Experiment 3
0 4.16% 3.15% 3.40%
2 4.33% 3.19% 3.23%
5 24.69% 27.04% 16.98%
10 16.86% 21.82% 24.87%
20 8.03% 5.41% 4.82%
40 5.87% 4.51% 3.68%
Table 4.12: Data for Case Study 2: stimulation with PKA agonist and EGF.
A similar experiment was also performed when no EGF stimulation was
provided, and only PKA agonist (10 µM) was used. This experiment has shown
no activation of ERK at all.
Cilostamide and EPAC agonist stimulation The cells were stimulated
with EPAC agonist and Cilostamide (10 µM each) for ten minutes. In the
second stage the cells were stimulated with EGF (100 ng/ml) for 0, 2, 5, 10, 20,
and 40 minutes. This experiment was replicated 3 times. The results are given
in Table 4.13.
Cilostamide and PKA agonist stimulation The cells were stimulated with
PKA agonist and Cilostamide (10 µM each) for ten minutes. In the second
stage the cells were stimulated with EGF (100 ng/ml) for 0, 2, 5, 10, 20, and
40 minutes. This experiment was replicated 3 times. The results are given in
Table 4.14.CHAPTER 4. MODEL-BASED INFERENCE 145
Time Experiment 1 Experiment 2 Experiment 3
0 5.89% 3.57% 4.02%
2 22.48% 22.99% 5.09%
5 73.63% 90.76% 66.43%
10 51.31% 46.28% 78.12%
20 10.88% 16.14% 11.64%
40 5.32% 6.84% 4.81%
Table 4.13: Data for Case Study 2: stimulation with EPAC agonist, Cilostamide,
and EGF.
Time Experiment 1 Experiment 2 Experiment 3
0 6.53% 4.16% 2.56%
2 9.73% 6.00% 5.64%
5 78.98% 80.19% 52.69%
10 53.42% 67.72% 49.20%
20 10.27% 12.86% 10.25%
40 8.17% 4.55% 4.23%
Table 4.14: Data for Case Study 2: stimulation with PKA agonist, Cilostamide,
and EGF.
EPAC and PKA agonists stimulation The cells were stimulated with PKA
and EPAC agonists (10 µM each) for ten minutes. In the second stage the cells
were stimulated with EGF (100 ng/ml) for 0, 2, 5, 10, 20, and 40 minutes. This
experiment was replicated 3 times. The results are given in Table 4.15.
Time Experiment 1 Experiment 2 Experiment 3
0 5.06% 4.11% 3.75%
2 10.36% 7.27% 4.77%
5 46.72% 38.85% 30.17%
10 50.00% 32.02% 27.09%
20 10.44% 6.52% 6.02%
40 6.65% 4.04% 4.55%
Table 4.15: Data for Case Study 2: stimulation with EPAC and PKA agonists;
and EGF.
EPAC and PKA agonists, plus Cilostamide stimulation The cells were
stimulated with PKA and EPAC agonists, and Cilostamide (10 µM each) for ten
minutes. In the second stage the cells were stimulated with EGF (100 ng/ml)
for 0, 2, 5, 10, 20, and 40 minutes. We replicated this experiment 3 times. TheCHAPTER 4. MODEL-BASED INFERENCE 146
results are given in Table 4.16.
Time Experiment 1 Experiment 2 Experiment 3
0 6.92% 3.26% 3.51%
2 38.56% 26.06% 20.21%
5 100.00% 64.48% 63.24%
10 73.15% 58.24% 46.89%
20 9.12% 10.23% 9.41%
40 7.00% 6.16% 4.20%
Table 4.16: Data for Case Study 2: stimulation with EPAC and PKA agonists;
Cilostamide and EGF.
Models
Three simpliﬁcations to the pathway models were made. These were done to
reduce the size of the model by removing parts which are not covered by the
experiments described above. The following simpliﬁcations of the models are
adopted:
1. For simpliﬁcation we consider that cilostamide is a direct activator of
EPAC and PKA as it exerts its action solely by increasing cAMP;
2. cAMP itself (along with AMP, and PDE3) will not be considered as a part
of the model, as we have no data available for this part of the pathway;
3. Receptor adaptor proteins activation process will be simpliﬁed (as in Brown
et al.’s (2004) model), and deﬁned as EGFR → Sos → Ras and EGFR →
C3G → Rap1 pathways.
The goal of our analysis is to test the main hypothesis concerning the path-
way: Whether the pathway topology is best described by the utilisation of one
or both branches.
We consider two ODE models (see below: Model 1, Model 2) to test these
hypotheses. Model 1 is deﬁned using only one branch of the pathway, and Model
2 has both branches.
Model 1
This model considers only one path of ERK activation through the pathway
stimulated with EGF. The model topology is depicted in Figure 4.19(a). TheCHAPTER 4. MODEL-BASED INFERENCE 147
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(a) Model 1: The ERK pathway model
with only one activation path deﬁned. Rap1
can still be activated by EPAC, however
there are no reactions which can activate
Rap1 by EGFR receptor.
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(b) Model 2: The ERK pathway model
with two activation paths deﬁned. In this
case Rap1 can be activated by the receptor
through C3G activation.
Figure 4.19: Models used in Case Study 2.
Rap1 → B-Raf → MEK → ERK path is also present in this model, but it cannot
be activated by the receptor.
Model 2
This model considers both paths of ERK activation through the pathway stim-
ulated with EGF. The model topology is depicted in Figure 4.19(b).
The overall statistical models used for inference also include noise parameters
for the likelihood function depicted in equation 4.19. Following the previous
deﬁnitions of the likelihood in Section 4.2, forty-seven noise parameters were
added to each of the models. These noise parameters were inferred from the
data in the same way as the rest of the model parameters.
Non-zero initial concentrations (measured in abstract concentration units, as
no proper calibration is possible when using relative data) used in our models
are:
unboundEGFR|t=0 = 500 inactiveSos|t=0 = 1200 inactiveRas|t=0 = 1200
inactivePKA|t=0 = 1000 inactiveEPAC|t=0 = 1000 inactiveRap1|t=0 = 1200
BRaf|t=0 = 1500 MEK|t=0 = 3000 ERK|t=0 = 10000
Gap|t=0 = 2400 cRaf|t=0 = 1500
We choose the concentrations of drugs used for the experiments as follows:
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are treated with a large amount of EGF to ensure maximal activation. The
concentrations for Cilostamide; EPAC and PKA agonists are chosen to be 100,
which corresponds to the fact that the cells are treated with a tiny amount of
those drugs to ensure that they do not cause signal activation by themselves.
The models are deﬁned in SBML (Hucka et al. 2003) and in average contain
29 species and 28 reactions. They are omitted here due to their size, but elec-
tronically submitted with this theses as supplementary material. The models
can also be obtained from the author.
An application of the Bayesian framework will now be demonstrated to per-
form posterior parameter inference of these models, which in its turn allows
us to generate predictive posterior distributions of the system behaviour taking
the overall underlying uncertainty into account. This analysis is then concluded
with an application of Bayesian Inference for objective model comparison, which
allows testing of the above formulated hypotheses about the pathway topology.
Analysis results
Wide Gamma priors were used for the parameters of our models which corre-
sponds to our ignorance about the parameter values. The important properties
of such Gamma priors are
1. Priors have only positive support, so negative values for the parameters
will not appear in the posterior. This is quite reasonable, given the kinetic
laws used to deﬁne our models.
2. Priors are not limited to the right (unlike uniform priors) and therefore
vary large values for the parameters can be considered during the MCMC
simulation.
A description of the kinetic parameters and corresponding priors are listed
in Appendix A.
We applied our implementation of the Bayesian inference algorithms on a
case study of the ERK signal transduction pathway described above. One of
the important features of the Bayesian inferential machinery is how knowledge
is updated when new experimental evidence is considered. To illustrate this
feature we performed posterior inference over parameters in two stages:
1. Wide Gamma priors for model parameters were used and posterior sam-
pling was performed using a subset of the experimental protocols. TheCHAPTER 4. MODEL-BASED INFERENCE 149
experiments involving PKA agonist stimulation were intentionally omit-
ted. Therefore, the process of PKA activation by the PKA agonist is
not covered with experimental observations. The obtained posterior for
the PKA activation parameter is depicted in Figure 4.20(a) which demon-
strates that the posterior hardly diverged from the uninformative prior,
so from a diagnostic perspective we can assess how informative a suite of
experiments has been about certain parts of the network topology;
2. By including the data from PKA activation by the PKA agonist we see in
Figure 4.20(b) a signiﬁcant divergence of the posterior from the uninformed
prior.
 0  5K  10K  15K  20K
Posterior
Prior
(a) Limited dataset. The posterior dis-
tribution is very similar to the prior dis-
tribution which means that there was
no information in the dataset to update
available knowledge about this parameter
value.
 0  5K  10K  15K  20K
Posterior
Prior
(b) Complete dataset. In this case pos-
terior diverged from the prior in a signif-
icant degree. This means that there was
information which allowed us to identify
the parameter more precisely.
Figure 4.20: Distributions for PKA activation by the PKA agonist parameter
Km.
We also computed the correlation of the posterior samples for both mod-
els. Heat maps of the correlation matrices are depicted in Figure 4.21 and
Figure 4.22.
Bayesian model comparison was performed to assess the proposed hypotheses
about the pathway structure embodied in models 1 and 2. Bayes factors were
computed for hypotheses testing.
The marginal likelihoods for the alternative models were estimated using
annealing-melting integration (see Section 4.1.5):
log(p(D|M1)) = −1355.178 log(p(D|M2)) = −1344.778445CHAPTER 4. MODEL-BASED INFERENCE 150
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Figure 4.21: A heat map of the correlation matrix for the parameter posterior
of Model 1.
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Figure 4.22: A heat map of the correlation matrix for the parameter posterior
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The obtained Bayes factor:
p(D|M1)
p(D|M2)
≈ 3 × 10
−5,
p(D|M2)
p(D|M1)
≈ 32845.
The double logarithm of Bayes factor p(D|M2)/p(D|M1) is approximately 20.8,
which is bigger than 10. This, according to Kass and Raftery (1995) (see Ta-
ble 4.2), suggests “Very Strong” preference of the two-branched pathway topol-
ogy over the single-branched one.
After we identiﬁed two-branched Model 2 to be the best supported one, we
resampled the model parameter values from the identiﬁed posterior distribution
and generated some behavioural predictions using the preferred model. We
simulated two experimental conditions for these predictions as following:
1. Condition 1: The cells are treated with PKA and EPAC agonists for 10
minutes and then stimulated with EGF (Epidermal growth factor). This
corresponds to one of the performed experiments, so we will be able to
compare model predictions to the real data.
2. Condition 2: C3G is knocked out using a speciﬁc siRNA; and the pathway
is stimulated with Epidermal Growth Factor.
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(a) Condition 1: PKA and EPAC ago-
nists + EGF Stimulation. The widest
part of the predicted behaviours distribu-
tion corresponds to a time interval where
no data was collected, and therefore we
still some uncertainty as to how the sys-
tem behaves there.
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(b) Condition 2: C3G knockout + EGF
Stimulation. This is another example of
how the identiﬁed model preserves the
amount of uncertainty, as it predicts a
very wide range of possible behaviours in
such condition.
Figure 4.23: Behaviours predicted with Model 2 using the identiﬁed parameter
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The predictions are depicted in Figure 4.23. The top line corresponds to
the 95% percentile of the predicted behaviours distribution, and the bottom one
to the 5% percentile. The median is depicted with a dashed line between the
percentiles. The widest part of the envelope corresponds to the time intervals
where the model behaviour cannot be predicted with enough certainty. These
time intervals are located in the areas where model behaviour is transient and
changes rapidly. When planning subsequent experiments these time intervals
will be the best candidates in which to perform additional measurements.
We conclude that the proposed experimental condition when C3G knockout
is simulated is a good candidate for subsequent experiments, as reducing the
uncertainty in this condition should signiﬁcantly improve our conﬁdence.
Summary of Case Study 2
In this case study we applied the methods of Bayesian inference to an open prob-
lem in Systems Biology of a realistic size. We employed distributed computations
system to produce samples from the parameter posteriors of the alternative mod-
els of the studied system. Each of the statistical models considered in this Case
Study contains over 100 parameters, which causes performance diﬃculties when
sampling from the parameter posteriors.
We managed to produce the posterior samples, behaviour predictions and
compute Bayes factors for these models. We demonstrated that the experimental
data, collected in the laboratory supervised by Prof. Houslay, supports the
hypotheses of two signalling pathways involvement in this signalling network
signiﬁcantly stronger than the alternative one which considers only one pathway.
This case study, due to its complexity, also helped us to identify problems
and bottlenecks of the proposed methodology. We discuss possible improvements
of the methods in Chapter 5.
4.4 Discussion
In this chapter we have investigated how the methods of Bayesian inference can
be applied to problems in Systems Biology.
We compared alternative methods to perform Bayesian inference and found
that deterministic approximations to the parameter posterior around the max-
imum a posteriori estimate are quite simple to formulate, however, their appli-CHAPTER 4. MODEL-BASED INFERENCE 153
cation is justiﬁed only when the parameter posterior is unimodal and approxi-
mately normal. This condition may not be satisﬁed when dealing with nonlinear
ODE models. And ever though this method produces quite satisfactory results
with some of the models, its correctness and reliability cannot be guaranteed in
a general case.
We selected Markov chain Monte Carlo methods to perform Bayesian infer-
ence over ODE models, as these are the least constrained in applicability. The
practical use of the MCMC samplers, however, exposed a number of technical
challenges which had to be addressed to guarantee proper convergence of the
Markov chains to the target distribution within reasonable time. We employed
parallel sampling of multiple chains with convergence monitoring, and adaptive
proposal distributions to address these technical challenges.
Evidential hypotheses testing in turn presented another methodological chal-
lenge as it requires estimation of the marginal likelihoods integrated over the
whole parameter space. We had to employ the latest developments in applied
statistics, such as thermodynamic integration methods built upon the path sam-
pling ideas) to produce stable (repeatable with small variation of the result)
estimates of the marginal likelihoods. At the same time we have demonstrated
that alternative methods for model comparison, such as information criteria,
cannot guarantee the correct result on a general case due to the methodological
restrictions.
The selected methods were applied to actual problems in Systems Biology,
demonstrating applicability, tractability and the value of the proposed approach.
The results were produced taking the uncertainty of the data and available
knowledge into account; this was not achievable using traditional methods based
on maximum likelihood estimates.
Summary
In this chapter we developed a Bayesian inferential framework to
enable quantitative plausible reasoning about models of biological
systems. The methods of Bayesian inference were demonstrated,
with a discussion about how model parameters can be inferred from
the data, and how diﬀerent models can be compared for evidence
driven hypotheses testing. Through two case studies, we applied
Bayesian inference methods to models of biochemical pathways andCHAPTER 4. MODEL-BASED INFERENCE 154
demonstrated how this approach supports the scientiﬁc method in
biological research.
The ﬁrst case study describes four alternative models of a small bio-
chemical network which were speciﬁcally built to demonstrate the
proposed methods on a small example with a known solution. We
generated the experimental data from the ﬁrst of four proposed mod-
els by adding some noise to the selected parameter values. Then, we
discarded all the information about the parameter values used for
data simulation, and assigned wide Gamma priors to the model pa-
rameters. Parameter posteriors were then inferred using these priors
and the data simulated from the ﬁrst model. Inferred parameter
posteriors for the ﬁrst model essentially support the original values
used for data simulation: this conﬁrms the correctness of the chosen
method. We also performed Bayesian model comparison to test al-
ternative hypotheses expressed with the models. The correct model
gained the most of evidence support from the simulated data.
In Case Study 2, we performed Bayesian inference and analysis of
an open problem. We consider two alternative hypotheses about
the topology of the ERK signalling pathway. The ﬁrst hypothe-
sis assumes that only one of the signalling branches is involved in
passing the signal from the EGF receptor. The second hypothesis
assumes that two parallel branches are used. Starting with wide
uninformative parameter priors, we performed Bayesian inference of
the model parameters; and then estimated a Bayes factor to test
the hypotheses about the pathway topology. The two branched
model has been found to be “signiﬁcantly stronger” (in terms of Kass
and Raftery 1995) supported by the experimental evidence than the
single-branched one.
In both of our case studies we produced possible behaviour predic-
tions from the inferred models.Chapter 5
Conclusions and Further Work
Overview
In this chapter we summarise the contributions of our work, and de-
scribe its limitations. We also discuss the future of our work, includ-
ing possible improvements and extensions to the proposed method-
ology as well as other work which may be inspired by it.
5.1 Conclusions
Reasoning based on available evidence is the foundation for consistent research
in life sciences.
This thesis demonstrates how mathematical models can be used to describe
hypotheses about the structure of biological systems, and how the methods of
probabilistic reasoning and inference can be used to test alternative hypotheses
and perform plausible reasoning in uncertain conditions.
A probabilistic reasoning methodology proposed in Chapter 3 enables quan-
titative logical analysis of models of biological systems. The proposed methodol-
ogy suggests modelling biological systems using continuous time Markov chains.
Probabilistic model checking is used to verify logical properties of biological
models and to produce estimates of system behaviours. The consistency of the
proposed modelling technique is demonstrated as an approximation of ODE so-
lutions. A practical application of the reasoning methodology is demonstrated
on an example involving the RKIP inhibited ERK pathway. The main contri-
butions made in the area of probabilistic modelling and model-based reasoning
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are the following. The problem of faithful stochastic modelling of large chemical
populations is investigated, demonstrating that traditional modelling of indi-
vidual molecules does not perform suﬃciently well. Individual-based models
either lead to enormous state spaces or largely misrepresent the dynamics of
large populations. A population-based modelling approach is proposed, obser-
vational uncertainty is addressed by employing symbolic intervals to abstract
from numerical values for model variables. Behaviour simulation and quan-
titative reasoning about the proposed models is performed using probabilistic
symbolic model checking.
A Bayesian inferential approach to plausible reasoning about models of bi-
ological systems is considered in Chapter 4. A variety of algorithms which im-
plement Bayesian inference methods are investigated and critically compared.
Markov chain Monte Carlo methods are selected as the “gold standard” as these
are based on the least constrained foundations. The most challenging problem
is hypotheses testing using noisy experimental data. This requires the latest
developments in applied statistics, such as path sampling methods, to be used
to obtain stable results. We demonstrated the eﬀectiveness of our methods with
two case studies, one of which is an open problem in Systems Biology.
Our approach enables consideration of uncertain knowledge and data at all
stages, this is not possible using traditional maximum likelihood methods.
Parameter inference for ODE models of biological systems is achieved by
Markov chain Monte Carlo sampling using the Metropolis-Hastings algorithm.
The identiﬁed parameter posteriors are then used to produce model behaviour
predictions, taking the underlying uncertainty about the parameter values into
account. Alternative models which correspond to competing hypotheses about
the system structure are then systematically compared by the evidence support,
evaluated as the marginal (integrated) likelihoods of the experimental data con-
ditioned by each model. The employed hypotheses testing approach is consistent
with the scientiﬁc method paradigm, and implements Occam’s razor principle
which allows the simplest model suﬃciently explaining observed data to be se-
lected.
We demonstrate applications of the proposed Bayesian inferential framework
implementation on two case studies in the area of signal transduction pathways.
The ﬁrst case study operates on artiﬁcially designed models and generated data
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analysis capabilities on simple models where the correct answers are known.
The second case study demonstrates an application of the proposed inferen-
tial methodology to an open problem in Systems Biology. In this study we
perform model parameter inference and consequent hypotheses testing to de-
termine which of the alternative hypotheses about the structure of the ERK
signal transduction pathway is better supported by the evidence collected in a
biochemical laboratory. The models considered in the second case study are sig-
niﬁcantly more complex than the ones traditionally considered in this context.
Many solutions to nontrivial scientiﬁc challenges were investigated and adopted
to enable suﬃcient performance of the inference algorithms. The main solutions
which allowed inference over realistically large models are simulating several
Markov chains in parallel monitoring their convergence to the common target
distribution, use of adaptive proposal distributions which adjust their shape to
match the current approximation to the posterior, use of marginal likelihood
estimator based on thermodynamic integration principles.
The case studies have also demonstrated the main problems and bottlenecks
of the current methods. We will discuss some ideas for improvements and ex-
tensions in the next section.
5.2 Further Work
There are three main areas where the work presented in this thesis can be sig-
niﬁcantly improved or extended.
The ﬁrst opportunity for future improvement is to apply the inferential
methodology discussed in Chapter 4 to the stochastic models of biological sys-
tems proposed in Chapter 3.
As structural models of biological systems deﬁned with the PRISM language
are parametric, it would be beneﬁcial to implement inference methods for such
stochastic models. But since the method for model behaviour prediction de-
scribed in Chapter 3 provides only the mean estimate for system behaviour,
it would not be appropriate to substitute this estimate directly into equation
(4.19) deﬁned in Section 4.2 (see page 112), because this would not address the
variance of such predictions properly. A more sophisticated method of likeli-
hood deﬁnition is required to implement inference over stochastic models. If a
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parameters for these models from experimental data, and consequently evidence-
based model comparison and a sound description of uncertainty for parameter
values. On the other hand, the models identiﬁed with the inferential methodol-
ogy can then be analysed deductively using the reasoning methods discussed in
Chapter 3.
The second area for further improvement is performance of the Monte Carlo
samplers proposed in Chapter 4. Producing a sample from the posterior distri-
bution of model parameters of a nonlinear model in parameter space of many
dimensions is indeed the biggest challenge and the toughest bottleneck for the
methodology proposed in Chapter 4. As mentioned in Section 4.2.2, the analysis
of Case Study 2 (Section 4.3.2), the problem of a realistic size, has taken three
weeks of computing time on a large computer cluster.
We propose to investigate and apply two of the promising methods for im-
proving the sampling performance: Hamiltonian MCMC sampling (MacKay
2003) and population Monte Carlo sampling (Iba 2001). The former method
utilises gradient information to reduce random walk behaviour, and, conse-
quently, to reduce the time required to obtain eﬀectively independent samples
from the posterior distribution. The population-based Monte Carlo methods
are also designed to improve sampling performance by simulating several ran-
dom walks through the parameter space in parallel and allowing such parallel
samplers to share the information about the shape of the target distribution.
Evolutionary Monte Carlo algorithm (Liang and Wong 2001), for example, sim-
ulates a population of parallel Markov chains updating such a population us-
ing genetic operations of mutation and crossover. The chains are embedded at
diﬀerent temperature ladders to incorporate the attractive features of parallel
tempering.
The third option for future extensions is development of a methodology to
utilise expert knowledge for formulation of informative priors which then can be
utilised more eﬀectively (than noninformative ones) in inferential analysis.
When performing Bayesian inference and evidential hypotheses testing it is
required to formulate the prior knowledge ﬁrst. In the work presented in this the-
sis we use only highly uninformed assumptions to formulate the initial knowledge
and corresponding priors. However, using informative priors for the hypotheses
enables utilisation of some additional knowledge when performing the inference.
Such knowledge will then be updated using information from experimental ev-CHAPTER 5. CONCLUSIONS AND FURTHER WORK 159
idence while the inference is performed. An example of an informative prior
can be some information about a plausible model parameter value which can be
estimated using additional experimentation using a diﬀerent technique. In the
case when this kind of more particular information about the parameter value
is available, it is possible to formulate a more complex hypothesis assignment to
the conﬁdence distribution for this parameter: for example, a narrow Gamma
distribution located at the estimated value with variance related to the experi-
mental error. In such a case, the value estimated with an additional technique
is eﬃciently deﬁned as the most likely one, but other values are still taken into
consideration if the experimental evidence strongly suggests alternative options.
Another valuable source of initial knowledge is published biological litera-
ture. The main challenge here, however, is not only to ﬁnd appropriate articles
and formalise the knowledge contained therein, but also to assign proper con-
ﬁdence distributions to the found statements. This problem is quite complex
as there is inconsistent knowledge published in diﬀerent articles, so alternative
hypotheses should be taken into account. In the case where several alternatives
are described in the published literature, we can consider the number of pub-
lications supporting each of the hypotheses as an initial conﬁdence assignment
for the prior. For example, the number of articles found in PubMed1 weighted
with a journal impact factor can be utilised as a relative probability for each of
the hypotheses.
Expert questionnaires can also be used to collect subjective conﬁdence to
formulate informative priors. The experts can be asked to rate the alternative
hypotheses on a semantic scale (saying that they would, for example, strongly
prefer hypotheses X over hypotheses Y). The relative probabilities then can be
assigned to alternative hypotheses on a scale similar to the one proposed in
Table 4.2.
New work which can be developed on the foundation established in this thesis
can be done along the following two directions:
The ﬁrst one is to build upon the predictive possibilities of the uncertain
models, especially the ones with parameter distributions inferred with Bayesian
methodology. The next step in this direction can be investigation of optimal
experimental design methods to suggest the most promising experiments for fu-
ture investigation to be performed ﬁrst. For example, in the cases when two
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alternative hypotheses cannot be distinguished eﬀectively using the available
experimental evidence the predictions can be drawn using each of the alterna-
tive models for a number of future experiments. Then, the experiment which
proposes the largest diﬀerence in the predicted outcomes with diﬀerent mod-
els should be performed ﬁrst as it is likely to provide more valuable data for
hypotheses testing.
The second direction is utilisation of approximate methods either to perform
approximate inference or to guide the MCMC sampler during the initial random
walk, thus optimising sampling performance. For example, Laplace approxima-
tions can be used to perform approximate parameter posterior inference, and
then the approximate posterior distribution can be used as a proposal distri-
bution for the Metropolis-Hastings sampler to produce a sample from the true
posterior more eﬀectively. Another method we plan to consider in our future
work is usage of Gaussian processes (see Rasmussen and Williams 2006 Gibbs
and MacKay 2000) for likelihood approximation. Such likelihood approximation
can serve either as a quick guide for the initial random walk, as a sampling
distribution for a part of particle population in population-based Monte Carlo
methods, or as a proposal distribution for the Metropolis-Hastings sampler.
We plan to investigate possible improvements and usage of approximate
methods, and also to address the issues of optimal experiment design in follow-up
projects to this work.
Summary
Probabilistic methods for model-based reasoning and inference pro-
posed in this thesis address the problem of reasoning and hypotheses
testing for Systems Biology in uncertain conditions.
The main scientiﬁc contributions of this work are
1. A novel population-based stochastic modelling approach is pro-
posed to model biological systems which involve large chemical
populations.
2. Probabilistic reasoning is performed over the proposed stochas-
tic models enabling logical analysis of possible model behaviours.
3. A Bayesian inferential framework implementation is developed
to enable parameter inference and evidential model comparison
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4. Diﬀerent methods for estimation of the marginal likelihoods are
compared, and the method based on annealing-melting integra-
tion is selected and implemented to enable hypotheses testing
using realistically sized nonlinear ODE models to describe al-
ternative hypotheses.
5. The proposed methods are applied to perform modelling, rea-
soning and inference in the area of signal transduction pathways.
The work described in this thesis opens several directions for further
extensions and improvements.Appendix A
Model Parameters for Case
Study 2
The following table deﬁnes the parameters for Model 1 used in Case Study 2:
Table A.1: Parameters for Model 1 in Case Study 2
Parameter
index
Description Prior
1 Sos inhibition by ERKPP, Kcat Γ(1.1111,9.0)
2 Sos inhibition by ERKPP, Km Γ(2.0,3333.0)
3 Sos activation, Kcat Γ(1.1111,9.0)
4 Sos activation, Km Γ(2.0,3333.0)
5 Binding of the EGF to the receptor, for-
ward, mass action k
Γ(1.1111,9.0)
6 Binding of the EGF to the receptor, back-
ward, mass action k
Γ(2.0,3333.0)
7 Sos deactivation, Km Γ(2.0,3333.0)
8 Sos deactivation, V Γ(2.0,3333.0)
9 Ras activation, Kcat Γ(1.1111,9.0)
10 Ras activation, Km Γ(2.0,3333.0)
11 Ras deactivation by Gap, Kcat Γ(1.1111,9.0)
12 Ras deactivation by Gap, Km Γ(2.0,3333.0)
13 cRaf activation, Kcat Γ(1.1111,9.0)
14 cRaf activation, Km Γ(2.0,3333.0)
162APPENDIX A. MODEL PARAMETERS FOR CASE STUDY 2 163
15 cRaf deactivation, Km Γ(2.0,3333.0)
16 cRaf deactivation, V Γ(2.0,3333.0)
17 MEK activation, Kcat Γ(1.1111,9.0)
18 MEK activation, Km Γ(2.0,3333.0)
19 MEK deactivation, Km Γ(2.0,3333.0)
20 MEK deactivation, V Γ(2.0,3333.0)
21 ERK activation, Kcat Γ(1.1111,9.0)
22 ERK activation, Km Γ(2.0,3333.0)
23 cRaf inhibition by PKA, Kcat Γ(1.1111,9.0)
24 cRaf inhibition by PKA, Km Γ(2.0,3333.0)
25 PKA activation by PKA agonist, Kcat Γ(1.1111,9.0)
26 PKA activation by PKA agonist, Km Γ(2.0,3333.0)
27 PKA activation by Cilostamide, Kcat Γ(1.1111,9.0)
28 PKA activation by Cilostamide, Km Γ(2.0,3333.0)
29 PKA deactivation, Km Γ(2.0,3333.0)
30 PKA deactivation, V Γ(2.0,3333.0)
31 EPAC activation by EPAC agonist, Kcat Γ(1.1111,9.0)
32 EPAC activation by EPAC agonist, Km Γ(2.0,3333.0)
33 EPAC activation by Cilostamide, Kcat Γ(1.1111,9.0)
34 EPAC activation by Cilostamide, Km Γ(2.0,3333.0)
35 EPAC deactivation, Km Γ(2.0,3333.0)
36 EPAC deactivation, V Γ(2.0,3333.0)
37 Rap1 activation by EPAC, Kcat Γ(1.1111,9.0)
38 Rap1 activation by EPAC, Km Γ(2.0,3333.0)
39 Rap1 deactivation by Gap, Kcat Γ(1.1111,9.0)
40 Rap1 deactivation by Gap, Km Γ(2.0,3333.0)
41 BRaf activation by Rap1, Kcat Γ(1.1111,9.0)
42 BRaf activation by Rap1, Km Γ(2.0,3333.0)
43 BRaf deactivation, Km Γ(2.0,3333.0)
44 BRaf deactivation, V Γ(2.0,3333.0)
45 MEK activation by BRaf, Kcat Γ(1.1111,9.0)
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47 BRaf activation by Ras, Kcat Γ(1.1111,9.0)
48 BRaf activation by Ras, Km Γ(2.0,3333.0)
49 ERK deactivation, Km Γ(2.0,3333.0)
50 ERK deactivation, V Γ(2.0,3333.0)
The following table deﬁnes the parameters for Model 2 used in Case Study 2:
Table A.2: Parameters for Model 2 in Case Study 2
Parameter
index
Description Prior
1 Sos inhibition by ERKPP, Kcat Γ(1.1111,9.0)
2 Sos inhibition by ERKPP, Km Γ(2.0,3333.0)
3 Sos activation, Kcat Γ(1.1111,9.0)
4 Sos activation, Km Γ(2.0,3333.0)
5 Binding of the EGF to the receptor, for-
ward, mass action k
Γ(1.1111,9.0)
6 Binding of the EGF to the receptor, back-
ward, mass action k
Γ(2.0,3333.0)
7 Sos deactivation, Km Γ(2.0,3333.0)
8 Sos deactivation, V Γ(2.0,3333.0)
9 Ras activation, Kcat Γ(1.1111,9.0)
10 Ras activation, Km Γ(2.0,3333.0)
11 Ras deactivation by Gap, Kcat Γ(1.1111,9.0)
12 Ras deactivation by Gap, Km Γ(2.0,3333.0)
13 cRaf activation, Kcat Γ(1.1111,9.0)
14 cRaf activation, Km Γ(2.0,3333.0)
15 cRaf deactivation, Km Γ(2.0,3333.0)
16 cRaf deactivation, V Γ(2.0,3333.0)
17 MEK activation, Kcat Γ(1.1111,9.0)
18 MEK activation, Km Γ(2.0,3333.0)
19 MEK deactivation, Km Γ(2.0,3333.0)
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21 ERK activation, Kcat Γ(1.1111,9.0)
22 ERK activation, Km Γ(2.0,3333.0)
23 cRaf inhibition by PKA, Kcat Γ(1.1111,9.0)
24 cRaf inhibition by PKA, Km Γ(2.0,3333.0)
25 PKA activation by PKA agonist, Kcat Γ(1.1111,9.0)
26 PKA activation by PKA agonist, Km Γ(2.0,3333.0)
27 PKA activation by Cilostamide, Kcat Γ(1.1111,9.0)
28 PKA activation by Cilostamide, Km Γ(2.0,3333.0)
29 PKA deactivation, Km Γ(2.0,3333.0)
30 PKA deactivation, V Γ(2.0,3333.0)
31 EPAC activation by EPAC agonist, Kcat Γ(1.1111,9.0)
32 EPAC activation by EPAC agonist, Km Γ(2.0,3333.0)
33 EPAC activation by Cilostamide, Kcat Γ(1.1111,9.0)
34 EPAC activation by Cilostamide, Km Γ(2.0,3333.0)
35 EPAC deactivation, Km Γ(2.0,3333.0)
36 EPAC deactivation, V Γ(2.0,3333.0)
37 Rap1 activation by EPAC, Kcat Γ(1.1111,9.0)
38 Rap1 activation by EPAC, Km Γ(2.0,3333.0)
39 Rap1 deactivation by Gap, Kcat Γ(1.1111,9.0)
40 Rap1 deactivation by Gap, Km Γ(2.0,3333.0)
41 BRaf activation by Rap1, Kcat Γ(1.1111,9.0)
42 BRaf activation by Rap1, Km Γ(2.0,3333.0)
43 BRaf deactivation, Km Γ(2.0,3333.0)
44 BRaf deactivation, V Γ(2.0,3333.0)
45 MEK activation by BRaf, Kcat Γ(1.1111,9.0)
46 MEK activation by BRaf, Km Γ(2.0,3333.0)
47 C3G activation, Kcat Γ(1.1111,9.0)
48 C3G activation, Km Γ(2.0,3333.0)
49 C3G deactivation, mass action k Γ(2.0,3333.0)
50 Rap1 activation by C3G, Kcat Γ(1.1111,9.0)
51 Rap1 activation by C3G, Km Γ(2.0,3333.0)
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53 BRaf activation by Ras, Km Γ(2.0,3333.0)
54 ERK deactivation, Km Γ(2.0,3333.0)
55 ERK deactivation, V Γ(2.0,3333.0)
Detailed semantics of these parameters and the kinetic laws used for mod-
elling biochemical reactions can be found in a formal model deﬁnition using
SBML format (see Hucka et al. 2003) which can be obtained from the author.Bibliography
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